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A B S T R A C T
Background
Urinary incontinence is common after radical prostatectomy and can also occur in some circumstances after transurethral resection of the
prostate (TURP). Conservative management includes pelvic floor muscle training with or without biofeedback, electrical stimulation,
extra-corporeal magnetic innervation (ExMI), compression devices (penile clamps), lifestyle changes, or a combination of methods.
Objectives
To determine the effectiveness of conservative management for urinary incontinence up to 12 months after transurethral, suprapubic,
laparoscopic, radical retropubic or perineal prostatectomy, including any single conservative therapy or any combination of conservative
therapies.
Search methods
We searched the Cochrane Incontinence Group Specialised Register (5 February 2014), CENTRAL (2014, Issue 1), EMBASE (January
2010 to Week 3 2014), CINAHL (January 1982 to 18 January 2014), ClinicalTrials.gov and World Health Organization (WHO)
International Clinical Trials Registry Platform (ICTRP) (both searched 29 January 2014), and the reference lists of relevant articles.
Selection criteria
Randomised or quasi-randomised controlled trials evaluating conservative interventions for urinary continence in men after prostate-
ctomy.
Data collection and analysis
Two or more review authors assessed the methodological quality of the trials and abstracted data. We tried to contact several authors
of included studies to obtain extra information.
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Main results
Fifty trialsmet the inclusion criteria, 45 inmen after radical prostatectomy, four trials after TURP and one trial after either operation. The
trials included 4717 men of whom 2736 had an active conservative intervention. There was considerable variation in the interventions,
populations and outcome measures. Data were not available for many of the pre-stated outcomes. Men’s symptoms improved over time
irrespective of management.
There was no evidence from eight trials that pelvic floor muscle training with or without biofeedback was better than control for men
who had urinary incontinence up to 12 months after radical prostatectomy; the quality of the evidence was judged to be moderate (for
example 57% with urinary incontinence in the intervention group versus 62% in the control group, risk ratio (RR) for incontinence
after 12 months 0.85, 95% confidence interval (CI) 0.60 to 1.22). One large multi-centre trial of one-to-one therapy showed no
difference in any urinary or quality of life outcome measures and had narrow CIs. It seems unlikely that men benefit from one-to-one
PFMT therapy after TURP. Individual small trials provided data to suggest that electrical stimulation, external magnetic innervation,
or combinations of treatments might be beneficial but the evidence was limited.
Amongst trials of conservative treatment for all men after radical prostatectomy, aimed at both treatment and prevention, there was
moderate evidence of an overall benefit from pelvic floor muscle training versus control management in terms of reduction of urinary
incontinence (for example 10% with urinary incontinence after one year in the intervention groups versus 32% in the control groups,
RR for urinary incontinence 0.32, 95% CI 0.20 to 0.51). However, this finding was not supported by other data from pad tests. The
findings should be treated with caution because the risk of bias assessment showed methodological limitations.
Men in one trial were more satisfied with one type of external compression device, which had the lowest urine loss, compared to two
others or no treatment. The effect of other conservative interventions such as lifestyle changes remained undetermined as no trials
involving these interventions were identified.
Authors’ conclusions
The value of the various approaches to conservative management of postprostatectomy incontinence after radical prostatectomy remains
uncertain. The evidence is conflicting and therefore rigorous, adequately powered randomised controlled trials (RCTs) which abide by
the principles and recommendations of the CONSORT statement are still needed to obtain a definitive answer. The trials should be
robustly designed to answer specific well constructed research questions and include outcomes which are important from the patient’s
perspective in decision making and are also relevant to the healthcare professionals. Long-term incontinence may be managed by an
external penile clamp, but there are safety problems.
P L A I N L A N G U A G E S U M M A R Y
Conservative management for men with urinary incontinence after prostate surgery
Background information
The prostate is a male sex gland that surrounds the outlet of the bladder. Two main diseases of the prostate (cancer of the prostate, and
benign (non-cancerous) prostatic enlargement) can be treated by surgery but some men suffer leakage of urine (urinary incontinence)
afterwards. Conservative treatments of the leakage such as pelvic floor muscle training with or without biofeedback or anal electrical
stimulation are thought to help men control this leakage.
The main findings of the review
The review of trials found that there was conflicting evidence about the benefit of therapists teaching men to contract their pelvic floor
muscles for either prevention or treatment of urine leakage after radical prostate surgery for cancer. However, information from one
large trial suggested that men do not benefit from seeing a therapist to receive pelvic floor muscle training after transurethral resection
(TURP) for benign prostatic enlargement. Overall, there was insufficient evidence to demonstrate a beneficial effect from pelvic floor
muscle training.
Of three external compression devices tested, one penile clamp seemed to be better than the others.
Adverse effects
This one penile clamp needed to be used cautiously because of safety risks.
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Any limitations of the review
In future updates it may be worth considering two separate reviews, looking separately at ’treatment’ and ’prevention’ trials. More
research that is of better quality is also needed to assess conservative management.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Treatment of UI after radical: PFMT±biofeedback versus no treatment; for postprostatectomy urinary incontinence
Patient or population: patients with postprostatectomy urinary incontinence
Intervention: treatment of UI after radical: PFMT ± biofeedback versus no treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Treatment
of UI after radical: PFMT
±biofeedback versus no
treatment
Number of incontinent
men - after 12 months
623 per 1000 529 per 1000
(374 to 760)
RR 0.85
(0.6 to 1.22)
665
(3 studies)
⊕⊕⊕©
moderate1,2
Urinary
Incontinence Score (ICI-
SF) - after first year
The mean urinary incon-
tinence score (ici-short
form) - after first year
in the intervention groups
was
0.5 lower
(1.35 lower to 0.35
higher)
391
(1 study)
⊕⊕©©
low2,3,4
Adverse events See comment See comment Not estimable 138
(1 study)
⊕⊕⊕⊕
high2,3,5
Economic analysis using
QALY - not reported
See comment See comment Not estimable - See comment
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio4
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Wide CI (0.60 to 1.22)
2 Funnel plot could not be used as there are fewer than 10 trials
3 Not applicable (only one trial)
4 95% CI is very wide (-1.35 to 0.35)
5 Not estimable as the event rate is zero in each arm
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B A C K G R O U N D
Description of the condition
It is not uncommon for men to have urinary incontinence (UI) af-
ter prostatectomy. UI can be divided into three groups of urgency
urinary incontinence (UUI), stress urinary incontinence (SUI) and
mixed urinary incontinence (MUI). UUI is described by the In-
ternational Continence Society (ICS) as the complaint of involun-
tary leakage of urine associated with a sudden desire to void urine
(Altman 2013). SUI is defined as the involuntary leakage of urine
with concurrent coughing, sneezing or physical exertion, whilst
MUI, as the name suggests, is a mixture of the symptoms found
in both of these types (Altman 2013). The reported frequency
varies depending on the type of surgery and surgical technique
(Grise 2001; Peyromaure 2002), the definition and quantification
of incontinence (Grise 2001; Peyromaure 2002), the timing of
the evaluation relative to the surgery, and who evaluates the pres-
ence or absence of incontinence (physician or patient) (Donnellan
1997; McCammon 1999). Furthermore, the costs associated with
UI can be substantial. The annual cost to the National Health
Service (NHS) in the UK for treating clinically significant storage
symptoms in men was estimated to be GBP 303 million (Turner
2004) and the annual direct cost of UI in the US was estimated
to be USD 3.8 billion (Wilson 2001).
The prevalence of UI after radical prostatectomy is widely re-
ported, ranging from 2% to 60%, albeit at varying times after op-
eration (Milsom 2009). For example, in one study at threemonths
after radical prostatectomy (Donnellan 1997) 51% were subjec-
tively wet (self-report) but 36% were wet on pad testing (objective
reporting). By 12months, 20%were subjectively still wet but only
16% were classed as wet using objective criteria.
UI is less common after transurethral resection of the prostate
(TURP) for benign prostate disease (Omar 2014) and most cases
are due to persistent incontinence pre-dating the surgery. Early
UUI affects up to 30% to 40% of men but late SUI is rare affect-
ing less than 0.5% of men (Rassweiler 2006). This is a less inva-
sive operation than a radical prostatectomy and usually does not
involve damage to pelvic nerves. Due to these clinical differences,
we have analysed data relating to TURP separately.
After both types of operation the problem tends to improve with
time, so that it declines and plateaus within one to two years
postoperatively (Hunskaar 2002). However, some men are left
with incontinence that persists for years afterwards.
Continence mechanisms
Urinary continence depends on a complex interaction of smooth
and striated muscle fibres blended together to form the continence
mechanism. Considerable debate has existed in the literature as to
whether incontinence after prostatectomy is due to an effect on the
detrusor (bladder) muscle or on the sphincter, as commonly these
abnormalities coexist (Peyromaure 2002). New detrusor overac-
tivity and intrinsic sphincter deficiency due to sphincteric in-
jury (Ficazzola 1998; Groutz 2000; McGuire 1990) or weakness
(Majoros 2006) are cited as the most important causes of persis-
tent incontinence after radical prostatectomy. Debate continues
on whether detrusor overactivity is a primary or secondary factor.
Whereas some report overactivity as the primary cause of post-
prostatectomy incontinence (Golubuff 1995; Leach 1995) oth-
ers argue strongly that even if other factors play a role, intrinsic
sphincter deficiency is the primary cause of UI after radical prosta-
tectomy (Aboseif 1996; Chao 1995; Groutz 2000; Gudziak 1996;
Kondo 2002; Majoros 2006; Winters 1997).
Risk factors for postprostatectomy UI after radical prostatectomy
include pre-existing abnormalities of detrusor contractility (Leach
1995) and older age (Kondo 2002). This is possibly because in
older men there is evidence of rhabdosphincter atrophy and neural
degeneration (Burnett 1998; Chao 1995). Other risk factors in-
clude previousTURP (Jacobsen 2007); pre-operative radiotherapy
(Kondo 2002; Rainwater 1988); trauma; a spinal cord lesion; new
obstruction due to recurrence, bladder neck contracture, or ure-
thral stricture (Litwiller 1997); Parkinson’s disease (Kondo 2002);
dementia; and medications (Khan 1991). A surgeon’s inadequate
skill and expertise can determine post-operative incontinence rates
(Eastham 1996). In addition, having surgery in a hospital which
performs fewer than 20 radical prostatectomies a year may be a
factor (Albertsen 1997).
After TURP, UI is thought most likely to be due to pre-existing
abnormalities of bladder function, such as poor compliance or
detrusor overactivity, rather than direct sphincter injury (Abrams
1991), possibly because removal of the prostatic tissue removed
some of the protective mechanism for continence.
Description of the intervention
Many of the treatments used in current practice for postprosta-
tectomy UI are ’conservative’, which is usually considered as not
involving drugs or surgery. Treatments such as biofeedback with
surface intra-anal probes are defined as non-invasive in this con-
text, as opposed to surgical interventions. Five categories of con-
servative management are considered in this review, both singly
and in combination when appropriate.
1. Pelvic floor muscle training (PFMT)
This involves any method of training the pelvic floor muscles to
contract. It includes teaching performance of an accurate volun-
tary pelvic floor muscle contraction using biofeedback and co-
ordinating and timing the contraction against increases in intra-
abdominal pressure, often called functional PFMT.
Traditionally, biofeedback involves the use of equipment to pro-
vide visual or auditory feedback about the pelvic floormuscle func-
tion to enable one to train, strengthen and increase endurance and
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co-ordination of the pelvic floor muscle contractions. Simple au-
ditory biofeedback can also be provided by the therapist informing
the patient when a contraction is felt through digital anal exam-
ination during the pelvic floor muscle contraction. Additionally,
pelvic floor muscle contraction electromyography (EMG) can be
used as a surrogate for biofeedback, as well as for measuring the
intra-rectal pressure.
The theoretical basis of PFMT is that repeated, volitional contrac-
tions of selected pelvic floor muscles may improve their strength
and efficiency during periods of increased intra-abdominal pres-
sure and can inhibit detrusor activity. In a systematic review of
the literature on female UI, Berghmans and colleagues noted that
a pelvic floor muscle contraction may raise the urethra and press
it towards the symphysis pubis, prevent urethral descent, and im-
prove structural support of the pelvic organs (Berghmans 1998).
They further pointed out that PFMTmay result in hypertrophy of
the peri-urethral striated muscles thereby increasing the ’external
mechanical pressure’ on the urethra.
2. Electrical stimulation (non-invasive) delivered via
surface electrodes
Electrical stimulation (ES) works by activating the motor fibres of
the pudendal nerve, which can result in contraction of the pelvic
floor muscles or the striated peri-urethral musculature, support-
ing the intrinsic part of the urethral sphincter closing mechanism
(Berghmans 2013). This may be important in the management of
men with SUI by stimulating the intrinsic sphincter, strengthen-
ing the pelvic muscles and raising the patient’s awareness of these
muscles in a similar way to biofeedback. ES can also be helpful in
men with detrusor overactivity or UUI because it can stimulate
afferent fibres of the pudendal nerve, decreasing the sensation of
urgency and inhibiting parasympathetic activity which results in a
decrease in involuntary detrusor contractions (Berghmans 2013).
Two types of non-invasive ES are detailed below. The parameters
of the ES used in studies vary depending on the type of UI and
ES. Parameters include pulse width and duration, current inten-
sity, stimulus frequency, current source, pulse shape, duration of
treatment and total number of sessions, and rest to work ratio.
Anal electrical stimulation (ES)
Any type of ES using a non-invasive surface anal probe designed
for the therapy. The intention of ES is to facilitate contraction of
the peri-urethral striated muscle by inserting the probe into the
anal canal (Jabs 2001).
Sticky patch electrodes, also called transcutaneous electrical
nerve stimulation (TENS)
TENS is a low intensity, sensory nerve stimulation used for de-
trusor overactivity. It is delivered at various sites using patch elec-
trodes. Sites include the sacral dermatomes, dorsal penile nerve,
hamstring and quadriceps muscle, and the posterior tibial or per-
ineal nerves (Berghmans 2013).
3. Lifestyle adjustment
This includes fluid adjustment, healthy diet, avoiding excessive
caffeine, physical exercise, weight loss and cessation of smoking.
4. Extra-corporeal magnetic innervation
This involves the use of a magnetic chair to stimulate contraction
of the pelvic floor muscles and sacral nerve roots, without the
discomfort of inserting an anal probe (Galloway 2000).
5. External penile compression devices (penile
clamps)
These devices use an external clamp to achieve non-surgical com-
pression of the urethra.
Timing of the intervention
Conservative treatment can be started before or after surgery. In
general, when it is delivered to all men (whether before or after)
the aim is to prevent the development or persistence of UI. We
have therefore distinguished between treatment of all men who
do have UI (treatment) as opposed to a mixed population of men
some of whom do not have UI (prevention).
How the intervention might work
All of these interventions, apart from lifestyle adjustment and a
penile clamp, work by inducing contraction of pelvic muscles to
increase their strength and efficiency, whilst improving co-ordina-
tion and bladder control by inhibiting overactive detrusor activity.
Repetitive contractions can raise urethral closure pressure at rest
and during an increase in intra-abdominal pressure.
Why it is important to do this review
The uncertainty about the benefit of conservative treatment for
men with UI after prostate surgery was confirmed in the initial
Cochrane review, first published in 1999 (Moore 1999b) and up-
dated in 2001 (Moore 2001). The review originally only con-
sidered post-operative PFMT, biofeedback and electrical stimula-
tion. In a subsequent update (Hunter 2004) the review was broad-
ened to include trials evaluating lifestyle adjustment, external pe-
nile compression devices and extracorporealmagnetic innervation.
The most recent update also included trials on men after TURP
(Hunter 2007) but still did not provide reliable evidence on the
effects of conservative treatment. The current update includes 13
new trials.
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O B J E C T I V E S
To determine the effectiveness of conservative management for
urinary incontinence (UI) up to 12 months after transurethral or
radical retropubic prostatectomy, including any single conservative
therapy or any combination of conservative therapies.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials and quasi-randomised trials of con-
servative management to prevent or treat UI after TURP or radical
prostatectomy were included. Trials were included if they used any
single conservative therapy or any combination of conservative
therapies. Other forms of clinical trials were excluded. Analysis
of trials in men having radical prostatectomy was done separately
from those in men having a TURP.
Types of participants
Adult men with UI following prostatectomy.
Types of interventions
PFMT; biofeedback (verbal ormachine-mediated); electrical stim-
ulation (ES) via a surface electrode (e.g. anal probe ES, sticky patch
electrode, transcutaneous electrical nerve stimulation (TENS));
extra-corporeal magnetic innervation (ExMI); lifestyle adjust-
ment; and external penile compression devices. These interven-
tions could be compared with no treatment or with each other,
alone or in combination.
The following comparisonsweremade for treatment or prevention
of UI after prostatectomy.
Radical prostatectomy
Treatment (of men with UI after radical prostatectomy)
(1) Treatment of UI after radical prostatectomy: PFMT plus or
minus biofeedback versus no treatment or sham therapy or verbal
instruction
(2) Treatment of UI after radical prostatectomy: electric or mag-
netic energy (e.g. anal ES (EStim), perineal ES, transcutaneous
electrical nerve stimulation (TENS), extra-corporeal magnetic in-
nervation (ExMI)) versus no treatment or sham treatment
(3) Treatment of UI after radical prostatectomy: lifestyle interven-
tions versus no treatment or sham treatment
(4) Treatment of UI after radical prostatectomy: combinations of
treatments versus no treatment or sham treatment
(5) Treatment of UI after radical prostatectomy: one treatment
versus another active treatment
Prevention (of UI in men after radical prostatectomy)
(6) Prevention of UI after radical prostatectomy: PFMT plus or
minus biofeedback versus no treatment or sham therapy or verbal
instruction
(7) Prevention of UI after radical prostatectomy: electric or mag-
netic energy (e.g. anal ES (EStim), perineal ES, TENS, extra-cor-
poreal magnetic innervation (ExMI)) versus no treatment or sham
treatment
(8) Prevention of UI after radical prostatectomy: lifestyle inter-
ventions versus no treatment or sham treatment
(9) Prevention of UI after radical prostatectomy: combinations of
treatments versus no treatment or sham treatment
(10) Prevention of UI after radical prostatectomy: one treatment
versus another active treatment
TURP
Treatment (of men with UI after TURP)
(11) Treatment of UI after TURP: PFMT plus or minus biofeed-
back versus no treatment or sham therapy or verbal instruction
(12) Treatment of UI after TURP: electric or magnetic energy (e.g.
anal ES (EStim), perineal ES, TENS, extra-corporeal magnetic
innervation (ExMI)) versus no treatment or sham treatment
(13) Treatment of UI after TURP: lifestyle interventions versus
no treatment or sham treatment
(14) Treatment of UI after TURP: combinations of treatments
versus no treatment or sham treatment
(15) Treatment of UI after TURP: one treatment versus another
active treatment
Prevention (of UI in men after TURP)
(16) Prevention of UI after TURP: pre or post-operative PFMT
plus or minus biofeedback versus no treatment or sham therapy
or verbal instruction
(17) Prevention of UI after TURP: electric or magnetic energy
(e.g. anal ES (EStim), perineal ES, TENS,extra-corporeal mag-
netic innervation (ExMI)) versus no treatment or sham treatment
(18) Prevention of UI after TURP: lifestyle interventions versus
no treatment or sham treatment
(19) Prevention of UI after TURP: combinations of treatments
versus no treatment or sham treatment
(20) Prevention of UI after TURP: one treatment versus another
active treatment
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Containment of urinary incontinence (UI) from any cause
(21) External penile compression devices (penile clamps) versus
no treatment or sham treatment
We have not listed all possible comparisons here. As and when new
trials address new comparisons these will be added to the review.
Pharmacological agents will be considered in separate reviews. Ver-
bal or written instructions, as well as sham therapy, were consid-
ered as ’no treatment’. The use of the term ’sham therapy’ in this
review meant any therapy that could not influence the pelvic floor
muscles such as placing an ES probe in the anus but not turning
it on.
Types of outcome measures
Primary outcomes
• Number of men reporting urinary incontinence (UI) after
12 months
• Quality of life assessed using the International Consultation
on Incontinence Questionnaire Urinary Incontinence Short
Form (ICIQ-UI-SF) or (ICIQ-SF)
• Number of men reporting adverse effects
Secondary outcomes
1. Participant reported observations
• Number of men reporting UI (number not cured, in the
short, medium or long term)
• Number of men with no improvement in UI (number not
cured or improved)
• Self-report of satisfaction with method
• Compliance
2. Quantification of symptoms
• Standardised pad test (24 hour or 1 hour) measuring grams
of urine lost
• Frequency of micturitions per 24 hours
• Number of pad or clothing changes (pad changes per 24
hours)
• Frequency of UI from self-report or diary (incontinent
episodes per 24 hours)
3. Clinician reported urinary outcome measures
• Objective or observed leakage
• Urodynamic outcome measures
4. Quality of life
• Impact of UI e.g. Incontinence Impact Questionnaire
(Uebersax 1995)
• General health status e.g. Short Form 36 (Ware 1993)
5. Adverse effects
• Pain or discomfort
• Other adverse outcomes as reported by individual trials and
judged to be important
6. Health economics outcomes
• Cost of intervention
• Resource implications of differences in outcome
• Cost effective analysis
7. Other outcomes
• Non-prespecified outcomes judged important when
performing the review
The quality of evidence was assessed using the Grading of Recom-
mendations Assessment, Development and Evaluation (GRADE)
approach (Guyatt 2011a; Guyatt 2011b; Guyatt 2013; Guyatt
2013a). This approach divides the quality of evidence into four
categories: high, moderate, low and very low. Randomised con-
trolled trials (RCTs) start as high quality evidence and non-ran-
domised trials begin as low quality evidence. The quality of evi-
dence can be rated down for RCTs and up or down for non-RCTs
depending on predefined characteristics. The factors considered
when assessing the quality of evidence included:
1. limitations in study design and implementation;
2. indirectness of evidence;
3. unexplained heterogeneity or inconsistency of results;
4. imprecision of results;
5. high probability of publication bias.
Primary and secondary outcomes were classified as critical, impor-
tant or not important for decision making from theman’s perspec-
tive. The GRADE working group strongly advises a maximum of
seven outcomes in a systematic review (Guyatt 2011a). The critical
outcomes for assessing quality of evidence included in this review
were:
1. number of men reporting UI after 12 months;
2. quality of life assessed using the ICIQ-UI-SF;
3. number of men reporting adverse effects;
4. cost effective analysis.
Search methods for identification of studies
We did not impose any language or other limits on the searches.
Details of the searchmethods used for the previous versions of this
review can be found in Appendix 1 and Appendix 2.
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Electronic searches
This review has drawn on the search strategy developed for the
Incontinence Review Group. Relevant trials were identified from
the Incontinence Review Group Specialised Register of controlled
trials which is described, along with the Group’s search strategy, in
the Incontinence Group’s module in The Cochrane Library. The
register contains trials identified from the Cochrane Central Reg-
ister of Controlled Trials (CENTRAL), MEDLINE, MEDLINE
In-Process, andhandsearching of journals and conference proceed-
ings. The Incontinence Group Specialised Register was searched
using the Group’s own keyword system; the search terms used
were:
({design.cct*} OR {design.rct*})
AND
({topic.urine.incon.postprost*})
(All searches were of the keyword field of Reference Manager
2012).
The date of the most recent search of the Specialised Register for
this review was 5 February 2014. Most of the trials in the Incon-
tinence Group Specialised Register are also contained in CEN-
TRAL.
Specific searches were also performed for this update of the review.
• CENTRAL (OvidSP) (2014, Issue 1) was searched on 26
February 2014.
• EMBASE (OvidSP) (January 2010 to Week 3 2014) was
searched on 20 January 2014.
• CINAHL (EBSCOhost) (January 1982 to 18 January
2014) was searched on 22 January 2014.
• ClinicalTrials.gov (via the Cochrane Register of Studies
(CRS) interface) and World Health Organization (WHO)
International Clinical Trials Registry Platform (ICTRP) (both
searched on 29 January 2014).
The strategies used to search these databases can be found in
Appendix 3.
Searching other resources
Reference lists of relevant articles
The reference lists of relevant articles were searched for other pos-
sibly relevant trials.
Contact with investigators in the field
We contacted investigators to ask for other possibly relevant trials,
published or unpublished.
Data collection and analysis
Comparisons of the outcomes of the chosen interventions with no
treatment, with each other, and in combination were planned a
priori for the reviewupdate.Datawere not available for all planned
comparisons. Therewas considerable diversity in the length of time
interventions were carried out for and in the timing of outcome
measurements relative to randomisation. The data were therefore
reported at three monthly time points.
Selection of studies
The list of abstracts for each update was reviewed independently
by two review authors and results compared. The full text arti-
cles of references or abstracts identified as potentially relevant by
either review author were retrieved and reviewed by both. Refer-
ence lists of relevant review articles were reviewed to identify any
further trials. References were assessed based on the population,
interventions, control management, outcomes and overall study
design. Using the full texts of the potentially relevant published
studies and abstracts, the same two review authors independently
reviewed the studies for relevance and inclusion. Authorswere con-
tacted for further data or clarification of methods. Disagreements
were resolved through discussion; third party arbitration was not
required.
Attempts were made to contact authors of trial reports if clarifica-
tion was necessary. Studies were excluded from the review if they
made comparisons other than those pre-specified or if data were
unavailable. Excluded studies were listed with reasons for their ex-
clusion.
Data extraction and management
Data for the trials were extracted independently by two review
authors using a standard form developed for this purpose. The
following information was included:
• study method and characteristics (design, method of
randomisation, inclusion and exclusion criteria, withdrawals and
dropouts);
• participants (type of surgery, age, timing of randomisation,
baseline incontinence or not);
• type of intervention, timing (before or after surgery, or
both) and duration of therapy, co-interventions;
• control (no treatment or sham therapy or other active
treatment);
• outcomes (types of outcome measures, reported outcomes,
adverse events).
Extracted datawere compared by two review authors for complete-
ness and accuracy, and cross-checked by another review author
if necessary. Disagreements were resolved through discussion and
review of the trial report. New data were entered using RevMan5
software.
Assessment of risk of bias in included studies
The risk of bias of the trials was assessed using the Cochrane ’risk
of bias’ tool.
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The following methodological parameters were recorded:
1) identification of study as randomised or quasi-randomised;
2) description of inclusion and exclusion criteria;
3) potential for selection bias (method of sequence generation,
adequacy of random allocation concealment) rating;
4) potential for bias around the time of treatment or during out-
come assessment (blinding of participants, personnel, outcome as-
sessors);
5) potential for selection bias in the analysis (description of with-
drawals, dropouts, participants lost to follow up, analysis based on
intention to treat).
Measures of treatment effect
Analyses were based on available data from all included trials that
were relevant to the comparisons and outcomes of interest. Meta-
analysis was undertaken where data were available frommore than
one study assessing the same outcome. A fixed-effect model was
used for calculations of pooled estimates and their 95% confidence
intervals (CIs), or a random-effects model if there was heterogene-
ity. For categorical outcomes we related the numbers reporting an
outcome to the numbers at risk in each group to calculate a risk
ratio (RR) with 95% CI. For continuous variables we used means
and standard deviations to calculate a mean difference (MD) with
95% CI. If similar outcomes were reported on different scales, we
calculated the standardised mean difference (SMD). We reversed
the direction of effect if needed to ensure consistency across trials.
If data to calculate RRs or MDs were not given, we utilised the
most detailed numerical data available to calculate the actual num-
bers or means and standard deviations (for example test statistics,
P values).
Unit of analysis issues
The primary analysis was per man randomised.
Dealing with missing data
Analysis of the data was on an intention-to-treat basis to the fur-
thest possible extent. This meant all participants were analysed in
the groups to which they were randomised. If this was not the
case, we considered whether to exclude the trial. Attempts were
made to obtain missing data from the original trialists. However,
if this was not possible data were reported as given in the stud-
ies, except if there was evidence of differential loss to follow up
from the randomised groups. In that case, the use of imputation of
missing data was considered. If trials reported sufficient detail to
calculateMDs but gave no information on the associated standard
deviation (SD), the outcome was assumed to have a SD equal to
the highest SD from other trials within the same analysis.
Assessment of heterogeneity
Trials were only combined if they were thought to be clinically
similar. We assessed heterogeneity between studies by visual in-
spection of plots of the data, the Chi2 test for heterogeneity and
I2statistic (Higgins 2011). We used the thresholds for interpreta-
tion of the I2 statistic in accordance with the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2003).
Assessment of reporting biases
Due to the difficulty of detecting and correcting for publication
bias and other reporting biases, the authors aimed to minimise
their potential impact by ensuring a comprehensive search for
eligible studies and by being careful to watch for duplication of
data. Funnel plots could not be utilised because there were fewer
than 10 trials in each meta-analysis.
Data synthesis
Included trial data were processed as described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
For dichotomous outcomes, data were summarised (for example
number of people for whom an outcome is present or not) and
risk ratios (RR) calculated with their 95% CIs. For continuous
outcomes, each trial was summarised using the mean value for
each group and SD, and combined as mean difference (MD) if the
same scale (for example pad test in grams of urine) was used for
the outcome measurement in more than one trial. A fixed-effect
model was used to calculate the summary statistic and the 95%
CI. Heterogeneity was assessed visually and using the Chi2 test for
heterogeneity and the I2 statistic (Higgins 2003). Forest plots were
examined and potential sources influencing heterogeneity identi-
fied. Possible sources of heterogeneity were explored statistically
through subgroup analysis. Where synthesis was deemed not ap-
propriate, a narrative overview was planned.
Trials were combined if interventionswere based on similar clinical
criteria. To combine trial data, a meta-analysis was conducted and
a fixed-effect model approach to the analysis was utilised unless
there was evidence of heterogeneity across studies, in which case
a random-effects model was used.
Subgroup analysis and investigation of heterogeneity
We planned to perform subgroup analysis based on cancer stage
but there were not enough data.
Sensitivity analysis
We planned to perform sensitivity analysis to investigate the effect
of including or excluding trials at high risk of bias, however not
enough trials were in the meta-analysis.
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R E S U L T S
Description of studies
Results of the search
For the current update (2014) of the review 764 possibly relevant
articles and abstracts were identified. Sources and numbers of po-
tentially eligible titles were:
• Incontinence Review Group Specialised Register (193);
• CENTRAL (37);
• updated search of EMBASE (354);
• CINAHL (23);
• ClinicalTrials.gov (125);
• WHO ICTRP (32).
Overall 96 reports of 50 studies were included in the qualitative
synthesis. Fifty-nine reports of 27 studies were included in the
quantitative synthesis. Four trials are awaiting further information
from the authors (Crivellaro 2011; Delmastro 2010; Lilli 2006
NEW; Zhang 2007) and eight trials are ongoing (Burnett 2012;
Burnett 2013; Fode 2012 NEW; Goode 2014; Mina 2013; Ng
2011; Terrone 2007; Zopf 2012).
Forty-one reports of 36 studies were excluded and reasons are given
in the ’Characteristics of excluded studies’ table. The flow of the
literature through the assessment process is shown in the PRISMA
study flow chart (Figure 1).
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Figure 1. PRISMA study flow diagram.
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New included trials
After abstract and full text screening 13 relevant new trials (Ahmed
2012; Dijkstra-Eshuis 2013; Fader 2013; Fode 2014; Geraerts
2013; Ghanem 2013; Hou 2013; Laurienzo 2013; Marchiori
2010; Martini 2011; Morihiro 2011; Park 2012; Tienforti 2012)
were identified. We also identified 12 new reports of the trials
which were already identified in the previous update (Campbell
2012). The trialists were contacted for additional information and
data.
One previously included trial published as an abstract was updated
with data from a full publication (Centemero 2009).
Included studies
Types of populations
The trials included 4717 men, of whom 2736 had an active con-
servative intervention.
Surgery
Forty-five trials involved patients undergoing radical prostatec-
tomy (Ahmed 2012; Bales 2000; Burgio 2006; Centemero 2009;
Dijkstra-Eshuis 2013; Dubbelman 2004; Fader 2013; Filocamo
2005; Floratos 2002; Fode 2014; Franke 1998; Geraerts 2013;
Ghanem 2013; Glazener RP 2011; Goode 2009;Hoffman 2005;
Koo2009;Laurienzo 2013;Liu 2008;Manassero 2007;Marchiori
2010; Mariotti 2009; Martini 2011; Mathewson-Chapman 97;
Moore 1999;Moore 2004;Moore 2008;Morihiro 2011; Nowak
2007; Opsomer 1994; Overgard 2008; Park 2012; Parekh 2003;
Perissinotto 2008;Ribeiro 2008;Robinson 2008;Robinson 2009;
Seleme 2008; Tienforti 2012; Tobia 2008; van Kampen 1998;
Wille 2003; Yamanishi 2006; Yokoyama 2004; Zhang 2007).
One very small trial included one patient having a TURP while
the rest were radical prostatectomy patients (Joseph 2000) but
this was included in the radical prostatectomy group for analysis.
Also, as all the men in this trial were incontinent for some time
after surgery, they may have represented a group with persistent
(longer than one to two years) UI. There were many potentially
confounding variables in this trial, acknowledged by the author.
Four trials involved patients after TURP (Glazener TURP 2011;
Hou 2013; Porru 2001; Tibaek 2007).
The trials involving post-TURP patients only (Glazener TURP
2011; Hou 2013; Porru 2001; Tibaek 2007) were analysed sepa-
rately from the trials amongst men having radical prostatectomy.
Continence status of populations
There was variation in continence status, which led to differ-
ent populations being studied separately: those with persistent
UI and those with all men undergoing surgery (many of whom
were likely to recover continence spontaneously). The compar-
isons were therefore structured to reflect this: trials which included
only men with post-operative incontinence were deemed to be
trials of treatment, while trials in which all men were treated (irre-
spective of continence status) were deemed to be trials of preven-
tion.
• Twenty-three treatment trials enrolled only men with post-
operative UI (diagnosis of UI varied with recruitment time)
(Dubbelman 2004; Fader 2013; Floratos 2002; Franke 1998;
Glazener RP 2011; Glazener TURP 2011; Goode 2009;
Hoffman 2005; Joseph 2000; Koo 2009; Liu 2008; Manassero
2007; Marchiori 2010; Moore 1999; Moore 2004; Moore 2008;
Opsomer 1994; Robinson 2009; Seleme 2008; van Kampen
1998; Yamanishi 2006; Yokoyama 2004; Zhang 2007).
• Twenty-seven prevention trials included all men who
underwent surgery, some of whom m.ay have been dry or
become dry spontaneously (Ahmed 2012; Bales 2000; Burgio
2006; Centemero 2009; Dijkstra-Eshuis 2013; Filocamo 2005;
Fode 2014; Geraerts 2013; Ghanem 2013; Hou 2013; Laurienzo
2013; Mariotti 2009; Martini 2011; Mathewson-Chapman 97;
Morihiro 2011; Nowak 2007; Overgard 2008; Park 2012; Parekh
2003; Perissinotto 2008; Porru 2001; Ribeiro 2008; Robinson
2008; Tibaek 2007; Tienforti 2012; Tobia 2008; Wille 2003).
Timing of recruitment
As the populations and the type and timing of interventions varied
so greatly among the trials, the decision was made by the authors
to also identify the timing of the recruitment to the trials and the
timing of the intervention (before or after surgery):
• only post-operative treatment for UI (Ahmed 2012;
Dubbelman 2004; Floratos 2002; Franke 1998; Glazener RP
2011; Glazener TURP 2011; Goode 2009; Hoffman 2005; Hou
2013; Joseph 2000; Koo 2009; Liu 2008; Manassero 2007;
Marchiori 2010; Mariotti 2009; Moore 1999; Moore 2008;
Morihiro 2011; Nowak 2007; Overgard 2008; Park 2012;
Ribeiro 2008; Robinson 2009; Seleme 2008; van Kampen 1998;
Yokoyama 2004; Zhang 2007) or containment (Fader 2013;
Moore 2004); and
• pre-operative recruitment of all men undergoing surgery,
which included a pre-operative intervention with or without a
post-operative intervention (Bales 2000; Burgio 2006;
Centemero 2009; Dijkstra-Eshuis 2013; Filocamo 2005; Fode
2014; Geraerts 2013; Ghanem 2013; Laurienzo 2013; Martini
2011; Mathewson-Chapman 97; Parekh 2003; Perissinotto
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2008; Porru 2001; Robinson 2008; Tibaek 2007; Tienforti
2012; Tobia 2008; Wille 2003; Yamanishi 2006).
Time of recruitment of participants to the trial relative to the time
of their surgery also varied:
• pre-operatively (Ahmed 2012; Bales 2000; Burgio 2006;
Centemero 2009; Dijkstra-Eshuis 2013; Fode 2014; Geraerts
2013; Ghanem 2013; Hou 2013; Laurienzo 2013; Martini
2011; Mathewson-Chapman 97; Moore 2008; Nowak 2007;
Overgard 2008; Parekh 2003; Perissinotto 2008; Robinson
2008; Tibaek 2007; Tienforti 2012; Tobia 2008; Wille 2003);
• within days or up to two weeks post-operatively or after
catheter removal (Dubbelman 2004; Filocamo 2005; Floratos
2002; Franke 1998; Glazener RP 2011; Glazener TURP 2011;
Hoffman 2005; Koo 2009; Liu 2008; Manassero 2007;
Marchiori 2010; Mariotti 2009; Park 2012; Porru 2001; Ribeiro
2008; Robinson 2009; van Kampen 1998; Yamanishi 2006);
• weeks to months after surgery (Goode 2009; Joseph 2000;
Moore 1999; Moore 2004; Opsomer 1994; Seleme 2008; Zhang
2007).
Types of interventions
In the included trials, there was considerable variation in the type
and intensity of interventions. Table 1 gives the exact details of
the interventions used in each trial. The duration of the treatment
varied from four weeks up to one year. The interventions included:
• PFMT alone (Centemero 2009; Dubbelman 2004;
Filocamo 2005; Glazener RP 2011; Glazener TURP 2011;
Goode 2009; Laurienzo 2013; Martini 2011; Park 2012;
Perissinotto 2008; Porru 2001; Tobia 2008);
• PFMT plus biofeedback (Bales 2000; Burgio 2006;
Dijkstra-Eshuis 2013; Floratos 2002; Franke 1998; Geraerts
2013; Hou 2013; Joseph 2000; Manassero 2007; Marchiori
2010; Mathewson-Chapman 97; Moore 1999; Moore 2008;
Overgard 2008; Parekh 2003; Ribeiro 2008; Robinson 2008;
Robinson 2009; Tibaek 2007; Tienforti 2012);
• ESl with PFMT (Ahmed 2012; Hoffman 2005; Laurienzo
2013; Morihiro 2011; Wille 2003; Yamanishi 2006);
• ES with PFMT and biofeedback (Ahmed 2012; Goode
2009; Mariotti 2009; Opsomer 1994; Seleme 2008; Wille 2003;
Zhang 2007);
• extra-corporeal magnetic innervation (ExMI) with PFMT
(Koo 2009; Liu 2008; Nowak 2007);
• extra-corporeal magnetic innervation (ExMI) with PFMT
or ES with PFMT (Yokoyama 2004);
• penile compression (Fader 2013; Moore 2004);
• transcutaneous mechanical nerve stimulation by vibration
with PFMT (Fode 2014).
No trials testing lifestyle changes alone were identified.
Types of comparators
Therewas considerable variation in the types of comparators. Table
1 provides the details of the comparators used in each trial. The
comparators included:
• no treatment, verbal or written instructions or sham
therapy (Ahmed 2012; Bales 2000; Burgio 2006; Centemero
2009; Dubbelman 2004; Filocamo 2005; Franke 1998; Glazener
RP 2011; Glazener TURP 2011; Hou 2013; Laurienzo 2013;
Liu 2008; Manassero 2007; Marchiori 2010; Mariotti 2009;
Martini 2011; Mathewson-Chapman 97; Moore 2004; Moore
2008; Morihiro 2011; Nowak 2007; Opsomer 1994; Overgard
2008; Park 2012; Parekh 2003; Perissinotto 2008; Porru 2001;
Ribeiro 2008; Robinson 2008; Robinson 2009; Tibaek 2007;
Tienforti 2012; Tobia 2008; van Kampen 1998; Wille 2003;
Yamanishi 2006; Yokoyama 2004);
• active treatment (Ahmed 2012; Dijkstra-Eshuis 2013;
Floratos 2002; Fode 2014; Geraerts 2013; Ghanem 2013;
Goode 2009; Hoffman 2005; Joseph 2000; Koo 2009;
Laurienzo 2013; Moore 1999; Seleme 2008; Zhang 2007).
Types of outcome measures
There was a lack of consistency in the reporting of outcome mea-
sures. In terms of the primary outcomes of interest in this review
these included:
• number of men with incontinence, for radical surgery
(Ahmed 2012; Bales 2000; Burgio 2006; Centemero 2009;
Dijkstra-Eshuis 2013; Dubbelman 2004; Filocamo 2005;
Floratos 2002; Fode 2014; Franke 1998; Geraerts 2013;
Ghanem 2013; Glazener RP 2011; Goode 2009; Manassero
2007; Marchiori 2010; Mariotti 2009; Mathewson-Chapman
97; Moore 1999; Moore 2004; Morihiro 2011; Opsomer 1994;
Overgard 2008; Parekh 2003; Park 2012; Tobia 2008; van
Kampen 1998; Yamanishi 2006) and for TURP (Glazener
TURP 2011; Porru 2001; Tibaek 2007; Tienforti 2012);
• number not cured (Zhang 2007) (assumed to indicate
number of incontinent men);
• time until continent (Fode 2014; Marchiori 2010; Mariotti
2009);
• number of pad changes over 24 hours (Floratos 2002; Koo
2009; Mathewson-Chapman 97; Ribeiro 2008; Tienforti 2012);
• number of men using pads (Glazener RP 2011; Glazener
TURP 2011);
• number of incontinence episodes per day (Glazener RP
2011; Glazener TURP 2011; Goode 2009; Tienforti 2012);
• pad test weights, grams of urine lost in 24 hours (Ahmed
2012; Geraerts 2013; Joseph 2000; Koo 2009; Mariotti 2009;
Mathewson-Chapman 97; Moore 1999; Moore 2008; Overgard
2008; Park 2012; Ribeiro 2008; Yamanishi 2006), 1 hour
(Floratos 2002; Geraerts 2013; Hoffman 2005), 20 minutes
(Wille 2003);
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• number with severe incontinence (pad test weight > 150 g)
(Centemero 2009);
• quality of life (condition-specific such as incontinence
scores): ICIQ-SF score (Centemero 2009; Glazener RP 2011;
Glazener TURP 2011; Park 2012; Ribeiro 2008; Yamanishi
2006), severity of UI (Zhang 2007), I-QoL (Seleme 2008), ICI-
Q-SF (Liu 2008), IIQ (Ahmed 2012; Ribeiro 2008), ICIQ-SF
QoL score (Glazener RP 2011; Glazener TURP 2011; Yamanishi
2006), EPIC-UI (Goode 2009), KHQ (Dijkstra-Eshuis 2013);
• pelvic floor muscle strength (Overgard 2008);
• carrying out PFMT or compliance (Glazener RP 2011;
Glazener TURP 2011; Goode 2009; Overgard 2008; Zhang
2007).
Excluded studies
In total 36 studies were excluded. The majority of the studies that
did not meet the inclusion criteria were excluded because the study
design was not appropriate or the intervention was not relevant
for the population of interest. See the Excluded studies table for a
more detailed description.
Risk of bias in included studies
The assessment criteria of The Cochrane Collaboration assume
that the avoidance of bias is best achieved by: a randomised trial
with an adequate method of random sequence generation; secure
concealment of allocation prior to formal entry; adequate blind-
ing of patients, healthcare providers and outcome assessors; de-
scription of reasons and numbers of withdrawals and dropouts;
and analysis on an intention-to-treat basis. None of the early trials
fulfilled all these criteria. However recent trials have fared much
better in terms of secure concealment of allocation and blinding
but overall this continues to be problematic in many trials (Figure
2; Figure 3).
Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 3. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Allocation
Sequence generation
Although all trials were identified as RCTs only 24 trials (Ahmed
2012; Burgio 2006; Centemero 2009; Dijkstra-Eshuis 2013;
Dubbelman 2004; Filocamo 2005; Fode 2014; Glazener RP
2011; Glazener TURP 2011; Goode 2009; Laurienzo 2013;
Manassero 2007; Mathewson-Chapman 97; Moore 1999; Moore
2004; Moore 2008; Overgard 2008; Park 2012; Robinson 2008;
Robinson 2009; Tibaek 2007; Tienforti 2012; van Kampen 1998;
Yamanishi 2006) described a method of adequate sequence gen-
eration (for example computer generated random numbers) and
were assessed as low risk of bias. The remainder did not provide
enough information to make a judgement and were assessed as
unclear.
Allocation concealment
Only 20 trials (Ahmed 2012; Burgio 2006; Centemero 2009;
Dijkstra-Eshuis 2013; Dubbelman 2004; Fode 2014; Geraerts
2013; Glazener RP 2011; Glazener TURP 2011; Goode 2009;
Manassero 2007; Moore 1999; Moore 2004; Moore 2008;
Overgard 2008; Park 2012; Robinson 2008; Tibaek 2007; van
Kampen 1998; Yamanishi 2006) adequately described a technique
of allocation concealment (for example sealed envelopes or com-
puterised randomisation) and were assessed as low risk of bias.
The remainder did not provide enough information to make a
judgement and were assessed as unclear.
Blinding
Blinding was not described in most trials. In complex interven-
tions such as physical therapy it is not possible to blind either
the clinicians or the participants from the intervention, however,
if blinding did not take place in trials they were judged to be at
high risk of bias. This may have an impact on the outcome of in-
terest and was considered while assessing the quality of evidence.
Yamanishi 2006 used a sham device for the control group and this
was the only trial that was deemed to be at low risk of bias in terms
of blinding of participants.
In terms of blinding of personnel:
• 9 trials (Burgio 2006; Centemero 2009; Dijkstra-Eshuis
2013; Geraerts 2013; Moore 1999; Moore 2008; Porru 2001;
Tienforti 2012; Yamanishi 2006) were deemed to be at low risk
of bias;
• 17 trials (Bales 2000; Filocamo 2005; Floratos 2002;
Glazener RP 2011; Glazener TURP 2011; Hou 2013; Joseph
2000; Liu 2008; Manassero 2007; Marchiori 2010; Moore 2004;
Overgard 2008; Parekh 2003; Park 2012; Ribeiro 2008;
Robinson 2008; Seleme 2008) were deemed to be at high risk of
bias; and
• 23 trials (Ahmed 2012; Dubbelman 2004; Fader 2013;
Fode 2014; Franke 1998; Ghanem 2013; Goode 2009; Hoffman
2005; Koo 2009; Laurienzo 2013; Mariotti 2009; Martini 2011;
Mathewson-Chapman 97; Morihiro 2011; Nowak 2007;
Opsomer 1994; Perissinotto 2008; Robinson 2009; Tobia 2008;
van Kampen 1998; Wille 2003; Yokoyama 2004; Zhang 2007)
were at unclear risk.
Burgio 2006;Moore 1999 andMoore 2008 indicated that a single
therapist, blinded to control group outcomes, provided all treat-
ment. Dijkstra-Eshuis 2013 and Geraerts 2013 reported that the
post-operative physiotherapist was blinded to allocation and phys-
ical therapy provided by the pre-operative therapist.
In terms of blinding of outcome assessment:
• 7 trials (Burgio 2006; Dijkstra-Eshuis 2013; Geraerts 2013;
Moore 2008; Park 2012; Tienforti 2012; Yamanishi 2006) were
deemed to be at low risk of bias because they had outcome
assessors who were not involved in the provision of the
intervention or were not aware of allocation when entering data;
• 1 trial (Fode 2014) was found to be at high risk of bias; and
• 42 trials (Ahmed 2012; Bales 2000; Centemero 2009;
Dubbelman 2004; Fader 2013; Filocamo 2005; Floratos 2002;
Franke 1998; Ghanem 2013; Glazener RP 2011; Glazener
TURP 2011; Goode 2009; Hoffman 2005; Hou 2013; Joseph
2000; Koo 2009; Laurienzo 2013; Liu 2008; Manassero 2007;
Marchiori 2010; Mariotti 2009; Martini 2011;
Mathewson-Chapman 97; Moore 1999; Moore 2004; Morihiro
2011; Nowak 2007; Opsomer 1994; Overgard 2008; Parekh
2003; Perissinotto 2008; Porru 2001; Ribeiro 2008; Robinson
2008; Robinson 2009; Seleme 2008; Tibaek 2007; Tobia 2008;
van Kampen 1998; Wille 2003; Yokoyama 2004; Zhang 2007)
were at unclear risk because this information was not provided.
Yamanishi 2006 used a shamdevice for the control group but there
was no statement of whether assessors were aware of this or not.
Incomplete outcome data
Several trials gave no description or did not report dropouts (
Centemero 2009; Ghanem 2013; Koo 2009; Marchiori 2010;
Morihiro 2011; Perissinotto 2008; Ribeiro 2008; Robinson 2009;
Seleme 2008; Yamanishi 2006; Yokoyama 2004), or did not have
withdrawals or dropouts (Bales 2000; Liu 2008; Moore 2004;
Tobia 2008).
All others reported the number of withdrawals or dropouts, al-
though the reasons were not consistently reported and few, except
Moore 2008 and Robinson 2008, discussed how this was dealt
with in the analysis. In one trial, outcomes beyond eight weeks
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were not available for the control group because all the men were
treated, and data were not available for over a third of the men in
the other two intervention groups (Goode 2009). Two trials were
thought to be at risk of bias because of differential dropout from
the randomised groups (Dubbelman 2004;Manassero 2007).One
trial (Marchiori 2010) that was judged to be at high risk of bias
reported that the survey questionnaire used for one of their out-
comes was completed correctly but returned by fewer than 10%
of the men.
Six trials (Fader 2013; Martini 2011; Nowak 2007; Perissinotto
2008; Robinson 2008; Robinson 2009) did not provide any us-
able data. Three of these trials (Nowak 2007; Perissinotto 2008;
Robinson 2009) did not report how many men were randomised
to each group.
Selective reporting
There was significant difficulty in assessing selective outcome re-
porting because the protocols for most of the included trials were
not available for assessment or could not be found. For a few of
the trials, data were not available for some of the outcomes stated
in the methods section.
Other potential sources of bias
Information about funding was available for 27 of the in-
cluded studies (Burgio 2006; Centemero 2009; Dijkstra-Eshuis
2013; Fader 2013; Fode 2014; Franke 1998; Geraerts 2013;
Ghanem 2013; Glazener RP 2011; Glazener TURP 2011; Goode
2009; Laurienzo 2013; Moore 1999; Moore 2004; Moore 2008;
Morihiro 2011; Overgard 2008; Park 2012; Perissinotto 2008;
Ribeiro 2008; Robinson 2008; Robinson 2009; Seleme 2008;
Tibaek 2007; van Kampen 1998; Yamanishi 2006; Zhang 2007)
and the studies were judged to be at low risk of bias. The rest of
the trials were judged to be at unclear risk of bias because there
was a lack of information even after contacting the authors.
Thirty-two trials reported obtaining approval from a medical
ethics committee (Ahmed 2012; Burgio 2006; Centemero 2009;
Dijkstra-Eshuis 2013; Dubbelman 2004; Fader 2013; Filocamo
2005; Fode 2014; Geraerts 2013; Ghanem 2013; Glazener RP
2011; Glazener TURP 2011; Goode 2009; Laurienzo 2013; Liu
2008; Manassero 2007; Mathewson-Chapman 97; Moore 1999;
Moore 2004; Moore 2008; Morihiro 2011; Overgard 2008; Park
2012; Perissinotto 2008; Ribeiro 2008; Robinson 2008; Robinson
2009; Seleme 2008; Tibaek 2007; Tienforti 2012; Yamanishi
2006; Yokoyama 2004) and were judged to be at low risk of bias.
The remaining 18 trials did not report their source of medical
ethical approval and were judged to be at unclear risk of bias after
no further information was provided by the authors.
Fourteen trials were deemed to be at unclear risk of bias in terms of
obtaining informed consent (Bales 2000; Burgio 2006; Hoffman
2005; Hou 2013; Joseph 2000; Koo 2009; Liu 2008; Marchiori
2010; Martini 2011; Nowak 2007; Opsomer 1994; Parekh 2003;
Tobia 2008; Zhang 2007). These authors were contacted but no
further information on this matter was provided. The other trials
did report obtaining informed consent frompatients and therefore
were deemed to be at low risk of bias for this domain.
Effects of interventions
See: Summary of findings for the main comparison Treatment
of UI after radical: PFMT ± biofeedback versus no treatment; for
postprostatectomy urinary incontinence; Summary of findings 2
Treatment ofUI after radical: electric ormagnetic energy versus no
treatment for postprostatectomy urinary incontinence; Summary
of findings 3 Treatment of UI after radical: combinations of
treatments versus no treatment for postprostatectomy urinary
incontinence; Summary of findings 4 Treatment of UI after
radical: one active treatment versus another active treatment for
postprostatectomy urinary incontinence; Summary of findings
5 Prevention of UI after radical: PFMT ± biofeedback versus
no treatment for postprostatectomy urinary incontinence;
Summary of findings 6 Prevention of UI after radical: electric
or magnetic energy versus no treatment for postprostatectomy
urinary incontinence; Summary of findings 7 Prevention of UI
after radical: combinations of treatments versus no treatment for
postprostatectomy urinary incontinence; Summary of findings 8
Prevention of UI after radical: one active treatment versus another
active treatment (PFMT pre and post-operation versus PFMT
post-operation) for postprostatectomy urinary incontinence;
Summary of findings 9 Prevention of UI after radical: one
active treatment versus another active treatment (PFMT + penile
vibration pre and post-operation versus PFMT pre and post-
operation) for postprostatectomy urinary incontinence;Summary
of findings 10 Prevention of UI after radical: one active treatment
versus another active treatment (pre-operative PFMT + electrical
stimulation versus pre-operative PFMT) for postprostatectomy
urinary incontinence; Summary of findings 11 Treatment of
UI after TURP: PFMT ± biofeedback versus no treatment for
postprostatectomy urinary incontinence; Summary of findings
12 Prevention of UI after TURP: pre or post-operative PFMT
± biofeedback versus no treatment for postprostatectomy urinary
incontinence
Radical prostatectomy: treatment of incontinent men
after surgery
1. Treatment of UI after radical prostatectomy: post-
operative PFMT with or without biofeedback versus no
treatment or sham therapy or verbal instruction
(Comparison 1)
Nine trials (Dubbelman 2004; Floratos 2002; Franke 1998;
Manassero 2007; Glazener RP 2011; Goode 2009; Moore 1999;
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Moore 2008; van Kampen 1998) compared PFMT with or with-
out biofeedback to no treatment (sham or verbal instruction)
amongst men who had UI after radical prostatectomy. The qual-
ity of the evidence is given in Summary of findings for the main
comparison.
Differences between trials
All the men were incontinent at baseline.
In one trial (Manassero 2007) there was evidence of unexplained
differential dropout from the control group (13 of 53 men, while
there were no dropouts from the 54 in the intervention group).
The missing men have therefore been assumed to be dry for the
purpose of an intention-to-treat analysis. The other trials have
been analysed as reported since dropouts (if any) were balanced
between the groups.
Sources of heterogeneity
(1) Definition of incontinence varied with each trial:
• more than 1 g urine on one hour pad test (Dubbelman
2004);
• more than 8 g urine loss on 24 hour pad test (Moore 2008);
• more than 2 g urine loss on one hour (van Kampen 1998)
or 24 hour pad test (Moore 1999);
• men who were not pad free (Franke 1998);
• a visual analogue score of 10 = completely incontinent and
0 = completely continent (Manassero 2007); or
• no leakage based on bladder diaries (Goode 2009).
(2) The type of PFMT regimens differed between the trials:
• four trials (Dubbelman 2004; Goode 2009; Manassero
2007; Moore 1999) evaluated PFMT alone (without
biofeedback);
• three trials evaluated PFMT with biofeedback, verbal
instruction (Manassero 2007; Moore 2008) or ES (van Kampen
1998);
• two trials (Floratos 2002; Franke 1998) used PFMT with
biofeedback via a perineal patch (surface) EMG.
Formal PFMT post-operative sessions directed by a therapist
ranged from: twice a week for 12 weeks (Moore 1999); three times
a week for three weeks (Floratos 2002); in up to nine sessions
(Dubbelman 2004); weekly for 24 weeks (Moore 2008); four ses-
sions over eight weeks (Goode 2009); five sessions over 16 weeks
(Franke 1998); to as long as the UI persisted (van Kampen 1998).
Men received only four therapy sessions in three months in one
of these trials (Glazener RP 2011) and men in another trial were
seen weekly for up to six months (Moore 2008).
(3) Control interventions differed between the trials and included:
• information (verbal or written) about PFMT only
(Dubbelman 2004; Floratos 2002; Moore 1999; Moore 2008);
• no treatment (Manassero 2007);
• sham placebo PFMT and contact with therapist (van
Kampen 1998);
• monitoring of UI only (e.g. by bladder diary or phone calls)
(Franke 1998; Goode 2009).
(4) The participants differed between the trials.
Two trials (Goode 2009; Moore 1999) recruited participants with
persistent incontinence (some longer than one year) post-oper-
atively, and these participants may have differed from those en-
rolled pre-operatively (Moore 2008) but still incontinent at four
weeks after surgery) or from those recruited within a week or two
of catheter removal (Dubbelman 2004; Floratos 2002; Glazener
RP 2011; Manassero 2007; van Kampen 1998) or up to six weeks
after radical prostatectomy (Franke 1998).
Incontinence in men and incontinence episodes
Because there was evidence of significant statistical heterogeneity
between the trials included in this comparison (see below), meta-
analysis was carried out using a random-effects model, therefore
widening the CI. There were no significant differences at any time
period in the UI rates, and the CIs were wide (for example RR for
UI up to 12 months 0.91, 95% CI 0.73 to 1.14, Analysis 1.1.3;
and after 12months 57%withUI versus 62% in the control group,
RR 0.85, 95% CI 0.60 to 1.22, Analysis 1.1.4). Only two trials
(Manassero 2007; van Kampen 1998) favoured the treatment and
of these, only one (van Kampen 1998) used biofeedback. The esti-
mates from the other trials had CIs that did not rule out clinically
important effects. Overall, as one of the pre-defined GRADE-spe-
cific outcomes, the quality of evidence for the outcome ’number
of incontinent men after 12 months’ was found to be moderate.
The meta-analysis was dominated by the Glazener RP 2011 trial,
which was a large pragmatic multi-centre trial conducted in a
context where information on PFMT was widely available. This
showed no good evidence to support one-to-one training by a
therapist (for example RR for UI after 12 months 0.98, 95% CI
0.87 to 1.09, Analysis 1.1.4) (Glazener RP 2011). This one large
trial had narrow CIs which did not include a clinically significant
difference, pre-specified to be 15%. One other trial (Moore 2008)
was in line with the Glazener RP 2011 findings but had wider CIs
(RR 1.02, 95% CI 0.70 to 1.48, Analysis 1.1.4) (Moore 2008).
In one large trial (Glazener RP 2011), men did not report differ-
ences in UI episodes at any time period, based on urinary diary
data (for example after 12monthsMD 0.1, 95%CI -0.82 to 1.02,
Analysis 1.2.4). Alternatively, one trial (Goode 2009) did report a
significant difference, however this measurement was obtained at
less than 3 months (MD -1.14, 95% CI -1.46 to -0.82, Analysis
1.2.1).
Use of pads
Use of pads could be considered to be a measure of more severe
incontinence. There was no statistically significant difference in
20Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
the number of men using pads in one large trial (40% in inter-
vention group versus 42% in control group after 12 months, RR
0.94, 95% CI 0.72 to 1.22, Analysis 1.3) (Glazener RP 2011).
Floratos 2002 used number of pad changes over 24 hours as the
outcome measure, with no statistically significant difference in the
MD between treatment and control groups at any time period
(Analysis 1.4).
Urinary incontinence score and effect on quality of life
In one large trial (Glazener RP 2011), there was no evidence of a
difference in the ICIQ-SF (a composite score of frequency, amount
and effect of UI on quality of life) at any time period after the
intervention up to or beyond one year (MD after 12 months -0.5,
95% CI -1.35 to 0.35, Analysis 1.5) or quality of life as a single
score from 0 to 10 (MD -0.30, 95% CI -0.73 to 0.13, Analysis
1.6), however the quality of evidence for this outcome was found
to be low.
Pad tests
Two trials (Moore 1999; Moore 2008) reported 24 hour pad test
results and one (Floratos 2002) reported a one hour pad test.
Dubbelman 2004 and van Kampen 1998 also measured urine loss
on a 24 hour pad test, but did not report SDs and therefore these
data could not be included in the meta-analysis. Amongst the two
trials which gave 24 hour pad test data, there were no statistically
significant differences between the groups at 3, 6 or 12 months, or
after 12months (Analysis 1.8). Similarly, using a one hour pad test
(Floratos 2002), there were no statistically significant differences
between the groups up to six months (Analysis 1.9). In the smaller
trials (Floratos 2002; Moore 1999; Moore 2008) the SDs were
often larger than the means, suggesting highly skewed data.
2. Treatment of UI after radical prostatectomy: post-
operative interventions using electric or magnetic energy
(for example post-operative anal ES, perineal ES, TENS,
extra-corporeal magnetic innervation (ExMI) versus no
treatment or sham treatment (Comparison 2)
Four trials were identified which addressed this comparison
(Marchiori 2010;Moore 1999; Morihiro 2011; Yamanishi 2006).
These trials compared anal ES with oral (verbal) PFMT. The con-
trol group in Moore’s trial received oral information about PFMT
only, whereas in Yamanishi’s trial the control group also received
sham ES. The quality of the evidence is given in Summary of
findings 2.
Number of incontinent men
In the short term (less than three months), there were fewer in-
continent men in the intervention groups in two trials (64% ver-
sus 84% in the control groups, RR 0.77, 95% CI 0.60 to 0.98,
Analysis 2.1.1) (Moore 1999; Yamanishi 2006) and the quality of
the evidence for this outcome was deemed to be moderate. This
remained the same at 6 to 12 months (19% versus 53% in the
control groups, RR 0.37, 95% CI 0.18 to 0.73, Analysis 2.1.3)
and after 12 months (7% versus 33% in the control groups of
three trials, RR 0.26, 95% CI 0.09 to 0.74). However, the data
were too few to be reliable in the longer term.
Adverse effects
One small trial (Yamanishi 2006) reported adverse effects, with
twomen in the active ES group and fourmen in the group receiving
sham treatment reporting anal pain or discomfort. No statistically
significant differences were found between the groups (RR 0.58,
95% CI 0.11 to 2.90, Analysis 2.2).
Pad test
There were no statistically significant differences between the
groups on grams of urine lost (24 hour pad test) at any of the time
points (Analysis 2.3). SSs were large, indicating skewed distribu-
tion of data, and the CIs were wide with evidence of significant
statistical heterogeneity.
UI score
Men in the intervention group in one trial (Yamanishi 2006) had
lower (better) UI scores using a quality of life outcome combined
with amount and frequency of urine lost (for example MD -3.9,
95% CI -7.15 to -0.65, Analysis 2.4.3, at one year) though this
did not quite reach statistical significance when quality of life was
analysed on its own (MD -0.40, 95% CI -2.02 to 1.22, Analysis
2.5).
Time until continence achieved
Men achieved continence on average about 5 months sooner in
the intervention group of one trial (MD -4.11 months, 95% CI -
6 to -2.23, Analysis 2.6) (Yamanishi 2006).
3. Treatment of UI after radical prostatectomy: post-
operative lifestyle adjustment versus no treatment or sham
treatment (Comparison 3)
No trials were identified.
4. Treatment of UI after radical prostatectomy: post-
operative combinations of treatments versus no treatment
or sham treatment (Comparison 4)
Two trials reported using PFMT with anal ES as well as biofeed-
back (Goode 2009; Opsomer 1994) versus control management.
Goode 2009 compared behavioural therapy comprising biofeed-
back and ES for eight weeks with a control group. Opsomer 1994
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treated incontinent men in the intervention group with two ses-
sions of ES with biofeedback as well as continuing the PFMT
taught to both groups at six weeks after radical prostatectomy. The
quality of the evidence is given in Summary of findings 3.
Number of incontinent men
Goode 2009 reported fewer incontinent men in the intervention
group compared with the control group (83% versus 94% in the
control group at less than 3 months, RR 0.88, 95% CI 0.78 to
0.99, Analysis 4.1.1). In the other trial (Opsomer 1994), four
men in total had incontinence at 3 to 6 months, with 3/20 in the
intervention group and 1/19 in the control group, but this was not
statistically significant (RR 2.85, 95% CI 0.32 to 25.07, Analysis
4.2). Overall, the quality of evidence for this outcome was very
low.
Adverse events
There were two adverse events (haemorrhoidal irritation) reported
by men receiving ES in one trial (Goode 2009), and the quality of
evidence for this outcome was deemed to be of low quality with
wide CIs indicating uncertainty (RR 4.86, 95% CI 0.24 to 99.39,
Analysis 4.4.1).
5. Treatment of UI after radical prostatectomy: post-
operative use of one treatment versus another active
treatment (Comparison 5)
Nine trials comparing one active treatment to another were iden-
tified (Floratos 2002; Goode 2009; Hoffman 2005; Joseph 2000;
Koo 2009; Moore 1999; Seleme 2008; Yokoyama 2004; Zhang
2007).
• PFMT plus anal ES (EStim) (Hoffman 2005; Moore 1999).
• PFMT plus perineal ES (EStim) (Hoffman 2005).
• PFMT plus visual biofeedback (Joseph 2000; Zhang 2007).
• PFMT plus visual biofeedback plus support group (Zhang
2007).
• PFMT plus oral (verbal) biofeedback (Joseph 2000).
• PFMT plus biofeedback plus ES(Estim) (Goode 2009;
Seleme 2008).
• PFMT alone (Goode 2009; Hoffman 2005; Koo 2009;
Moore 1999; Seleme 2008).
• Extra-corporeal Magnetic Innervation (ExMI) (Koo 2009).
The quality of the evidence is given in Summary of findings 4.
Number of incontinent men
Four small trials provided data for this outcome (Goode 2009;
Moore 1999; Yokoyama 2004; Zhang 2007). The definition of
incontinence varied with each trial:
• no urine loss recorded in bladder diaries (Goode 2009);
• less than 8 g urine loss on 24 hour pad test (Moore 1999);
• ’urine loss’ (Yokoyama 2004); and
• use of pad or brief (Zhang 2007).
There was no difference in the incontinence rates in the trials at
any time period, but CIs were wide, up to 3 months (RR 0.96,
95% CI 0.83 to 1.12, Analysis 5.1); 3 to 6 months (RR 0.59,
95% CI 0.33 to 1.05, Analysis 5.2); 6 to 12 months (RR 2, 95%
CI 0.21 to 18.23, Analysis 5.3) and the quality of evidence was
deemed to be of very low quality.
Pad tests
For the majority of the comparisons there were no statistically sig-
nificant differences between the groups, SDs were large, indicating
skewed distribution of data, and the CIs were wide.
However, men having extra-corporeal magnetic innervation
(ExMI) compared to PFMT alone had less urine loss on the 24
hour pad test at 3 to 6months in one small trial (Koo 2009) (com-
pared to PFMT alone, MD -36 g, 95% CI -55 to -17, Analysis
5.12.3) and used fewer pads per day (MD -0.5, 95% CI -0.79 to
-0.21, Analysis 5.13.1) (Koo 2009).
Quality of life
In another small trial (Seleme 2008) men receiving PFMT plus
biofeedback plus ES reported better quality of life using the In-
continence Quality of life score than those receiving PFMT alone
(MD -28.63, 95% CI -34.60 to -22.66, Analysis 5.6.1).
In a third trial (Liu 2008), PFMTsupplemented by extra-corporeal
magnetic innervation (ExMI) seemed to be better than PFMT
alone in terms of quality of life assessed using the ICIQ-SF score
(MD -1.60, 95%CI -2.73 to -0.47, Analysis 5.7.1) but the quality
of the evidence for this outcome was judged to be of low quality.
Adverse events
Two men in one trial (Goode 2009) had an adverse event with ES
(haemorrhoidal irritation, RR 5, 95% CI 0.24 to 102.30, Analysis
5.8.1) but the evidence for this outcome was judged to be of low
quality.
Radical prostatectomy: prevention of UI in all men
having surgery, intervention before or after
prostatectomy or both
6. Prevention of UI after radical prostatectomy: PFMT ±
biofeedback versus no treatment or sham therapy or verbal
instruction (Comparison 6)
Ten trials addressed this comparison (Bales 2000; Burgio 2006;
Filocamo 2005; Laurienzo 2013; Mathewson-Chapman 97;
Overgard 2008; Parekh 2003;Ribeiro 2008;Tienforti 2012;Tobia
2008). The quality of the evidence is given in Summary of findings
5.
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Differences between trials
The participants were not selected because they were incontinent
so included a mixed population of men with and without incon-
tinence after surgery.
Sources of heterogeneity
(1) The type of PFMT regimens differed between the trials:
• PFMT plus biofeedback (Bales 2000; Burgio 2006;
Laurienzo 2013; Mathewson-Chapman 97; Parekh 2003;
Ribeiro 2008; Tienforti 2012);
• PFMT alone (Filocamo 2005; Overgard 2008; Tobia 2008).
Biofeedback was delivered via surface electrodes (Bales 2000) or
via a digital or anal probe (Burgio 2006; Mathewson-Chapman
97; Parekh 2003; Tienforti 2012). In one trial (Ribeiro 2008) the
type of biofeedback was not described.
(2) Control interventions differed between the trials and included:
• no treatment (Filocamo 2005; Mathewson-Chapman 97;
Parekh 2003; Tobia 2008);
• post-operative verbal or written instruction on PFMT only
(Bales 2000; Laurienzo 2013; Overgard 2008; Ribeiro 2008;
Tienforti 2012);
• usual care with simple instructions to interrupt the stream
when voiding (Burgio 2006).
(3) The timing of the interventions relative to surgery also varied:
• two trials delivered an intervention before surgery only
(Laurienzo 2013; Tobia 2008);
• five trials delivered their intervention before and after
surgery (Bales 2000; Burgio 2006; Parekh 2003;
Mathewson-Chapman 97; Tienforti 2012);
• three trials delivered their intervention after surgery only
(Filocamo 2005; Overgard 2008; Ribeiro 2008).
Number of men with UI
Data describing UI were reported by 8 of the 10 trials. While there
was no statistically significant difference at 3 months (Analysis
6.1.1), there was evidence from the findings of this systematic
review of an overall benefit from PFMT in the number of men
with UI within 6 to 12 months (24% versus 52%, RR 0.51, 95%
CI 0.35 to 0.75, Analysis 6.1.3) and after 1 year (10% versus 32%,
RR 0.32, 95% CI 0.20 to 0.51, Analysis 6.1.4), but the quality of
evidence was judged to be moderate. The data were driven mainly
by two trials (Filocamo 2005; Overgard 2008), neither of which
included biofeedback. One of these trials did not disclose details of
allocation concealment (Filocamo 2005) and the other was small
(Overgard 2008). The remaining trials showed conflicting results
and there was statistically significant heterogeneity, hence the use
of a random-effects model.
Pad changes and pad tests
In the four trials which reported these outcomes (Filocamo 2005;
Mathewson-Chapman 97; Overgard 2008; Ribeiro 2008) there
was statistical heterogeneity. One small trial favoured PFMT
(Ribeiro 2008) but using a random-effects model there was only a
significant difference at 6 to 12 months (MD -15 g less urine loss
on 24 hour pad test with treatment, 95% CI -18 to -11, Analysis
6.4.3). Men in the intervention group in this trial received PFMT
plus biofeedback weekly for three months until they were conti-
nent or until three months. The findings from the Filocamo 2005
andOvergard 2008 trials (no significant difference in pad weights)
was in contrast to their report of fewer incontinentmenwith active
treatment (RR 0.32, 95% CI0.20 to 0.51, Analysis 6.1.4). How-
ever, the SDs were large and the CIs were wide. Laurienzo 2013
did not find a significant difference up to 12 months when using
a 1 hour pad test (MD 19.80, 95% CI -9.15 to 48.75, Analysis
6.3) and comparing PFMT with no standard treatment.
Mean number of incontinence episodes per day
Tienforti 2012 favoured PFMTat all time points (MD -1.43, 95%
CI -2.35 to -0.51, Analysis 6.5) when quantifying episodes of UI
in men each day, with men in the intervention group suffering
fewer mean numbers of episodes.
Quality of life
Quality of life was assessed using the ICIQ-SF by two trials (
Laurienzo 2013; Ribeiro 2008) but the quality of the evidence was
found to be very low. No significant difference was found within
6 to 12 months (MD -0.69, 95% CI -3.19 to 1.81, Analysis 6.6).
Ribeiro 2008 also assessed quality of life using the IIQ, favouring
the intervention at 3 to 6 months (MD -2.70, 95% CI -4.88 to -
0.52, Analysis 6.7).
7. Prevention of UI after radical prostatectomy: electric or
magnetic energy (for example anal ES (EStim), perineal ES,
TENS, extra-corporeal magnetic innervation (ExMI)) versus
no treatment or sham treatment (Comparison 7)
One small trial that delivered the intervention pre-operatively only
was identified (Laurienzo 2013). There was no significant differ-
ence using a 1 hour pad test at 6 to 12 months (MD -1.15, 95%
CI -9.11 to 6.81, Analysis 7.1) or when assessing quality of life
using the ICIQ-SF (MD 1.60, 95% CI -2.15 to 5.35, Analysis
7.2), but the quality of evidence for this outcome was judged to
be very low (Summary of findings 6).
8. Prevention of UI after radical prostatectomy: lifestyle
interventions versus no treatment or sham treatment
(Comparison 8)
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No trials were identified.
9. Prevention of UI after radical prostatectomy:
combinations of treatments versus no treatment or sham
treatment (Comparison 9)
Only one small trial (Mariotti 2009) looked at this compari-
son. Men in the intervention group received PFMT plus ES with
biofeedback post-operatively and men in the control group re-
ceived verbal and written instructions on PFMT. There was a sta-
tistical difference with regards to:
• number of incontinent men within 6 to 12 months (RR
0.10, 95% CI 0.01 to 0.73, Analysis 9.2);
• using a 24 hour pad test (MD -24.30, 95% CI -45.02 to -
3.58, Analysis 9.4); and
• time until UI was regained (MD -1.50, 95% CI -2.44 to -
0.56, Analysis 9.5).
However, the quality of evidence for the primary outcome (num-
ber of incontinentmen)was found to be low (Summary of findings
7).
Adverse events
Adverse events were not reported.
10. Prevention of UI after radical prostatectomy: one
treatment versus another active treatment (Comparison 10)
Eight trials were identified (Ahmed 2012; Centemero 2009;
Dijkstra-Eshuis 2013; Fode 2014; Geraerts 2013 Nowak 2007;
Park 2012; Wille 2003). Five of these were new in this up-
date (Ahmed 2012; Dijkstra-Eshuis 2013; Fode 2014; Geraerts
2013; Park 2012) and one was updated with new information
(Centemero 2009).
• Ahmed 2012 was a three-armed trial, with patients
receiving PFMT plus TENS with biofeedback or TENS only or
guided PFMT only.
• Centemero 2009 compared PFMT before and after surgery
with PFMT delivered after surgery only.
• Dijkstra-Eshuis 2013 compared pre-operative guided
PFMT with biofeedback versus post-operative written
instructions on PFMT; however all men received PFMT plus
biofeedback plus ES if they were still incontinent after six weeks.
• Fode 2014 compared PFMT + penile vibration before and
after surgery with PFMT alone before and after surgery: all men
received a phosphodiesterase type 5 (PDE5) inhibitor after the
first month.
• Geraerts 2013 compared PFMT plus biofeedback versus
active PFMT.
• Nowak 2007 compared extra-corporeal magnetic
innervation (ExMI) versus PFMT alone but did not provide any
useable data.
• Park 2012 compared post-operative PFMT plus general
exercise versus post-operative PFMT alone.
• Wille 2003, a three-arm trial, compared PFMT plus ES
versus PFMT plus ES plus anal probe biofeedback versus PFMT
alone.
The trials were generally small and few were similar enough to
combine in a meta-analysis. The quality of the evidence is illus-
trated in Summary of findings 8.
Number of incontinent men
This outcome was reported by six trials (Ahmed 2012; Centemero
2009; Dijkstra-Eshuis 2013; Fode 2014; Ghanem 2013; Park
2012).
In one trial, Centemero 2009 reported fewer incontinent men at
less than 3 months and within 3 to 6 months when PFMT was
delivered pre andpost-operatively, comparedwith post-operatively
only, and this correlatedwith a statistically significant better quality
of life score (MD -3.70, 95% CI -6.00 to -1.40, Analysis 10.15.1;
MD -4.10, 95% CI -6.64 to -1.56, Analysis 10.16.1). However,
when combined with the data from Geraerts 2013, who used the
same interventions, there was no statistically significant difference
between the interventions at 3 months (RR 0.86, 0.69 to 1.06,
Analysis 10.1.1) or 3 to 6 months (RR 0.75, 95%CI 0.54 to 1.04,
Analysis 10.2.1). It should be noted that the CIs were very wide.
Ahmed 2012 compared three different treatments (PFMT plus
transcutaneous electrical stimulation with biofeedback; TENS
only; and guided PFMT only) and found no statistically signifi-
cant differences between the interventions in terms of number of
men with UI (Analysis 10.1, Analysis 10.2; Analysis 10.3) except
that at 6 to 12 months PFMT plus ES plus biofeedback proved to
be significantly better than PFMT only (RR 0.10, 95% CI 0.01
to 0.76, Analysis 10.3.3).
One small trial (Park 2012) found that general exercise added
to PFMT was statistically significantly better than PFMT alone
within 3 to 6 months (RR 0.48, 95% CI 0.23 to 0.99, Analysis
10.2.3).
Four trials reported the number of incontinent men after 12
months (Dijkstra-Eshuis 2013; Fode 2014; Geraerts 2013;
Ghanem 2013). The quality of the evidence was moderate
(Summary of findings 8). Three of these trials, comparing pre and
post-operative PFMT to post-operative PFMT only, found that
more men were incontinent after 12 months when PFMT began
before surgery (15.3% versus 10.7% with post-operative training
alone) but this did not reach statistical significance (RR 1.32, 95%
CI 0.78 to 2.25, Analysis 10.4.1). The Fode 2014 study was too
small to identify a difference between PFMT plus penile vibratory
stimulation pre and post-operatively compared with pre and post-
operative PFMT (Analysis 10.4.2).
Pad tests
In general, the short-duration pad tests did not distinguish be-
tween the various interventions being compared, apart from in
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one trial. At 6 months (but not at 3 months), Wille 2003 found
that PFMT plus anal ES both with and without extra biofeed-
back were both better than PFMT alone using a 20 minute pad
test (MD urine lost -3 g, 95% CI -6 to -0.5 in both compar-
isons, Analysis 10.8.1 and Analysis 10.8.2), while there was little
to choose between the two more intensive interventions (Analysis
10.8.3). However, the trial was small, the SDs large and the CIs
wide.
Using a longer-duration 24 hour pad test, the groups receiving
ES were generally better than those only having PFMT or only
having ES (Analysis 10.12; Analysis 10.13; Analysis 10.14) but
the interventions were to dissimilar to combine. At three to six
months, one small trial (Park 2012) did not find significant benefit
when comparing PFMT plus general exercise with PFMT alone
(Analysis 10.13.4).
Quality of life
ICIQ-SF
The ICIQ-SF score is amixedmeasure of both incontinence sever-
ity and effect on quality of life. One small trial (Park 2012) found
that there was a significant benefit in terms of the ICIQ-SF and
the intervention PFMT plus general exercise versus PFMT alone,
but the evidence for this outcome was found to be very low (MD
in scores -4.00, 95% CI -5.41 to -2.59, Analysis 10.16.2).
King’s Health Questionnaire
For all domains of the King’s Health Questionnaire, Dijkstra-
Eshuis 2013 did not find a statistically significant difference be-
tween PFMT given pre and post-operatively and PFMT given
post-operatively only (Analysis 10.18).
SF-36
In contrast, one trial (Park 2012) found that the intervention
PFMT with general exercise was favoured at 3 to 6 months when
using the health status measure SF-36 (MD -9.00, 95%CI -11.17
to -6.83, Analysis 10.19.1) compared with PFMT alone. This may
have been more of a measure of an effect of exercise on general
health than on incontinence itself.
Adverse events
One trial (Fode 2014) was in the meta-analysis and the authors
stated that 5/30 men reported adverse effects in the intervention
group using the group with a penile vibratory stimulation device.
The quality of evidence for this outcome was deemed to be low.
Adverse effects included:
• red spots on the glans penis;
• small laceration with some bleeding;
• soreness;
• frank pain.
TURP: treatment of incontinent men, after surgery
11. Treatment of UI after TURP: PFMT ± biofeedback versus
no treatment or sham therapy or verbal instruction
(Comparison 11)
One large trial comparedPFMTwith orwithout biofeedback tono
treatment (sham or verbal instruction) amongst men who had UI
after TURP (Glazener TURP 2011). All themenwere incontinent
at randomisation, six weeks after surgery, and received four one-
to-one sessions with a trained therapist over a three month period.
The quality of the evidence is illustrated in Summary of findings
11.
Incontinence in men and incontinence episodes
There were no significant differences at any time period in the
incontinence rates (for example RR for incontinence up to 12
months 1.04, 95% CI 0.90 to 1.20, Analysis 11.1.3; and after 12
months, 65% with UI versus 62% in the control group, RR 1.05,
95% CI 0.91 to 1.23, Analysis 11.1.4). The evidence was judged
to be moderate.
In one large trial (Glazener TURP 2011) men did not report
differences in incontinence episodes at any time period, based on
urinary diary data (for example after 12 months MD 0.2, 95% CI
-0.27 to 0.67, Analysis 11.2).
Use of pads
Use of pads could be considered to be a measure of more severe in-
continence. There was no statistically significant difference in the
number of men using pads in one large trial (16% in intervention
group versus 18% in control group after 12 months, RR 0.93,
95% CI 0.56 to 1.56, Analysis 11.3) (Glazener TURP 2011).
Urinary incontinence score and effect on quality of life
In one large trial (Glazener TURP 2011), there was no evidence
of a difference in the ICIQ-SF (a composite score of frequency,
amount and effect of UI on quality of life) at any time period after
the intervention up to or beyond one year (for example MD after
12 months -0.1, 95% CI -0.89 to 0.69, Analysis 11.4) or quality
of life as a single score from 0 to 10 (MD -0.1, 95% CI -0.51 to
0.31, Analysis 11.5). The quality of evidence for this outcome was
deemed to be low.
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Adverse events
No adverse events were reported.
12. Treatment of UI after TURP: electric or magnetic
energy (for example anal ES (EStim), perineal ES, TENS,
extra-corporeal magnetic innervation (ExMI)) versus no
treatment or sham treatment (Comparison 12)
No trials were identified.
13. Treatment of UI after TURP: lifestyle interventions
versus no treatment or sham treatment (Comparison 13)
No trials were identified.
14. Treatment of UI after TURP: combinations of
treatments versus no treatment or sham treatment
(Comparison 14)
No trials were identified.
15. Treatment of UI after TURP: one treatment versus
another active treatment (Comparison 15)
No trials were identified.
TURP: prevention of UI in all men having surgery,
intervention before or after prostatectomy, or both
16. Prevention of UI after TURP: pre or post-operative
PFMT ± biofeedback versus no treatment or sham therapy
or verbal instruction (Comparison 16)
Three small trials enrolled men before TURP for benign prostatic
hyperplasia (Hou 2013; Porru 2001; Tibaek 2007). Men in the
intervention groups in both trials received one session with a ther-
apist before surgery to teach them the correct contractions (us-
ing verbal biofeedback) and they were expected to practice PFMT
afterwards. In the second trial (Tibaek 2007), men also attended
three group teaching sessions. The control groups received infor-
mation only. The quality of the evidence is illustrated in Summary
of findings 12.
There were no statistically significant differences between the
groups in the number of men with incontinence at less than 3
months or 3 to 6 months, but the CIs were wide and the quality
of evidence was very low (< 3 months RR 0.60, 95% CI 0.21 to
1.77, Analysis 16.1.1; 3 to 6 months RR 0.51, 95% CI 0.14 to
1.89, Analysis 16.1.2).
Quality of life
One trial (Hou 2013) measured quality of life using a health sta-
tus measure Short-Form 36 (SF-36) questionnaire at three to six
months. No statistically significant differences were found on any
of the domains apart from those associated with mental health
(Analysis 16.2).
17. Prevention of UI after TURP: electric or magnetic
energy (for example anal ES (EStim), perineal ES, TENS,
extra-corporeal magnetic innervation (ExMI)) versus no
treatment or sham treatment (Comparison 17)
No trials were identified.
18. Prevention of UI after TURP: lifestyle interventions
versus no treatment or sham treatment (Comparison 18)
No trials were identified.
19. Prevention of UI after TURP: combinations of
treatments versus no treatment or sham treatment
(Comparison 19)
No trials were identified.
20. Prevention of UI after TURP: one treatment versus
another active treatment (Comparison 20)
No trials were identified.
Containment of UI (all men with residual UI)
21. External penile compression devices (penile clamps)
versus no treatment or sham treatment (Comparison 21)
One trial compared three different penile compression devices
(Cunningham clamp, U-Tex Male Adjustable Tension Band, and
C3 penile compression device) with a control period of no device
(Moore 2004). A randomised block assignment was used with a
multiple period cross-over design, so that each of the 12 partici-
pants had a control period of no device and three periods in which
the different devices were used.
All external compression devices reduced the weight of urine lost
on a four hour pad test compared to the control period (P <
0.05, Analysis 21.2), but none completely eliminated urine loss.
Satisfaction was based on ease of application, comfort and efficacy.
The device preferred by the largest number of men (Analysis 21.1)
was also that with the lowest urine loss (the Cunningham clamp)
(Analysis 21.2).
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Adverse events
The Cunningham clamp was also the device with the greatest
reduction in systolic blood flow velocity (P < 0.05 versus control
period, Analysis 21.3; Analysis 21.4), raising the possibility of
safety issues if applied too tightly. In the trial, men were able to
judge when to release the device. The authors recommended that
its use should therefore be limited to men who were cognitively
intact, aware of bladder filling, had normal genital sensation and
intact penile skin, and had sufficient manual dexterity to open and
close the device (Moore 2004).
In another trial with no useable data (Fader 2013), men pro-
vided qualitative informationwhich suggested that padsweremost
highly rated compared with sheath catheters (P = 0.31), clamps
(P < 0.01) and the body-worn urinal (P < 0.001). The clamp was
rated as more secure, less leaky and less restrictive on clothing
choice than the others (P < 0.05) but was more painful than the
rest (P < 0.002).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Treatment of UI after radical: electric or magnetic energy versus no treatment for postprostatectomy UI
Patient or population: Patients with postprostatectomy UI
Intervention: Treatment of UI after radical: electric or magnetic energy versus no treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Treatment of UI after
radical: electric or mag-
netic energy versus no
treatment
Number of incontinent
men - after 12 months
63 per 1000 16 per 1000
(6 to 47)
RR 0.26
(0.09 to 0.74)
413
(3 studies)
⊕⊕⊕©
moderate1,2
Urinary Incontinence
Score (ICIQ-SF UI score)
- after 12 months
The mean urinary incon-
tinence score (iciq-short
form ui score) - after 12
months in the intervention
groups was
1.4 lower
(5.03 lower to 2.23
higher)
47
(1 study)
⊕⊕©©
low2,3,4
Uri-
nary Incontinence Qual-
ity of Life Score (ICIQ-
SF) - after 12 months
See comment See comment Not estimable 47
(1 study)
⊕⊕©©
low2,3,5
Adverse events 133 per 1000 77 per 1000
(15 to 387)
RR 0.58
(0.11 to 2.9)
56
(1 study)
⊕⊕©©
low2,3,6
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Economic analysis using
QALY - not reported
See comment See comment Not estimable - See comment
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Random sequence generation and allocation concealment unclear is 1/2 trials taking part in the meta-analysis
2 Funnel plot could not be used as there are fewer than 10 trials
3 Not applicable. Only one trial
4 95% CI very wide (-5.03 to 2.23)
5 95% CI very wide (-2.02 to 1.22)
6 95% CI very wide (0.11 to 2.90)
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Treatment of UI after radical: combinations of treatments versus no treatment for postprostatectomy UI
Patient or population: patients with postprostatectomy UI
Intervention: Treatment of UI after radical: combinations of treatments versus no treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Treatment of UI after
radical: combinations of
treatments versus no
treatment
Number of incontinent
men with 3 to 6 months
53 per 1000 150 per 1000
(17 to 1000)
RR 2.85
(0.32 to 25.07)
39
(1 study)
⊕©©©
very low1,2,3,4
Uri-
nary Incontinence Qual-
ity of Life Score (ICIQ-
SF) after 12 months
Study population Not estimable 0
(0)
See comment
See comment See comment
Moderate
Adverse events - PFMT
+ anal EStim + BFB
0 per 1000 0 per 1000
(0 to 0)
RR 4.86
(0.24 to 99.39)
138
(1 study)
⊕⊕©©
low2,4,5
Economic Analysis using
QALY - not reported
See comment See comment Not estimable - See comment
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio
3
0
C
o
n
se
r
v
a
tiv
e
m
a
n
a
g
e
m
e
n
t
fo
r
p
o
stp
ro
sta
te
c
to
m
y
u
rin
a
r
y
in
c
o
n
tin
e
n
c
e
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
5
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Random sequence generation and allocation concealment unclear
2 Not applicable, only one trial
3 No explanation was provided
4 Funnel plot cannot be used as there is only one trial
5 95% CI is very wide (0.24 to 99.39)
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Treatment of UI after radical: one active treatment versus another active treatment for postprostatectomy UI
Patient or population: Patients with postprostatectomy UI
Intervention: Treatment of UI after radical: one active treatment versus another active treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Treatment of UI after
radical: one active treat-
ment versus another ac-
tive treatment
Number of incontinent
men within 6 to 12
months - FES versus
ExMI
83 per 1000 167 per 1000
(17 to 1000)
RR 2
(0.21 to 19.23)
24
(1 study)
⊕©©©
very low1,2,3,4,5
Quality of Life Score
(ICI-Q-SF) within 6 to 12
months - PFMT + ExMI
versus PFMT
The mean quality of life
score (ICI-Q-SF) within 6
to 12 months - PFMT +
ExMI versus PFMT in the
intervention groups was
1.6 lower
(2.73 to 0.47 lower)
24
(1 study)
⊕⊕©©
low1,2,5,6
Adverse events PFMT +
Anal EStim versus PFMT
alone
0 per 1000 0 per 1000
(0 to 0)
RR 5
(0.24 to 102.3)
140
(1 study)
⊕⊕©©
low2,5,7
Economic analysis using
QALY
Study population Not estimable 0
(0)
See comment
See comment See comment
Moderate
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*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Random sequence generation and allocation concealment is unclear
2 Not applicable, only one trial
3 GRADE-specific outcome was number of incontinent men after 12 months
4 95% CI is very wide (0.21 to 19.23)
5 Funnel plot cannot be used as there was only one trial
6 GRADE-specific outcome was ICI-Q-SF after 12 months
7 95% CI very wide (0.24 to 102.30)
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Prevention of UI after radical: PFMT±biofeedback versus no treatment compared to for UI
Patient or population: All men after radical prostatectomy
Intervention: Prevention of UI after radical: PFMT ± biofeedback versus no treatment
Comparison:
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Prevention
of UI after radical: PFMT
±biofeedback versus no
treatment
Number of incontinent
men - after 12 months
321 per 1000 103 per 1000
(64 to 164)
RR 0.32
(0.2 to 0.51)
373
(2 studies)
⊕⊕⊕©
moderate1,2
Quality of life score as-
sessed using (ICI-SF UI
score) - within 6 to 12
months
The mean quality of life
score assessed using
(ICI-SF UI score) - within
6 to 12 months in the in-
tervention groups was
0.69 lower
(3.19 lower to 1.81
higher)
105
(2 studies)
⊕©©©
very low2,3,4
Adverse events - not re-
ported
See comment See comment Not estimable - See comment
Economic analysis using
QALY - not reported
See comment See comment Not estimable - See comment
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio34
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Allocation concealment is unclear for Filocamo 2005 which contributes 84.2% weightage
2 Funnel plot cannot be used as there are fewer than 10 trials
3 Sequence generation is unclear in Ribeiro 2008. Allocation concealment is unclear in both the trials taking part in the meta-analysis
4 95% CI is very wide (-3.19 to 1.81)
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Prevention of UI after radical: electric or magnetic energy versus no treatment for UI
Patient or population: All men after radical prostatectomy
Intervention: Prevention of UI after radical: electric or magnetic energy versus no treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Prevention of UI after
radical: electric or mag-
netic energy versus no
treatment
Number of incontinent
men after 12 months -
not reported
See comment See comment Not estimable - See comment
Quality of life score as-
sessed using (ICIQ-SF
score) - within 6 to 12
months
See comment See comment Not estimable 32
(1 study)
⊕©©©
very low1,2,3
Adverse events - not re-
ported
See comment See comment Not estimable - See comment
Economic analysis using
QALY - not reported
See comment See comment Not estimable - See comment
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval;
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Allocation concealment is unclear
2 95% CI is very wide (-2.15 to 5.35)
3 Funnel plot cannot be used as there are fewer than 10 trials
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Prevention of UI after radical: combinations of treatments versus no treatment compared to for postprostatectomy UI
Patient or population: All men after radical prostatectomy
Intervention: Prevention of UI after radical: combinations of treatments versus no treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Prevention of UI after
radical: combinations of
treatments versus no
treatment
Number of incontinent
men within 6 to 12
months - PFMT + anal
EStim + biofeedback
versus no treatment
See comment See comment Not estimable 60
(1 study)
⊕⊕©©
low1,2
Quality of life Score as-
sessed using (ICIQ-SF)
or (ICIQ- SF UI score) -
not reported
See comment See comment Not estimable - See comment
Adverse events - not re-
ported
See comment See comment Not estimable - See comment
Economic analysis using
QALY - not reported
See comment See comment Not estimable - See comment
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval;
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Sequence generation and allocation concealment are both unclear
2 Funnel plot cannot be used as there are fewer than 10 trials
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3
9
C
o
n
se
r
v
a
tiv
e
m
a
n
a
g
e
m
e
n
t
fo
r
p
o
stp
ro
sta
te
c
to
m
y
u
rin
a
r
y
in
c
o
n
tin
e
n
c
e
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
5
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
Prevention of UI after radical: one active treatment versus another active treatment compared to (PFMT pre and post-operation versus PFMT post-operation) for UI
Patient or population: All men after radical prostatectomy
Intervention: Prevention of UI after radical: one active treatment versus another active treatment
Comparison: (PFMT pre and post-operation versus PFMT post-operation)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
(PFMT pre and post-
operation versus PFMT
post-operation)
Prevention of UI after
radical: one active treat-
ment versus another ac-
tive treatment
Number of incontinent
men after 12 months
See comment See comment Not estimable 367
(3 studies)
⊕⊕⊕©
moderate1,2
Quality of Life Score as-
sessed using (ICIQ-SF)
or (ICIQ-SF UI score) af-
ter 12 months - not re-
ported
See comment See comment Not estimable - See comment
Adverse events See comment See comment Not estimable 102
(1 study)
⊕⊕⊕⊕
high3,4,5
Economic Analysis using
QALY - not reported
See comment See comment Not estimable - See comment
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Sequence generation is unclear 2/3 trials and allocation concealment is unclear in 1/3 trials
2 Due to clinical heterogeneity we decided not to pool the results
3 Not applicable
4 RR is not estimable as there is zero event in both arms of the trial
5 Funnel plot cannot be used as there were fewer than 10 trials
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Prevention of UI after radical: one active treatment versus another active treatment compared to (PFMT + penile vibration pre and post-operation versus PFMT pre and post-
operation) for
Patient or population: All men after radical prostatectomy
Intervention: Prevention of UI after radical: one active treatment versus another active treatment
Comparison: PFMT + penile vibration pre and post-operation versus PFMT pre and post-operation)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
(PFMT + penile vibra-
tion pre and post-oper-
ation versus PFMT pre
and post-operation)
Prevention of UI after
radical: one active treat-
ment versus another ac-
tive treatment
Number of incontinent
men after 12 months
71 per 1000 100 per 1000
(18 to 555)
RR 1.4
(0.25 to 7.77)
58
(1 study)
⊕⊕©©
low1,2,3
Quality of life Score as-
sessed using (ICIQ-SF)
or (ICIQ-SF UI score)
Study population Not estimable 0
(0)
See comment
See comment See comment
Moderate
Adverse events See comment See comment Not estimable 68
(1 study)
⊕⊕©©
low1,3,4
Economic analysis using
QALY - not reported
See comment See comment Not estimable - See comment
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio42
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Not applicable
2 95% CI very wide (0.25 to 7.77)
3 Funnel plot cannot be used as there were fewer than 10 trials
4 95% CI is very wide (0.80 to 240.77)
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Prevention of UI after radical: one active treatment versus another active treatment compared to (pre-operative PFMT + electrical stimulation versus pre-operative PFMT) for UI
Patient or population: All men after radical prostatectomy
Intervention: Prevention of UI after radical: one active treatment versus another active treatment
Comparison: Pre-operative PFMT + electrical stimulation versus pre-operative PFMT
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
(pre-
operative PFMT + elec-
trical stimulation versus
pre-operative PFMT)
Prevention of UI after
radical: one active treat-
ment versus another ac-
tive treatment
Number of incontinent
men after 12 months -
not reported
See comment See comment Not estimable - See comment
Quality of Life Score as-
sessed using (ICIQ-SF)
within 6 to 12 months
See comment See comment Not estimable 34
(1 study)
⊕©©©
very low1,2,3,4
Adverse events - not re-
ported
See comment See comment Not estimable - See comment
Economic analysis using
QALY - not reported
See comment See comment Not estimable - See comment
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Allocation concealment is unclear
2 Not applicable
3 95% CI very wide (-3.13 to 4.13)
4 Funnel plot cannot be used as there were fewer than 10 trials
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Treatment of UI after TURP: PFMT±biofeedback versus no treatment compared to for UI
Patient or population: Men with UI after TURP
Intervention: Treatment of UI after TURP: PFMT ± biofeedback versus no treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Treatment of UI after
TURP: PFMT ±biofeed-
back versus no treat-
ment
Number of incontinent
men- after 12 months
See comment See comment Not estimable 1609
(1 study)
⊕⊕⊕©
moderate1,2,3
Quality of life Score
assessed using Score
(ICIQ-SF UI score) - after
12 months
See comment See comment Not estimable 397
(1 study)
⊕⊕©©
low1,3,4
Adverse events - not re-
ported
See comment See comment Not estimable - See comment
Economic analysis using
QALY - not reported
See comment See comment Not estimable - See comment
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.4
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Very low quality: We are very uncertain about the estimate.
1 Not applicable
2 95% CI is wide (0.91 to 1.23)
3 Funnel plot cannot be used at there are fewer than 10 trials
4 95% CI is very wide (-0.89 to 0.69)
5 GRADE specific outcome is IIEF score
6 95% CI is very wide (0.86 to 1.72)
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Prevention of UI after TURP: pre or post-operative PFMT±biofeedback versus no treatment for UI
Patient or population: All men after TURP
Intervention: Prevention of UI after TURP: pre or post-operative PFMT ± biofeedback versus no treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Prevention of UI after
TURP: pre or post-op-
erative PFMT ±biofeed-
back versus no treat-
ment
Number of incontinent
men - within 3 to 6
months
227 per 1000 116 per 1000
(32 to 430)
RR 0.51
(0.14 to 1.89)
48
(1 study)
⊕©©©
very low1,2,3,4
Urinary
Incontinence Score as-
sessed using (ICIQ-SF)
or (ICIQ-SF UI score) at
12 months - not reported
See comment See comment Not estimable - See comment
Adverse events - not re-
ported
See comment See comment Not estimable - See comment
Economic analysis using
QALY - not reported
See comment See comment Not estimable - See comment
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Not applicable
2 GRADE specific outcome was number of incontinent men after 12 months
3 95% CI is very wide (0.14 to 1.89)
4 Funnel plot cannot be used as there are fewer than 10 trials
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D I S C U S S I O N
This review incorporates a broad array of possible interventions
under the umbrella term of conservative management of post-
prostatectomy UI. The populations studied included men under-
going prostatectomy for both benign (TURP) andmalignant (rad-
ical prostatectomy) disease. The interventions were delivered pre-
operatively, post-operatively or both. In some trials all the men
were incontinent at baseline, while at least some were dry in other
trials which recruited all men having surgery (these were classed
as prevention of incontinence trials). Seven trials (Goode 2009;
Joseph 2000; Moore 1999; Moore 2004; Opsomer 1994; Seleme
2008; Zhang 2007) included men who had been incontinent for a
considerable time after surgery while the rest recruitedmen around
the time of surgery. More recent trials have focused on the pre-
operative or post-operative period immediately after catheter re-
moval. It is acknowledged that UI after prostatectomy will resolve
over time in many men.
Conservative interventions tend to be resource-intensive strategies
that require people, equipment and clinic space, so administrators
will look for evidence of efficacy. Funding has been an issue given
the inconclusive nature of the evidence to date. For example, in
the United States, the centres for both Medicare and Medicaid
services have considered whether to withdraw funding for biofeed-
back and pelvic floor electrical stimulation (ES) in the treatment
of UI of any etiology based on a lack of evidence regarding ef-
fectiveness. Through a lobbying effort from service providers and
manufacturers, these modalities continued to be covered in the
United States (Thompson 2002). However, as controversy about
funding is likely to continue, there is a need for continued research
in the area to determine which groups of patients are most likely
to benefit from conservative interventions.
The findings of this review should continue to be treated with
caution. The effectiveness of conservative measures in the longer
term or in men with persistent UI remain inconclusive.
Summary of main results
Fifty trials met the inclusion criteria, 45 trials amongst men after
radical prostatectomy, four trials after TURP, and one small trial
which included one man with benign disease but was classed as
a radical prostatectomy trial. There was considerable variation in
the interventions, populations and outcome measures. Given this
clinical heterogeneity it was decided to differentiate the trials and
the comparisons, by type of surgery (TURP or radical prostate-
ctomy) and by whether the intervention was partly preventative
(in that not all men were incontinent, for example if all men be-
fore or after surgery were recruited, N = 27 trials), for treatment
only (when all included men were incontinent at baseline, N = 23
trials) or for containment (external penile compression devices, N
= 2 trials). Although the International Prostate Score (IPSS) was
used in many of the trials, the authors felt that this questionnaire
did not assess UI and therefore was not included in the outcome
of quality of life.
Treatment trials for urinary incontinence after
radical prostatectomy
Twenty-one trials investigated the effects of PFMT versus no treat-
ment or a variety of other means of stimulating the pelvic floor
muscles. There was considerable clinical and statistical heterogene-
ity in the populations and the timing and frequency of the inter-
ventions, hence a random-effects model was chosen for most of
the comparisons where meta-analysis was possible. Only two trials
(Manassero 2007; van Kampen 1998) showed a statistically sig-
nificant benefit from active treatment versus no treatment control
groups (at 12months andwithin 6 to 12months respectively), and
the other trials showed conflicting results. There was differential
dropout from the control group in theManassero 2007 trial (these
men were assumed to be dry for analysis purposes). Additionally,
men in the experimental group in the van Kampen 1998 trial re-
ceived one session of PFMT in hospital before discharge and were
then seen by a physiotherapist for one to two weeks, whereas those
in the Manassero 2007 trial were taught PFMT by two urologists
using verbal feedback and instructed to perform contractions at
home. Because of the heterogeneity a random-effects model was
used, which led to wider confidence intervals (CIs).
Overall, there was not enough evidence to say whether or not
PFMT with or without biofeedback was effective as the CIs were
wide (for example number of men with incontinence in the in-
tervention groups 193/339 (57%) versus 203/326 (62%) in the
control groups, RR for incontinence after 12 months 0.85, 95%
CI 0.60 to 1.22, Analysis 1.1.4).
The meta-analysis was dominated by the Glazener RP 2011 trial,
which was a large pragmatic multi-centre trial conducted in a
context where information on PFMT was widely available. This
showed no good evidence to support one-to-one training by a
therapist (for example RR for UI after 12 months 0.98, 95% CI
0.87 to 1.09, Analysis 1.1.4) (Glazener RP 2011). This one large
trial had narrow CIswhich did not include a clinically significant
difference, pre-specified to be 15%. The only other large trial
(Moore 2008) was in line with the Glazener RP 2011 findings but
with wider CIs (RR 1.02, 95% CI 0.70 to 1.48, Analysis 1.1.4)
(Moore 2008) despite a more intensive intervention. While men
in the Glazener RP 2011 trial had four therapy sessions over three
months, in the Moore 2008 trial men were seen weekly for up
to six months. The findings in these two trials concurred despite
different intensities of intervention, and the quality of evidence for
this GRADE-specific outcome was moderate. Data from quality
of lifemeasures and use of pads and pad tests supported the finding
of no differences between intervention and control groups.
Three small trials provided data and the meta-analysis suggested
that ES was better than control interventions in terms of less in-
continence, regaining continence more quickly and better quality
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of life, at least in the short term up to six months. The quality of
evidence was deemed to be moderate, however less information
was available for the longer term.
Individual small trials provided data to suggest that extra-corpo-
real magnetic innervation (ExMI) or combinations of treatments
might be beneficial but the evidence was limited.
Prevention trials for urinary incontinence after
radical prostatectomy
Nineteen trials, some of which enrolled men before surgery and
others all men as soon as the catheter was removed, included a
mixed population of men with and without incontinence after
surgery. Again a random-effects model was chosen to compensate
for the considerable clinical and statistical heterogeneity between
the trials. Including the information from the quasi-randomised
trial (Filocamo 2005), the chance of incontinence appeared to
be lower in the intervention groups in two trials with data after
12 months. The quality of evidence was judged to be moderate
(number of men with UI after one year 10.2% versus 32.1% in
the control groups, RR 0.32, 95% 0.20 to 0.51, Analysis 6.1.4).
The meta-analysis of prevention trials included a number of small
trials with wide CIs apart from Filocamo 2005, which was out of
line with the others. This was the only large trial to favour the
intervention group. The worry is that this trial may have been
biased due to a lack of reporting on concealment of allocation.
One small trial (Ribeiro 2008) suggested that men were more
likely to be carrying out PFMT, at least soon after the interven-
tion (Analysis 6.9), though this was not reflected in significant
differences in higher anal squeeze pressures (Analysis 6.8). An-
other trial of anal ES was too small to be conclusive (Laurienzo
2013). One small trial (Mariotti 2009) reported that adding anal
ES and biofeedback to PFMT was beneficial. One further small
trial (Wille 2003) found that PFMT plus anal ES with and with-
out extra biofeedback were both better than PFMT alone at six
months, but there was little to choose between the two more in-
tensive interventions (Analysis 10.8). Tienforti 2012 found that
pre-operative PFMT was associated with a reduction in number
of incontinence episodes per day, but this was a small trial and
larger sample sizes would be needed to draw reliable conclusions.
Nine trials compared one active treatment with another active
treatment. Overall there did not seem to be one intervention that
proved to be statistically significantly better than another.
Treatment trials for urinary incontinence after TURP
One large trial addressed this comparison (Glazener TURP 2011),
comparing four sessions of one-to-one therapywith standardman-
agement in a context where information about PFMT was widely
available. The quality of evidence for the number of incontinent
men was moderate but there were no differences between the
groups in any of the outcome measures except for performance of
PFMT, suggesting that the intervention had changed behaviour
but not incontinence or other clinical outcomes.
Prevention trials for urinary incontinence after TURP
Three small trials enrolled men before TURP to receive a minimal
PFMT intervention before and after surgery. There were no sta-
tistically significant differences in terms of number of incontinent
men between the groups but the quality of evidence was deemed
to be very low (Analysis 16.1).
Containment of urinary incontinence
One alternative intervention, a clamp fitted to the shaft of the
penis, can be used to control unwanted leakage. Men in one trial
reported a preference for one type of external compression device
compared to two others or no treatment; a Cunningham clamp
proved satisfactory to 10 of 12 men with intractable UI (Moore
2004). This may be a viable alternative for some cognitively capa-
ble men providing they take into account safety issues such as ad-
equate sensation and the ability to remove the device when it feels
too tight or the bladder is full. Another trial which compared pads,
sheath catheters, body-worn urinals and clamps also reported that
men found the clamps most effective but painful (Fader 2013).
Men whose incontinence cannot be otherwise controlled can use
absorbent pads (Fader 2007; Fader 2008) or a variety of external
sheath devices with leg bags. An alternative is an indwelling urinary
catheter (Jahn 2007; Moore 2007; Niël-Weise 2005).
Lifestyle changes
The effect of other conservative interventions such as lifestyle
changes remains undetermined as no trials involving these inter-
ventions were identified.
Overall completeness and applicability of
evidence
Few trials used the primary outcomes of interest, patient reported
symptoms and the standardised pad test. Most used a variety of
subjective outcomes derived from patient reported symptoms to
define continence. There were no trials which examined lifestyle
adjustments in alleviating UI after prostatectomy.
Attrition bias may have played a role in the results of some of the
included trials and therefore affected the outcome of this review.
One of the smaller trials (Franke 1998) lost half of the randomised
participants by the end of the data collection period. Although
most of those trials that lost participants provided an explanation
of these losses, none accounted for the missing data in their pri-
mary analyses. The intention-to-treat principle mandates, at mini-
mum, that patients stay in the group to which they are randomised
(Juni 2001), which the included trials appeared to do. It is also
suggested that primary outcomes for all patients randomised to
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groups should be recorded or estimated if not available. Three of
the included trials (Filocamo 2005; Moore 2008; Parekh 2003)
reported an analysis using the intention-to-treat principle, and
one trial (Burgio 2006) used survivor analysis in the original trial
analysis. In one trial where there was clear evidence of differential
dropout (Manassero 2007), the review authors elected to assume
that the men whose data were missing were continent. However,
attrition bias may have affected a number of the other trials which
did not present relevant data or discuss the issue.
In 21 trials in this review, men who were all incontinent were
analysed together. However, in seven of these trials (Goode 2009;
Joseph 2000; Moore 1999; Moore 2004; Opsomer 1994; Seleme
2008; Zhang 2007) men had longstanding or persistent inconti-
nence. It is possible that they might respond differently to the in-
terventions compared tomen recruited around the time of prostate
surgery.
Quality of the evidence
Trial quality and methodological assessment
The quality of the estimated treatment effect of any intervention is
determined partly by methodological assessment. Methodological
flaws within the included trials of this review were assessed using
the reports of the trials and therefore were reliant on the quality of
reporting. Data were not available in all the trials for many of the
pre-stated outcomes. CIs tended to be wide except for the more
recent large trials, and it was difficult to reliably identify or rule
out a useful effect.
All trials claimed to be randomised, but only 24 out of 50 tri-
als provided details of adequate sequence generation (Ahmed
2012; Burgio 2006; Centemero 2009; Dijkstra-Eshuis 2013;
Dubbelman 2004; Filocamo 2005; Fode 2014; Glazener RP
2011; Glazener TURP 2011; Goode 2009; Laurienzo 2013;
Manassero 2007; Mathewson-Chapman 97; Moore 1999; Moore
2004; Moore 2008; Overgard 2008; Park 2012; Robinson 2008;
Robinson 2009; Tibaek 2007; Tienforti 2012; van Kampen 1998;
Yamanishi 2006). Only 20 of the 50 trials provided details of
adequate concealment of randomisation (Ahmed 2012; Burgio
2006; Centemero 2009; Dijkstra-Eshuis 2013; Dubbelman 2004;
Fode 2014; Geraerts 2013; Glazener RP 2011; Glazener TURP
2011; Goode 2009; Manassero 2007; Moore 1999; Moore 2004;
Moore 2008; Overgard 2008; Park 2012; Robinson 2008; Tibaek
2007; vanKampen 1998; Yamanishi 2006) andwere subsequently
judged to be at low risk of selection bias. Additionally, blinding
to PFMT was not possible, and blinding of outcome assessment
appeared to be absent in many trials as it was not discussed. There-
fore, many trials were judged to be at high risk of performance
and detection bias.
The quality of the evidence was downgraded for the following.
• Study design i.e. there was evidence of methodological flaws
in the study design.
• Indirectness i.e. a surrogate outcome was selected when a
GRADE-specific outcome was not reported.
• Inconsistency, when there was evidence of statistical (either
clinical or methodological) heterogeneity.
• Imprecision, when the CIwas wide and crossed the line of
no effect.
• Publication bias. We planned to use funnel plot for
publication bias, however, there were fewer than 10 trials in the
meta-analysis and the funnel plot could not be used.
The quality of the evidence for the critical outcomes ranged from
moderate to very low, as evident in the summary of findings tables.
Potential biases in the review process
All relevant databases were searched and no language restriction
was imposed during the search process, which enabled as many
potentially eligible trials as possible to be included. Some reports
of trials may not be published and therefore the full extent of the
data may not have been obtained. One of the review authors was
involved in four of the included trials and another review author
was involved in two of the included trials. In order to account
for this potential bias in the review process, data extraction and
risk of bias assessment were performed by two independent review
authors, one of whom was not involved in any of the included
trials.
Agreements and disagreements with other
studies or reviews
A systematic review conducted by Macdonald et al (MacDonald
2007) was identified which addressed conservative management
of post-prostatectomy urinary incontinence. Macdonald and col-
leagues included 11 trials (Bales 2000; Burgio 2006; Filocamo
2005; Floratos 2002; Franke 1998; Mathewson-Chapman 97;
Moore 1999; Parekh 2003; van Kampen 1998; Wille 2003;
Yokoyama 2004), all of which were included in this review. They
did not distinguish between treatment and prevention trials. Mac-
donald and colleagues’ review analysed PFMT and PFMT with
biofeedback, focusing on any additional benefit from biofeedback.
The authors concluded that the use of guided PFMT was associ-
ated with superior patient outcomes compared with no treatment,
which differs from the findings of this review. TheMacdonald and
colleagues review did not include more recent trials because the
MEDLINE search only included trials up to 2006. Additionally,
the conclusions made in Macdonald’s review may have differed
because the authors did not utilise the GRADE approach, sug-
gesting the quality of the evidence was not assessed.
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A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In keeping with conclusions from earlier versions of this review, at
this point there remains no clear support that conservative man-
agement of any type is helpful for postprostatectomy UI whether
delivered as treatment to men who are incontinent or as preven-
tion to all men undergoing radical prostatectomy. The individual
result of one large multi-centre trial on its own did have narrow
confidence intervals which did not include a clinically significant
difference (of 15%) in the rate of incontinence between the groups.
It seems unlikely that men benefit from one-to-one PFMT ther-
apy after TURP.
Some small trials provided data to suggest that electrical stimu-
lation was better than control interventions (in one trial includ-
ing sham electrical stimulation), or active interventions which did
not include electrical stimulation, at least in the short term up to
six months. Individual small trials provided data to suggest that
extra-corporeal magnetic innervation (ExMI) or combinations of
treatments might be beneficial but the evidence was limited.
The trials suffered from a lack of standardised outcome measures.
Definitions of incontinence, measurement of quality of life and
types of pad tests (20 minute, 1 hour, 24 hour, number of pads,
weight of pads, number of men using pads and so on) varied in
almost every trial. The timing for measuring the primary outcome
should be at least 1 year.
No trials have tested the effect of lifestyle changes alone. Long-
term UI may be managed by absorbent pads or external penile
clamps, but there are safety problems with clamps.
This review did not find sufficient evidence as to whether or not
conservative management is effective in treating or preventing
postprostatectomy UI.
Implications for research
Urinary incontinence (UI) after prostatectomy is a distressing
problem and, although conclusive evidence does not exist, con-
servative approaches form part of current management. Well-de-
signed clinical trials are still needed to clarify the role of these ther-
apies. In addition, men with persistent severe UI could consider
surgical treatment for example with an artificial urinary sphincter
or male sling. However, these surgical options should also be tested
in RCTs as there is currently not enough evidence to support their
use (Silva 2011).
As there are known differences in the cause and prevalence of UI
between men after TURP and after radical prostatectomy, these
groups ofmen should continue to be studied separately. Prevention
trials in all men having surgery should be evaluated separately from
treatment trials of men who all have urinary incontinence after
surgery.
Most of the trials included in this review used very different pro-
tocols, of intervention type, timing and intensity. In order to de-
termine the effects of specific protocols and modalities, large ad-
equately powered trials using common protocols and common
standardised outcome measures are needed. Replication studies
using similar protocols in different populations would also assist
in identifying the populations in which specific conservative man-
agement approaches may be effective.
Definitions and measurement of outcomes varied in the included
trials. Future trials must attempt to use broadly accepted validated
outcome measures, such as those of the International Continence
Society (ICS). The primary outcome measure should be the par-
ticipant’s self-reported UI or its effects on his quality of life. Other
objective measures such as the pad test or urinary diaries can be
used to determine if continence has been achieved. Researchers
must also focus on either the 1 hour or 24 hour pad test, as the
results of these two measurements are not equivalent.
Lastly, authors should be encouraged to ensure appropriate mea-
sures are taken to avoid the risk of bias from selection, performance,
detection and attrition bias, in particular adequate sequence gen-
eration and secure concealment of allocation for randomisation,
and blinding of outcome measurement, and to report these ade-
quately using the guidelines of the CONSORT statement.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ahmed 2012
Methods RCT
Participants Time of recruitment: Pre-operatively
Population: 95 men after radical prostatectomy (whole population, with or without UI)
Included:men who underwent RP for clinically localized prostate cancer. Patients were
not taking anticholinergic drugs or any drug that may affect continence for the duration
of the study
Excluded: previous urethral, bladder or prostate surgery, prior urinary or faecal inconti-
nence, neurogenic and psychiatric disorders, pre-operative urinary tract complications,
radiotherapy
Age (mean, SD): A 57.2 (3.25); B 58.8 (5.4); C 56.3 (6.8)
Dropouts: 10 A: 4 (2 received radiotherapy, 2 had post-operative complications); B: 4 (2
received radiotherapy, 2 refused follow up); C: 2 (2 received radiotherapy)No differential
dropout
Baseline characteristics: Comparable at baseline
Interventions Time of intervention: Post-operative treatment
A (26): PFMT alone. At catheter removal men received standard care of verbal and
written instructions, active instructions from physiotherapist to perform 3 sets of 15 to
20 contractions daily, for a duration of 3 to 5 seconds with a 6 to 10 second rest period,
encouraged to perform exercises before functional activities such as sneezing, coughing,
or lifting weight, also in the supine position, sitting, squatting and going up and down
stairs
B (26): ES: treatment started one week after catheter removal, patients received 15
minutes of twice weekly electrical stimulation for 12 weeks
C (28): PFMT + BFB + ES: treatment started one week after catheter removal, patients
received twice weekly treatment with 15minutes of electrical stimulation and 15minutes
of biofeedback for 12 weeks, instructed to perform 3 series of 10 rapid contractions, 3
sustained contractions of 5, 7 or 10 seconds and then 10 contractions during prolonged
expiration in the supine position
All patients were given a logbook to complete daily regarding self-report of exercises
Duration of treatment: 12 weeks
Follow up: 6, 12 and 24 weeks
Outcomes Primary outcome (number of men with UI)
Number of incontinent men (defined as some pads required and weight gain of the pad
> 1 g during the test)
Baseline: A 22/26; B 22/26; C 23/28
2 months: A 21/26; B 19/26; C 18/28
3 months: A 17/26; B 12/26; C 20/28
6 months: A 9/26; B 6/26; C 1/28
Other outcomes
Leakage weight in grams on 24 hour pad test (mean (SD) N)
Baseline: A 791 (380.3) 26; B 790 (399.46) 26; C 785 (311.98) 28
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Ahmed 2012 (Continued)
2 months: A 533 (316.53) 26; B 383 (145.87) 26; C 263 (145.87) 28
3 months : A 260 (216.53) 26; B 132 (145.87) 26; C 83 (145.87) 28
6 months : A 123 (116.53) 26; B 98 (105.87) 26; C 36 (95.87) 28
Quality of life
(Higher score = worse)
Mean scores of IIQ-7 (mean (SD) N)
2 months: 40 (23) 26; B 36 (25) 26; C 26 (25) 28
3 months: 32 (26) 26; B 29 (28) 26; C 20 (24) 28
6 months: 25 (26) 26; B 23 (24) 26; C 15 (25) 28
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomised using “a computer-generated random-number list”
Allocation concealment (selection bias) Low risk “sealed envelopes”
Blinding of participants (performance bias) High risk Blinding to treatment not possible
Blinding of personnel (performance bias) Unclear risk “One experienced physiotherapist delivered all therapy”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk 4 (2 received radiotherapy, 2 had post-operative complications)
; B: 4 (2 received radiotherapy, 2 refused follow-up); C: 2 (2
received radiotherapy). No differential dropout
Selective reporting (reporting bias) Low risk All outcomes in methods were reported
Financial support Unclear risk Not reported. Therefore judged to be unclear risk.
Approved by medical ethics committee Low risk “At the time of this study, there was no Human Research Ethics
Committee established in the faculty, but the studywas approved
by the postgraduate affairs and departmental committee”
Informed consent Low risk “All patients signed an informed consent form”
ITT analysis Low risk Assumed from flow diagram of patients
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Bales 2000
Methods Randomised: yes
Method of allocation: not stated
Blinding: Outcome assessment nurse not involved in intervention
Dropouts: None mentioned
Participants Recruitment: pre-operative
Included: all men undergoing radical prostatectomy
N = 100 consecutive patients with stage T1c to T2c prostate cancer undergoing radical
retropubic prostatectomy by a single surgeon randomised into 2 groups
Interventions Pre-operative intervention
Group A (50) intervention: 2 to 4 weeks prior to surgery, participants underwent a 45
minute session with nurse trained in biofeedback. Patients were instructed to perform
graded PFMT. Contractions of 5 to 10 seconds, 10 to 15 repetitions were performedwith
biofeedback (surface electrodes used to measure muscle strength). Advised to practice
the exercises 4 times per day until surgery
Group B (50) control: no biofeedback training. Written and brief verbal instructions
from a nurse on how to perform PFMT (isolate muscle that stops urine flow, practice 4
times per day, 10 to 15 repetitions)
Both groups: Encouraged to perform PME 4 times per day after catheter removal 2
weeks post-operatively
Length of follow-up: 6 months
Outcomes Main outcome: time to return of continence measured by number of pads used
Continence definition: use of 1 pad or less per day
Data collection: at 1, 2, 3, 4, and 6 months post-operatively
There was no significant difference in incontinence between the groups
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description
Allocation concealment (selection bias) Unclear risk “Randomised”
Blinding of participants (performance bias) High risk Blinding not possible
Blinding of personnel (performance bias) High risk Blinding to intervention not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessment nurse not involved in
intervention
68Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Bales 2000 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Three patients dropped out of the biofeed-
back arm of the study because they never
completed their biofeedback session
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk No description
Approved by medical ethics committee Unclear risk Not reported
Informed consent Unclear risk Not reported
ITT analysis Unclear risk Not specified
Burgio 2006
Methods Randomised: yes
Method of allocation: stratified by age and tumour differentiation, then randomised
using computer generated random numbers, block size of 4 to ensure equity of number
in each group
Blinding: intervention providers and bladder diary scorers were blinded
Dropouts: 6 participants in the intervention group, and 7 in the control were excluded
after randomisation as surgery was cancelled. At 6 months, 6 in the intervention and 4
in the control were lost to follow-up
Participants Recruitment: pre-operative
Included: all men undergoing radical prostatectomy
N = 125 volunteer patients randomised, 13 excluded after randomisation
Analysis on N = 112 men aged 53 to 68 years who underwent radical prostatectomy for
prostate cancer. To be eligible, the men had to be ambulatory, continent and identified
at least 1 week prior to their surgery
Interventions Pre-operative intervention
Group A (57) intervention: single session of biofeedback (rectal probe to measure intra-
abdominal rectal pressure and external anal sphincter contraction) assisted behavioural
training. Feedback and verbal instruction used to teach control of pelvic muscles. Taught
to contract sphincter during 2 to 10 seconds periods separated by 2 to 10 seconds of
relaxation, dependent on ability. Written instructions for daily at home practice of 45
PFM exercises daily (3 sessions of 15 exercises each time). Additionally instructed to
slow or interrupt voiding once daily. Encouraged to exercise daily preoperatively, then
resume when catheter removed post-operatively
Group B (55) control: usual care of brief verbal instructions post operatively to interrupt
the voiding stream plus any instruction from physician
Length of follow-up: 6 months
Outcomes Main outcome:
Continual or episodic urine loss using bladder diaries, incontinent pads or other products
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Burgio 2006 (Continued)
Secondary outcomes:
Impact of incontinence and quality of life pre-operatively and at follow-up contacts by
IIQ, SCL-90-R and SF-36
Continence definition: 3 consecutive weekly 1 day diaries showing no leakage or a 7 day
diary showing no leakage
Data collection: 1 day bladder diaries mailed in each week. Questionaire on bladder
control, lifestyle and 7 day bladder diary at 6 weeks, 3 months and 6months post-surgery
Time to continence was significantly reduced in the intervention group. The intervention
group had a significantly smaller proportion of those with severe or continual leakage at
6 months, and stress type urine loss. No differences on quality of life, return to work or
activities between the groups
Notes Analysis by “intention to treat”. Additional data supplied to KFH by author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified by age and tumour differentia-
tion, then randomised using computer gen-
erated random numbers, block size of 4 to
ensure equity of number in each group
Allocation concealment (selection bias) Low risk Computer allocated. “The randomization
schedule was implemented by the research
nurse, so that interventionists would be
blinded to the next group assignment.”
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Low risk Intervention providers and bladder diary
scorers were blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Bladder diary scorers were blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 6 and 4 lost to follow-up at 6months; 6 and
7 excluded after randomisation as surgery
cancelled
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Low risk “Supported byGrant RO1DK50283 from
the National Institute for Diabetes and Di-
gestive and Kidney Diseases, National In-
stitutes of Health”
“The funding organization did not partici-
pate in the design or conduct of the study;
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Burgio 2006 (Continued)
collection, management, analysis or inter-
pretation of the data; or the preparation,
review or approval of the manuscript.”
Approved by medical ethics committee Low risk “This study was reviewed and approved by
the University and VA Medical center In-
stitutional Review Boards for Human use”
Informed consent Unclear risk “All participants provided informed con-
sent”
ITT analysis Low risk “intention to treat”. Patient flow diagram
Centemero 2009
Methods Randomised: yes
Method of allocation: 100 consecutive patients
Blinding: no
Participants Number of men 100
Recruitment: pre-operative
Included: all men undergoing radical prostatectomy
Excluded: impaired mental status, BMI.27, diabetes mellitus, neurological-rheumatic-
immune disease, neck-urethral surgery, prior catheterisation, post-operative catheterisa-
tion time longer than 6 days
Aged: 48-68 years
Interventions Group A (50) intervention: PFMT both pre and post-operatively. A structured PFMT
program 30 and 15 days before surgery, previous physiotherapist evaluation to provide
the patients with feedback about the quality of pelvic floor muscle function, PC test
(endurance and contraction quality), breathing co-ordination, typify muscle contraction
as tonic andmodify incorrect physical attitudes. Thiswas also repeated after the procedure
Group B (50) intervention: PFMT post-operatively only (no details as to whether this
is the same as the treatment pre-operatively above)
Duration of treatment: not stated
Length of follow-up: at one and three months
Outcomes UI at
1 month: A 33/59; B 47/59
3 month: A 24/59; B 37/59
24 hour pad test, number of subjects with pad test weight of > 150 g
1 month: A 15/59; B 20/59
3 month: A 10/59; B 19/59
Quality of life measured by the ICS male sf questionnaire, mean score
1 month: A 14.6 (6.36) 59; B 18.3 (6.36) 59
3month: A 8.1 (7.04) 59; B 12.2 (6.36) 59
Satisfaction scale (PGI-I) used only for Group A and 75% reported extreme satisfaction
for pre-operative PFMT
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Centemero 2009 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Individuals were randomised by a com-
puter-generated list that was centrally
maintained”. “Permuted block randomisa-
tion was used, with a block size of every 10
consecutively enrolled participants”
Allocation concealment (selection bias) Low risk “Individuals were randomised by a com-
puter-generated list that was centrally
maintained”. “Permuted block randomisa-
tion was used, with a block size of every 10
consecutively enrolled participants”
Blinding of participants (performance bias) High risk Blinding not possible
Blinding of personnel (performance bias) Low risk “The surgeon who performed the proce-
dures was blinded to randomisation alloca-
tion throughout the study”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “Only the statistician and the data moni-
toring committee saw unblinded data”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No description. It appears that there were
was no loss to follow-up
Selective reporting (reporting bias) Unclear risk Protocol not available. Therefore judged to
be unclear risk
Financial support Low risk None
Approved by medical ethics committee Low risk “The study was approved by the university
institutional review board”
Informed consent Low risk Patients were “provided written informed
consent”
ITT analysis Low risk Assumed from patient flow chart
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Dijkstra-Eshuis 2013
Methods RCT
Participants Time of recruitment: pre-operative
Population: men having a laparoscopic radical prostatectomy (whole population, with
or without UI)
Included: patients with prostate cancer, undergoing laparoscopic radical prostatectomy
Excluded: neurological disorders, a medical history with invasive perineal and/or rectal
surgery, preoperatively existing stress urinary incontinence, radiation, ≥ 75 years
Age (mean, SD): A 63.7 (5.3); B 63.7 (5.3)
Dropouts: 9 from A (1 unable to understand Dutch, 3 post-operative radiotherapy, 1
oesophageal cancer, 3 discontinued intervention at own request, 1 excluded due to poor
compliance) 8 from B (2 post operative radiotherapy, 1 pelvic lymph node dissection, 1
died of cause unrelated to prostate cancer, 5 discontinued intervention at own request,
1 prolonged catheter) Not differential dropout
Baseline characteristics: comparable at baseline
Interventions Time of intervention: pre-operative (+ postoperative treatment for all men)
A (56): 30 mins of guided PFMT + biofeedback weekly for 4 weeks before surgery,
received written instructions to: carry out two sets of 30 contractions during abdominal
breathing, one breath between each contraction; restart PFMT after catheter removal (7
to 10 days after surgery)
B (46): received written instructions on PFMT after catheter removal (7 to 10 days after
surgery)
All men were seen before surgery by a physiotherapist, who explained relevant anatomy,
anal visual inspection and digital palpation, biofeedback registration with rectal probe
All patients receivedPFMT+biofeedback and/or electrical stimulation if still incontinent
after 6 weeks
Duration of treatment
Follow up: 6 weeks, 3 months, 6 months, 9 months and 12 months after surgery
Outcomes Primary outcome (number of men with UI)
Number of incontinent men (leakage on 24 hour pad test)
12 months: A 20/58; B 9/45
Other outcomes
Number of continent men after 1 year (no leakage at all on 24 hour pad test)
12 months: 38/58; B 36/45
Adverse effects:
A 0/56; B 0/46
Quality of life
King’s Health Questionnaire (KHQ) (mean (SD) N):
General health
12 months: A 24.48 (50.7) 56; B 29.64 (50.7) 46
Role limitations
12 months: A 21.36 (22.2) 56; B 17.73 (22.2) 46
Physical limitations
12 months: A 16.49 (15.45) 56; B 13.48 (15.45) 46
Social limitations
12 months: A 7.98 (24.8) 56; B 4.15 (24.8) 46
Personal
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Dijkstra-Eshuis 2013 (Continued)
12 months: A 18.72 (4.4) 56; B 19.62 (4.4) 46
Emotional
12 months: A 5.08 (7.0) 56; B 4.24 (7.0) 46
Sleep or energy disturbance: A 9.13 (39.0) 56; B 6.13 (39.0) 46
Symptom severity: A 14.62 (86.1) 56; B 10.93 (86.1) 46
Notes Trial was stopped early because interim analysis found no benefit for group A
Additional information supplied by author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Computer-generated random numbers with block randomiza-
tion and variable block size”
Allocation concealment (selection bias) Low risk “central computer system”
Blinding of participants (performance bias) Unclear risk “participants were also blinded until their first visit to the pelvic
floor physiotherapist”
Blinding of personnel (performance bias) Low risk “The pelvic floor physiotherapists were blinded to randomiza-
tion” (to pre-operative randomisation)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessor blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 9 from A (1 unable to understand Dutch, 3 post-operative ra-
diotherapy, 1 oesophageal cancer, 3 discontinued intervention
at own request, 1 excluded due to poor compliance) 8 from B (2
post-operative radiotherapy, 1 pelvic lymph node dissection, 1
died of cause unrelated to prostate cancer, 5 discontinued inter-
vention at own request, 1 prolonged catheter á demeure). Not
differential dropout
Selective reporting (reporting bias) Low risk All outcomes in methods were reported
Financial support Low risk None
Approved by medical ethics committee Low risk “Medical ethical approval was obtained from theMedical Ethics
committee of our university hospital”
Informed consent Low risk “Informed consent was obtained”
ITT analysis Low risk Assumed from flow diagram
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Dubbelman 2004
Methods Randomised: yes
Participants Recruitment: post-operative
Included: men incontinent post-radical prostatectomy (≥ 1 g urine loss on 1 hour pad
test), one week after catheter removal
Excluded: pre-operative UI
N = 66 men completing the trial, 33 in intervention group, 33 in control
All participants had a radical retropubic prostatectomy and livedwithin 75 kmof hospital
Age range 61 to 67 years
Interventions Post-operative intervention
A (35) intervention: 9 or less sessions of physiotherapy guided pelvic floor exercises after
surgery plus information folder
B (44) control: exercise instruction through information folder only
Length of follow-up: 6.5 months
Dropouts: A 1, B 2 due to stricture; + A 1, B 3 refused further measurements; + B 5
withdrew consent or 1 did not understand
Outcomes Continence definition: incontinence defined as loss of at least 1 gram of urine on 1 hour
pad test and 4 grams on the 24 hour pad test
Main outcome: urinary incontinence on both 1 hour (> 1 g) and 24 hour (> 4 g) pad
tests
Secondary outcome: urodynamic study (urethral pressure profilometry)
Data collection: 1 and 26 weeks after catheter removal
Number of wet men at 6 months: A: 17/33, B: 20/33
No significance difference in continence rates between the groups
Notes Sample size required 96 men in each arm
Other data presented as median (IQR)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number generator to achieve 1:1 ratio
Allocation concealment (selection bias) Low risk Sealed envelopes, sequentially numbered, opened by trial nurse
after result of pad test was known
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Unclear risk “The physiotherapist who guided men in the PGPFME group
was unaware of the outcome data of both treatment groups”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “The data for outcome assessment (e.g. pad-tests, voiding di-
aries) were collected and entered in a data base by a trial nurse
who was not involved in the treatment or intervention”
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Dubbelman 2004 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk 13 dropped out (of which 2 from intervention group)
Selective reporting (reporting bias) Low risk All outcomes in methods reported
Financial support Unclear risk No description
Approved by medical ethics committee Low risk “approved by our institutional review board”
Informed consent Low risk “informed consent”
ITT analysis Unclear risk “the concept of an intent to treat analysis was not applied”.
Authors also state, “Participants were analysed in the group to
which they were allocated at randomization”
Fader 2013
Methods RCT Cross-over design
Participants Time of recruitment: post-operative
Population: 74 men with incontinence after prostate surgery
Included: men who were experiencing incontinence more than a year after prostate
cancer treatment and using absorbent pads
Excluded: no description
Age (mean, SD): no description
Dropouts: no information
Baseline characteristics: no information
Interventions Time of intervention: post-operative
A: penile compression device (clamp)
B: sheath drainage system (sheath)
C: body-worn urinals (BWU)
D: pads alone
All men tested each device for three weeks and asked to state which device was preferred
Duration of treatment: 3 weeks with each device
Follow-up: 3 months
Outcomes Primary outcome (number of men with UI)
Not reported
Other outcomes
Overall opinion: patient satisfaction questionnaire related to device performance
Asked to state which device they preferred:
Pads were most highly rated compared with sheaths (P = 0.31), clamps (P < 0.01) and
BWUs (P < 0.001)
The clamp was rated as more secure, less leaky and less restrictive of clothing choice than
the others (P < 0.05) but was more painful than the rest (P<0.002)
Three months later asked which products they were actually using and for what activities
and circumstances:
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Fader 2013 (Continued)
30/56 using a combination of devices and pads
Quality of life
EORTC QLC C30
IIQ-7
ICIQ-UI
King’s Health Questionnaire
Notes Awaiting further information from author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “random order” cross-over design
Allocation concealment (selection bias) Unclear risk “random order”
Blinding of participants (performance bias) High risk Blinding was not possible for participants
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be unclear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information. Therefore judged to be unclear risk
Selective reporting (reporting bias) High risk Quality of life outcome not reported
Financial support Low risk Prostate Cancer UK
Approved by medical ethics committee Low risk Southampton and South West Hampshire Research Ethics
Committee (REC)
Informed consent Low risk Yes
ITT analysis Unclear risk Not specified
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Filocamo 2005
Methods Randomised: yes
Method of allocation: block randomisation, block size of 4 for 2 groups (A and B) with
only one permutation code (ABBA)
Blinding: not described
Dropouts: at 12 months, 2 participants dropped out of the control group
Intention to treat: yes
Participants Recruitment: post-operative
Included: all men undergoing RRP
N = 300 consecutive men post RRP, randomised after catheter removal to 2 groups
Intervention group: N = 150
Control group: N = 150
Interventions Post-operative intervention
Group A (150) intervention: formal instruction (3 treatment sessions plus at home
exercises) in PFMT using verbal explanation, palpation and visualization of the base of
the penis with a mirror, in different positions and prior to sneezing, coughing or lifting
Group B (150) control: no formal instruction
Length of follow-up: 12 months
Outcomes Main outcome: urine loss on 1 hour and 24 hour pad tests plus number of pads used
daily
Continence definition: 0 to 1 pads per day
Data collection: 1, 3, 6, and 12 months
Wet (leakage or use of pads)
1 month: A 145/150, B 147/150
3 months: A 115/150, B 129/150
6 months: A 35/150, B 102/150
12 months: A 16/150, B 49/148
Surgical implantation of artificial urinary sphincter: A 2/150, B 3/148
Notes 74% of the intervention group achieved continence at 3 months compared to only 30%
of the control (a significant difference favouring intervention)
Differences between the groups declined between 6 to 12months, withmost participants
achieving continence in 1 year
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Block randomisation, block size of 4 for 2
groups (A and B) with only one permuta-
tion code (ABBA)
Allocation concealment (selection bias) Unclear risk Not stated. Therefore judged to be unclear
risk
Blinding of participants (performance bias) High risk Blinding to intervention not possible
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Blinding of personnel (performance bias) High risk Blinding to intervention not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description of blinding of pad test or
data entry from questionnaires
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 2 dropped out of control group but none
from intervention
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk Not reported. Therefore judged to be un-
clear risk
Approved by medical ethics committee Low risk “Approved by the Ethics Committee of our
Institution”
Informed consent Low risk “All patients signed an informed consent
form”
ITT analysis Unclear risk Not specified
Floratos 2002
Methods Randomised: yes
Method of allocation: randomised 2:1 to intervention: control groups
Blinding: not mentioned
Dropouts: 1 participant randomised to intervention unable to follow intervention pro-
tocol (unable to attend clinic, provided with control invention)
Intention to treat: yes
Participants Recruitment: post-operative
Included: men incontinent post-radical prostatectomy one week after catheter removal
N = 42 consecutive patients
Interventions Post-operative intervention
Group A (28) intervention: initiated after catheter removal. Intervention group received
15 treatment sessions (3 times per week for 30 minutes) of PFMT with EMG (surface)
biofeedback in clinic
Group B (14) control: instruction with verbal feedback and an information pamphlet
with instructions to perform PME 50 to 100 times daily at home
Length of follow-up: 6 months
Outcomes Main outcome: incontinence episodes measured by 1 hour pad test and continence
questionnaire (pads used, number of incontinence episodes)
Continence definition: incontinence defined as a urine loss of > 1 g on the 1 hour pad
test; 2 or more pads/day a not deemed a “socially acceptable continence rate”
Data collection: baseline, 1, 2, 3 and 6 months
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Floratos 2002 (Continued)
Level of incontinence in both groups declined over the 6 months of the study. Control
group had less urine loss and appeared to regain continence sooner, but the difference
was not significant
Notes Additional data supplied to KFH by author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description. Therefore judged to be un-
clear risk
Allocation concealment (selection bias) Unclear risk Randomised 2:1 to intervention: control
groups
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) High risk Blinding to intervention not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported. Therefore judged to be un-
clear risk
Incomplete outcome data (attrition bias)
All outcomes
High risk 1 dropped out of intervention group but
followed control intervention - unclear if
analysed as control
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk Not reported. Therefore judged to be un-
clear risk
Approved by medical ethics committee Unclear risk Not reported. Therefore judged to be un-
clear risk
Informed consent Low risk “Patientswere informed about the aims and
perspectives of the study. Eligible patients
consented”
ITT analysis Unclear risk “Analysed using the intention-to-treat ap-
proach”. Authors also state “One of the
patients initially randomized to group A
could not follow the programme but per-
formed PMEs under verbal instruction”
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Fode 2014
Methods RCT
Participants Time of recruitment: pre-operative
Population: 83men undergoing nerve sparing radical prostatectomy (whole population,
with or without UI)
Included: sexually active men with an IIEF score of at least 18 without aids, continent
pre-operatively
Excluded: condition thatmay prevent patient being able to have post-operative treatment
with PDE5-inhibitor
Age (mean, range): A 62 (46-73); B 65 (49 to 76)
Dropouts: 12 from group A (3 excluded because underwent non-nerve sparing surgery,
2 withdrew consent, 1 lost a partner, 6 non-compliance), 3 from group B (2 excluded
because underwent non-nerve sparing surgery, 1withdrew consent). Differential dropout
Baseline characteristics: comparable except Group A significantly more LUTS pre-
operatively
Interventions Time of intervention: pre-operative + post-operative
A (30): pre-operative session guided PFMT + instruction on how to use penile vibratory
stimulationdevice, instructed to stimulate frenulumonce daily, 10 seconds of stimulation
then 10 second pause, repeated 10 times for 1 week pre-operatively, Instructed to restart
stimulation after catheter removal for 6 weeks
B (38): pre-operative session guided PFMT
All men were offered a PDE5 inhibitor after 1 month post-operatively and also received
telephone contact to ensure compliance with treatment
Duration of treatment: 6 weeks
Follow up: 3, 6 and 12 months post-operatively
Outcomes Primary outcome (number of men with UI)
Number of incontinent men (men reporting use of more than one pad daily)
3 months: A 14/42; B 15/41
6 months: A 7/42; B 3/41
12 months: A 3/30; B 2/38
(dropout figures added to 3 and 6 months)
Other outcomes
Continence rate (patients reporting use of up to one pad daily for security reasons only)
3 months: A 65.5%; B 62.9%, P = 0.83
6 months : A 83.3%; B 91.9%, P = 0.28
12 months : A 90%; B 94.7%, P = 0.46
Median (range) pad use
3 months: A 1 (0 to 6); B 5 (0 to -34), P = 0.09
6 months: A 0 (0 to 3); B 1/3 (0 to 6), P = 0.14
12 months: A 0 (0 to 2); B 0 (0 to 3), P = 0.56
Median (range) IIEF-5
3 months : A 5 (0 to 25); B 5 (0-25), P = 0.25
6 months : A 10.5 (0 to 25); B 5 (0-25), P = 0.08
12 months : 18 (0 to 25); B 7.5 (0-25), P = 0.09
IIEF ≥ 18, n/N (%)
3 months: 5/30 (17); B 4/38 (11), P = 0.46
6 months: 13/30 (43); B 9/38 (24), P = 0.09
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Fode 2014 (Continued)
12 months: 16/30 (53); B 12/38 (32), P = 0.07
Adverse effects: A: 5/30 reported side effects as a result of penile vibratory stimulation (1
red spots on glans penis, 1 small laceration + some bleeding, 2 complained of soreness,
1 frank pain post-operatively)
B: 0/38
Quality of life
Median (range) DAN-PSS post-operatively
3 months: A 1 (0 to 34); B 5 (0-34), P = 0.74
6 months: A 2 (0 to 41); B 1 (0-48), P = 0.74
12 months: A 3 (0 to 36); B 0.5 (0-21), P = 0.13
Notes Further information provided by authors
PDE5 (phosphodiesterase yype 5) inhibitor is used for erectile dysfunction
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “randomized prospective trial” and “randomized by a draw”
Allocation concealment (selection bias) Low risk Used opaque sealed envelopes
Blinding of participants (performance bias) High risk “It was not possible to create a believable sham device, which
could maintain blinding of the study subjects”
Blinding of personnel (performance bias) Unclear risk Not reported. Therefore judged to be unclear risk
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcome assessor not blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk 12 from group A (3 excluded because underwent non-nerve
sparing surgery, 2 withdrew consent, 1 lost a partner, 6 non-
compliance), 3 from group B (2 excluded because underwent
non-nerve sparing surgery, 1 withdrew consent). Differential
dropout
Selective reporting (reporting bias) Low risk Outcomes in methods reported
Financial support Low risk “This study was funded by unrestricted grants from the Velux
Foundation and Grosserer L.F. Foghts Foundation”
Approved by medical ethics committee Low risk “The study was approved by the Danish ethical counsel and the
Danish Data protection Agency”
Informed consent Low risk Assumed as they acquired ethical approval
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Fode 2014 (Continued)
ITT analysis Low risk Assumed from patient flow diagram
Franke 1998
Methods Randomised: yes
Method of allocation: not stated
Blinding: none
Dropouts: 2with gravitational incontinence consistentwith intrinsic sphincter deficiency
Intention to treat: not clear
Participants Recruitment: post-operative
Included: men incontinence post-radical prostatectomy at 6 weeks post surgery
N = 30 men: 6 weeks post-radical prostatectomy with post-void residual of < 50 ml; no
previous TURP, no urinary tract infection, no neurological conditions
Interventions Post-operative intervention.
Group A (13): intervention, biofeedback (perineal patch EMG) enhanced PFMT; exer-
cise treatment sessions at 6, 7, 9, 11, and 16 weeks post-operatively
Group B (10): control, completed bladder diary but did not have any other intervention
Length of follow-up: 12 months
Outcomes Main outcome: urine loss measured by voiding diary, 48 hour pad test (reported as mean
grams of urine lost in 24 hours), and incontinence questionnaire
Continence definition: not clear. Participants described as “completely dry” or with
“significant incontinence”
Data collection: 6, 12 and 24 weeks
There were no significant differences between treatment or control groups on any of the
outcome measures at any of the measurement intervals
Notes Numbers in the groups unclear as 5 withdrew from the study after initial randomisation.
Not clear how many were in each group prior to follow-up at 6 weeks
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description. Therefore judged to be un-
clear risk
Allocation concealment (selection bias) Unclear risk “Randomised”
Blinding of participants (performance bias) High risk Blinding not possible. Therefore judged to
be at high risk
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be un-
clear risk
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Franke 1998 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description. Therefore judged to be un-
clear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Five men withdrew after initial randomi-
sation. Dropouts from 25 left at 6 weeks
appears to be 10
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Low risk None
Approved by medical ethics committee Unclear risk Not reported. Therefore judged to be un-
clear risk
Informed consent Low risk “Informed consent was obtained”
ITT analysis Unclear risk Not specified
Geraerts 2013
Methods RCT
Participants Time of recruitment: pre-operative
Population: men having a radical prostatectomy (whole population, with or without
UI)
Included:men planning to undergo open radical prostatectomy (ORP) or robot-assisted
laparoscopic radical prostatectomy (RARP)
Willing to accept ambulatory visits once a week until total continence was achieved;
willing to perform measurements pre-operatively and at 1 month, 3 months, 6 months
and 12 months after surgery
Excluded: cognitive problems; non-Dutch speaking; simultaneous other surgery; trans-
port problems; lack of time; psychosocial/other medical problems; refused participation;
insisted on preoperative PFMT; not approachable; not enough time between diagnosis
and date of planned surgery
Age (mean, SD): A 62 (5.90); B 62 (6.33)
Dropouts: 6 fromA; (1 died, 1 cerebrovascular accident, 3 transport problems, 1 refused
further participation) 4 from B: (2 transport problems, 2 refused further participation).
Not differential dropout
Baseline characteristics: Comparable at baseline
Interventions Time of intervention: pre-operative
A (85): 30 mins of guided PFMT + biofeedback weekly for 3 weeks before surgery
instructed to: carry out 60 contractions a day at home; contract their pelvic floor while
coughing, and sitting down or getting up from a chair; restart PFMT on day 4 after
surgery while catheter was in situ
B (85): instructed to start PFMT on the day after catheter removal (e.g. 2 to 3 weeks
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Geraerts 2013 (Continued)
after surgery)
All men performed an individual guided exercise programme with digital or EMG
biofeedback postoperatively weekly, delivered by a therapist (blinded to group allocation)
different from the pre-operative Group A therapist. This included advice on using PF
muscles to prevent leakage during functional activities
Duration of treatment: as long as any degree of UI persisted
Follow up: 1 month, 3 months, 6 months and 12 months after surgery
Outcomes Primary outcome (number of men with UI)
Number of incontinent men (1 hour pad test defined as ≤ 1 g)
1 month: A 37/85; B 35/86, P = 0.758
3 months: A 15/86; B 15/86, P = 1.000
6 months: A 8/86; B 5/85, P = 0.566
12 months: A 7/81; B 7/83, P = 1.000
Other outcomes
Cumulative incidence of number of continent men
1 month: A 44/85; B 44/85
3 months: A 67/85; B 71/85
6 months: A 80/85; B 80/85
12 months: A 83/85; B 81/85
Point prevalence of continence, 1 hour pad test, defined as 0 g
1 month: A 42/85; B 41/86
3 months: A 63/86; B 61/86
6 months: A 76/86; B 73/85
12 months: A 68/81; B 73/83
Point prevalence of continence, VAS scale, defined as ≤ 1/10
1 month: A 35/89; B 38/88
3 months: A 64/88; B 52/87
6 months: A 73/88; B 65/86
12 months: A 72/84; B 62/84
Urine loss on 24 hour pad test in grams (mean (SD) N):
1 month: A 90 (?) 85; B 85 (?) 85
3 months: A 17 (?) 85; B 13 (?) 85
6 months: A 12 (?) 85; B 3 (?) 85
12 months: A 2 (?) 85; B 3 (?) 85
Quality of life
International prostate SymptomScore (IPSS), King’sHealthQuestionnaire (KHQ): data
not given
Only one aspect of the King’s Health Questionnaire, incontinence impact, favoured A
at 3 (P = 0.008) and 6 months (P = 0.024) after surgery
Notes Some men had pre-operative incontinence
Risk of bias
Bias Authors’ judgement Support for judgement
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Geraerts 2013 (Continued)
Random sequence generation (selection
bias)
Unclear risk Sequence of randomisation was carried out using a “computer
program” and was “determined by the patients’ presence at the
outpatient urology clinic”. It is unclear what influence the pa-
tients’ presence had on randomisation
Allocation concealment (selection bias) Low risk “Allocation to the treatment groups was concealed”.Method not
reported
Blinding of participants (performance bias) High risk Blinding was not possible for participants
Blinding of personnel (performance bias) Low risk Post-operative treatment was delivered by a therapist who was
blinded to group allocation and treatment delivered by the pre-
operative Group A therapist
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “One blinded and well-trained assessor performed the measure-
ments”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Dropouts: Group A: 6 (1 died, 1 cerebrovascular accident, 3
transport problems, 1 refused further participation); Group B:
4 (2 transport problems, 2 refused further participation)
Selective reporting (reporting bias) High risk Results not reported for quality of life outcomes
Financial support Low risk Unconditional funding from the “Agency for innovation by Sci-
ence and Technology (Applied Biomedical Research): govern-
mental grant”
Approved by medical ethics committee Low risk “Ethical approval from the commission on medical ethics of the
University Hospitals Leuven”
Informed consent Low risk Patients “signed written informed consent”
ITT analysis Low risk “Data were analyzed according to the intention-to-treat princi-
ple”
Ghanem 2013
Methods RCT
Participants Time of recruitment: pre-operative
Population: 100 men undergoing a radical prostatectomy (whole population, with or
without UI)
Included: men undergoing RP for clinically localized prostate cancer.
Excluded: patients who had previous pelvic organ surgeries, patients with central or
peripheral neurologic diseases
Age (mean, SD): not reported
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Ghanem 2013 (Continued)
Dropouts: not reported
Baseline characteristics: not reported
Interventions Time of intervention: pre-operative (post-operative treatment for all men)
A (50): pre-operative PFMT for 2 weeks + post-operative PFMT programme
B (50): post-operative PFMT programme only
Duration of treatment
Follow-up: 3.5, 4.5, 12, 13 and 13.5 months
Outcomes Primary outcome (number of men with UI)
Number of incontinent men (defined as using > 1 pad on pad test)
12 months: A 2/50; B 3/50
13 months: A 2/50; B2/50
Other outcomes
Quality of life
ICS male SF questionnaire, results not reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients were divided randomly”
Allocation concealment (selection bias) Unclear risk Not reported. Therefore judged to be unclear risk
Blinding of participants (performance bias) High risk Blinding to treatment not possible
Blinding of personnel (performance bias) Unclear risk Not reported. Therefore judged to be unclear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not reported. Therefore judged to be unclear risk
Selective reporting (reporting bias) Unclear risk Protocol not available. Therefore judged to be unclear risk
Financial support Low risk None
Approved by medical ethics committee Low risk “Faculty of Physical Therapy Ethical committee, Cairo Univer-
sity”
Informed consent Low risk Yes
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ITT analysis Unclear risk Not specified
Glazener RP 2011
Methods RCT
Participants Recruitment: post-operative
Included:menwith persistent urinary incontinence at 6weeks after radical prostatectomy
Excluded: radiotherapy planned; unable to comply with study or intervention; previous
formal PFMT
Age (mean, SD): A 62.4 (5.8); B 62.3 (5.6)
Interventions A (205): one-to-one therapy sessions including PFMT and BT if OAB or urgency symp-
toms + PFMT and lifestyle leaflet
Duration of treatment: 4 sessions in 3 months starting 6 weeks after surgery
B (206): control group with standard care + lifestyle leaflet only, no individual PFMT
instruction or sessions
Outcomes UI defined as positive response to ICIQ-SF questionnaire
UI at 3 months: A 172/200, B 176/198
UI at 6 months: A 158/197, B 158/197
UI at 9 months: A 144/191, B 157/194
UI at 12 months: A 148/196, B 151/195
Severe UI at 12 months: A 74/196, B 78/195
UI episodes at 12 months from diaries (mean (SD N): A 3 (3.8) 105, B 2.9 (3) 106
ICI-Q score at 12 months (mean (SD N): A 4.9 (4.1) 196, B 5.4 (4.5) 195
QoL due to UI at 12 months (mean (SD N): A 1.4 (2) 193, B 1.7 (2.3) 193
Use of pads at 12 months: A 63/159, B 68/161
Men not doing PFMT at 12 months: A 63/191, B 91/189
Erectile dysfunction (no erection): A 105/189, B 105/190
QALYs virtually identical
Cost: NHS intervention cost was GBP 181 higher in intervention group (95% CI 107
to 255)
Other outcomes: use of other protection, catheters, sheath catheters, urinary frequency,
nocturia, faecal incontinence, urgency, constipation, EQ5D, SF-12
Notes Low dropout rates
ICI-Q score: 0 = no UI, no effect on QoL; 21 = maximum amount, frequency and effect
on QoL
QoL due to UI measured using ICIQ-SF: 0 = no effect, 10 = maximum effect
Compliance with therapy high
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated, minimised on centre, age and pre-existing
urinary incontinence
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Allocation concealment (selection bias) Low risk Remote computer allocation
Blinding of participants (performance bias) High risk Blinding to intervention not possible for men
Blinding of personnel (performance bias) High risk Blinding to intervention not possible for therapists
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcomes from questionnaires completed by men, data entry
clerks blinded to group
Incomplete outcome data (attrition bias)
All outcomes
Low risk No differential dropout from the groups
Selective reporting (reporting bias) Low risk Outcomes in methods were reported
Financial support Low risk “The trial was funded by the National Institute of Health
Research Health Technology Assessment (NIHR HTA) Pro-
gramme (project number 03-14-03) and will be published in
full in Health Technology Assessment. HSRU, HERU, and
NMAHP RU are funded by the Chief Scientist Office of the
Scottish Government Health Directorates”
Approved by medical ethics committee Low risk “Our trials were approved by the Multicentre Research Ethics
Committee, Edinburgh, Scotland and overseen by an indepen-
dent trial steering committee and a separate independent data
monitoring committee”
Informed consent Low risk “All men gave signed informed consent”
ITT analysis Low risk “We used intention-to-treat analysis”
Glazener TURP 2011
Methods RCT
Participants Recruitment: post-operative
Included: men with persistent urinary incontinence at 6 weeks after transurethral resec-
tion of the prostate (TURP)
Excluded: radiotherapy planned; channel TURP for palliation for prostate cancer; unable
to comply with study or intervention; previous formal PFMT
Age (mean, SD): A 68.2 (7.7); B 67.9 (8.1)
Interventions A (220): one-to-one therapy sessions including PFMT and BT if OAB or urgency symp-
toms + PFMT and lifestyle leaflet
Duration of treatment: 4 sessions in 3 months starting 6 weeks after surgery
B (222): control group with standard care + lifestyle leaflet only, no individual PFMT
instruction or sessions
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Glazener TURP 2011 (Continued)
Outcomes UI defined as positive response to ICIQ-short form questionnaire
UI at 3 months: A 142/205, B 132/208
UI at 6 months: A 140/199, B 129/201
UI at 9 months: A 133/197, B 131/202
UI at 12 months: A 126/194, B 125/203
Severe UI at 12 months: A 48/194, B 49/203
UI episodes at 12 months from diaries (mean (SD N): A 1.4 (2.3) 175, B 1.2 (2.2) 179
ICI-Q score at 12 months (mean (SD N): A 3.9 (3.7) 194, B 4 (4.3) 203
QoL due to UI at 12 months (mean (SD N): A 1.2 (1.9) 190, B 1.3 (2.2) 199
Use of pads at 12 months: A 24/146, B 24/136
Men not doing PFMT at 12 months: A 66/188, B 154/193
Erectile dysfunction (no erection): A 52/177, B 43/178
QALYs virtually identical
Cost: NHS intervention cost was GBP 209 higher in intervention group (95% CI 147
to 271)
Other outcomes: use of other protection, catheters, sheath catheters, urinary frequency,
nocturia, faecal incontinence, urgency, constipation, EQ5D, SF-12
Notes Low dropout rates
ICI-Q score: 0= no UI, no effect on QoL; 21 = maximum amount, frequency and effect
on QoL
QoL due to UI measured using ICIQ-SF: 0 = no effect, 10 = maximum effect
Compliance with therapy high
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated, minimised on centre, age and pre-existing
urinary incontinence
Allocation concealment (selection bias) Low risk Remote computer allocation
Blinding of participants (performance bias) High risk Blinding to intervention not possible for men
Blinding of personnel (performance bias) High risk Blinding to intervention not possible for therapists
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcomes from questionnaires completed by men, data entry
clerks blinded to group
Incomplete outcome data (attrition bias)
All outcomes
Low risk No differential dropout from the groups
Selective reporting (reporting bias) Low risk Outcomes in methods were reported
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Glazener TURP 2011 (Continued)
Financial support Low risk “The trial was funded by the National Institute of Health
Research Health Technology Assessment (NIHR HTA) Pro-
gramme (project number 03-14-03) and will be published in
full in Health Technology Assessment. HSRU, HERU, and
NMAHP RU are funded by the Chief Scientist Office of the
Scottish Government Health Directorates”
Approved by medical ethics committee Low risk “Our trials were approved by the Multicentre Research Ethics
Committee, Edinburgh, Scotland and overseen by an indepen-
dent trial steering committee and a separate independent data
monitoring committee”
Informed consent Low risk “All men gave signed informed consent”
ITT analysis Low risk “We used intention-to-treat analysis”
Goode 2009
Methods Randomised controlled trial
Participants Recruitment: post-operative
Included: men incontinent 1 to 16 years after radical prostatectomy (mean years since
operation: A 5.1, B 3.9, C 5.1)
N = 208 (prior to dropout). Analysis of 172 men at 8 weeks
Age between 51 to 84 years
% of men with prior PFMT instruction: A 36%, B 56%, C 47%
% of men using antimuscarinics: A 16%, B 20%, C 28%
% of men with urgency UI: A 1%, B 3%, C 2%
% of men with stress UI: A 44%, B 47%, C 44%
% of men with mixed UI: A 54%, B 50%, C 54%
Interventions A (70): behavioural therapy with PFMT alone for 8 weeks
B (70): behavioural therapy with biofeedback and electrical stimulation for 8 weeks
C (68): control, no treatment for 8 weeks, then offered choice of intervention A or B
Behavioural therapy consisted of pelvic floor muscle exercises and bladder control strate-
gies in both groups
Dropouts: A 19 at 6 months, 23 at 12 months; B 22 at 6 months, 36 at 12 months; C
3 at 8 weeks
Length of follow-up: 12 months for groups A and B C transferred to treatment at 8
weeks so no further follow up possible
Outcomes Frequency of UI, mean accidents in a week
Number of continent men at 8 weeks: A 11/70, B 12/70, C 4/68
Incontinence episodes per day at 8 weeks (mean, SD, N): A 1.86 (0.56) 58; B 1.71 (0.
54) 54; C: 3 (1.17) 64
Change in quality of life at 8 weeks using EPIC UI subscale (bigger change is better,
mean, SD, N): A 13.1 (15.5) 58; B 12.3 (14.6) 54; C 2.9 (12.4) 64
Adverse events: A 0/70, B 2/70 (haemorrhoidal irritation), C 0/68
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Patient’s Global Perceptions of Improvement (much better): A 90%, B 91%, C 10%
Completely satisfied with treatment progress: A 47%, B 47%, C not reported
Compliance with PFMT and bladder control strategies at 8 weeks: A 100%, B 93%
Compliance at 6 months: A 82%, B 84%
Compliance at 12 months: A 91%, B 81%
Notes Some baseline differences between groups, did not quite reach statistical significance
High dropout rates
No data available for control group after eight weeks as all received treatment
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified by site, type and frequency of UI, generated by
computer programme
Allocation concealment (selection bias) Low risk Sealed envelopes, opened sequentially
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Unclear risk Data entry staff blinded to group
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcomes from questionnaires completed by men, data
entry staff blinded to group
Incomplete outcome data (attrition bias)
All outcomes
High risk Analysis and reported tables on 172 men
Selective reporting (reporting bias) Low risk Results of outcomes reported
Financial support Low risk National Institutes of Health - National Institute of Di-
abetes and Digestive and Kidney Diseases, grant R01
DK60044-01A2
Approved by medical ethics committee Low risk Approved by “University of Alabama at Birmingham In-
stitutional Review Board”
Informed consent Low risk Yes
ITT analysis Unclear risk Not specified
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Hoffman 2005
Methods Randomised: yes
Method of allocation: computerised randomisation
Blinding: unclear
Dropouts: 1 participant from each intervention group had dropped out by discharge;
15 dropouts from the perineal group, 31 from the anal group and 5 from the control
group dropped out by 3 months
Intention to treat: no
Participants Recruitment: post-operative
Included: men incontinent post-radical prostatectomy in an inpatient rehabilitation
program
N= 180 men (prior to dropouts). Randomly assigned to 3 groups (60 in each group)
Interventions Post-operative intervention
Group A (60) intervention: perineal ES plus physiotherapy (PFMT)
Group B (60) intervention: anal ES plus physiotherapy (PFMT)
Group C (60) control: PFMT alone.
Length of follow-up: 3 months
Outcomes Main outcome: urine loss measure on 1 hour pad test
Secondary outcomes: quality of life (QLQ-C30)
Continence definition: self-reports of incontinence
Data collection: admission and discharge from the rehabilitation program and at 3
months after discharge
All groups improved on continence and quality of life. Use of ES was only of additional
value in a compliant subgroup. Perineal ES was better accepted than anal
Notes Additional data supplied to KFH by author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Computerised randomisation
Allocation concealment (selection bias) Unclear risk Method of allocation concealment not
specified
Blinding of participants (performance bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of personnel (performance bias) Unclear risk Insufficient information to permit judge-
ment
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit judge-
ment
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Hoffman 2005 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Dropouts: 22 out of 60 in anal ES group, 4
out of 60 in perineal ES group. No reasons
for dropouts given
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk Not reported. Therefore judged to be un-
clear risk
Approved by medical ethics committee Unclear risk Not reported. Therefore judged to be un-
clear risk
Informed consent Unclear risk Not reported. Therefore judged to be un-
clear risk
ITT analysis High risk No intention-to-treat analysis; insufficient
information on methods of statistical anal-
ysis; interventions unclear and insuffi-
ciently specified
Hou 2013
Methods RCT
Participants Time of recruitment: pre-operative
Population: 66 men who underwent TURP (whole population, with or without UI)
Included: patients with benign prostatic hyperplasia and underwent TURP, aged 60
to 90 years, remarkable lower urinary tract symptoms (LUTS) with poor response to
medication, ambulatory, able to communicate verbally
Excluded: indwelling catheter-dependent postdischarge, neurogenic bladder, dementia
or disability affecting verbal communication
Age (mean, SD): A 69.67 (6.09); B 71.41 (6.67)
Dropouts: 5 (2 catheter still in situ after discharge from hospital, 3 lost to follow-up).
Not differential dropout
Baseline characteristics: comparable at baseline
Interventions Time of intervention: post-operative treatment
A (32): guided PFMT+EMGbiofeedback after catheter removal (2 days postoperatively)
, instructed to: contract pelvic muscles for 5 seconds and relax for 10 seconds. After
discharge, patients were instructed to carry out 5 mins of each PFE three times daily.
Patients also received motivational telephone interviews once weekly
B (29): no description
Duration of treatment: 12 weeks
Follow up: 1 week, 1 month, 2 months and 3 months
Outcomes Primary outcome (number of men with UI)
Not reported
Other outcomes
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Hou 2013 (Continued)
Quality of life
SF-36 scores (mean (SD) N)
Physical component
3 months: A 54.86 (8.62) 32; B 49.86 (11.23) 29
Physical functioning
3 months: A 89.69 (17.13) 32; B 85.82 (21.60) 29
Body pain
3 months: A 93.66 (15.16) 32; B 89.48 (22.71) 29
General health
3 months: A 82.03 (14.05) 32; B 64.93 (27.16) 29
Physical role limitation
3 months: A 68.75 (36.48) 32; B 51.72 (38.92) 29
Mental health component
3 months: A 56.21 (6.20) 32; B 48.52 (11.94) 29
Mental role limitation
3 months: A 93.75 (21.48) 32; B 73.81 (37.80) 29
Vitality
3 months: A 80.47 (13.16) 32; B 64.14 (24.02) 29
Mental health
3 months: A 88.00 (10.51) 32; B 77.38 (18.68) 29
Social functioning
3 months: A 90.63 (14.20) 32; B 76.29 (29.57) 29
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “randomly classified”
Allocation concealment (selection bias) Unclear risk “randomly classified”
Blinding of participants (performance bias) High risk Blinding to intervention was not possible
Blinding of personnel (performance bias) High risk Blinding not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk 5 (2 catheter still in situ after discharge from hospital, 3 lost to
follow-up). Not differential dropout
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk Not reported. Therefore judged to be unclear risk
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Hou 2013 (Continued)
Approved by medical ethics committee Unclear risk Not reported. Therefore judged to be unclear risk
Informed consent Unclear risk Not reported. Therefore judged to be unclear risk
ITT analysis Unclear risk Not reported. Therefore judged to be unclear risk
Joseph 2000
Methods Randomisation: yes
Method of allocation: not described
Blinding: none
Dropouts: 3 did not return to clinic for all appointments, one had other health problems
Intention to treat: no
Participants Recruitment: post-operative
Included: men incontinent post-radical prostatectomy or post-TURP. UI of at least 6
months duration
N = 11 patients at least 6 months post-surgery (4 radical retropubic, 6 radical peritoneal,
1 TURP)
Interventions Post-operative intervention
Group A (6): intervention: Instruction in PFMT including biofeedback with visual
feedback as well as verbal to assist in identifying and discriminating muscles
Group B (5): comparator: Instruction in PFMT, squeezing of finger during digital rectal
examination
Both: weekly visit for a total of 4 clinic visits
Length of follow-up: 12 months
Outcomes Main outcome: urine loss measure by standardised pad test, bladder diary, subjective
estimation of degree of incontinence
Secondary outcomes: leak point pressure measured by video-urodynamics, Joseph Con-
tinence Assessment Tool
Continence definition: subjective evaluation by participants
Data collection: baseline, 3, 6, and 12 months
No differences between the groups. Improvement seen in all patients at 12 months
Notes Data not published in article. Raw data supplied to review author (KFH) who calculated
means and standard deviations. These were reviewed by a second review author (KNM)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description. Therefore judged to be un-
clear risk
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Joseph 2000 (Continued)
Allocation concealment (selection bias) Unclear risk Reported as “Randomised”. No additional
information provided
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) High risk Blinding to intervention not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported. Therefore judged to be un-
clear risk.\
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Three dropouts
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk Not reported. Therefore judged to be un-
clear risk
Approved by medical ethics committee Unclear risk Not reported. Therefore judged to be un-
clear risk
Informed consent Unclear risk Not reported. Therefore judged to be un-
clear risk
ITT analysis High risk No
Koo 2009
Methods Randomised: yes
Participants Recruitment: post-operative
Included: men with UI after radical prostatectomy
Randomised: N = 32
Interventions A (16) intervention: extra-corporeal magnetic innervation (ExMI), treatment sessions
were for 20 minutes twice weekly for 8 weeks
B (16) control: PFMT alone. Duration of treatment not specified
Length of follow-up: six months
Outcomes 24 hour pad test, g of urine
Baseline: A 655, B 646
1 month: A 147, B 187
2 months: A 33, B 81, P = 0.001
3 months: A 9 (SD 28), B 45 (28), P = 0.001
6 months: Less than 10 g in both groups
Number of pads used daily
Baseline: A 4.2, B 4.1
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Koo 2009 (Continued)
I month: A 1.5, B 1.8
2months: A 0.6, B 0.9, P = 0.033
3 months: A 0.1 (0.42), B 0.6 (0.42), P = 0.002
6 months: A 0, B 0.1
Quality of life measured by I-QoL
Notes Awaiting further translation - information from abstract only
SDs calculated using P values
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description, Chinese language
Allocation concealment (selection bias) Unclear risk “Randomly assigned”
Blinding of participants (performance bias) Unclear risk No description. Therefore judged to be unclear risk
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be unclear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No description Therefore judged to be unclear risk
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk Not reported, Chinese language
Approved by medical ethics committee Unclear risk Not reported. Therefore judged to be unclear risk
Informed consent Unclear risk Not reported. Therefore judged to be unclear risk
ITT analysis Unclear risk Not reported. Therefore judged to be unclear risk
Laurienzo 2013
Methods RCT
Participants Time of recruitment: pre-operative
Population: men having a radical prostatectomy (whole population, with or without
UI)
Included: patients with prostate cancer (stage T2) and candidates for RPP who were
referred for treatment
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Laurienzo 2013 (Continued)
Excluded: radiotherapy (previous or after RPP), previous transurethral resection, pre-
existing neurological disease, urinary fistula after RPP, prolonged indwelling urethral
catheterization (more than 15 days), clinical situations that rendered the patient unsuit-
able for surgical procedure, failure to attend all PFMR or electrical stimulation sessions,
loss of follow-up and desistance
Age (mean, SD): A 64 (8); B 62 (7); C 60 (8)
Dropouts: 9 (2 failed to attend all sessions, 2 desistance, 1 adjuvant radiotherapy, 1
postoperative urethral stenosis, 1 urinary fistula, 1 unsuitable for surgery due to cardio-
vascular risk, 1 inadequate follow up) Unclear from which group
Baseline characteristics: Comparable at baseline
Interventions Time of intervention: pre-operative only
A (15): standard treatment with verbal instructions for PFMT
B (17): pre-operative guided PFMT, with 10 physiotherapy sessions: contractions of the
pelvic floor muscles for 5 seconds in “dorsal decubitus” position for 10 times, in the
same position with the waist elevated (10 times), lying down with legs adducted against
a plastic ball performed 10 times and standing and flexing the hips to 60 (10 times)
C (17): pre-operative PFMT + electrical stimulation during 10 physiotherapy sessions,
electrical stimulation was with an anal probe lasting 15 minutes in total, and men also
received guided PFMT and followed the same training regime as above
Men did not receive PFMT post-operatively
Duration of treatment: 10 pre-operative sessions
Follow up: 1, 3 and 6 months
Outcomes Primary outcome (number of men with UI)
Not reported
Other outcomes
1 hour pad test score (mean (SD) N)
1 month: A 17.6 (38.5) 15; B 29.5 (35.8) 17; C 25.5 (35.4) 17
3 months:14.3 (34.4) 15; B 11.8 (28.4) 17; C 9.6 (18.8) 17
6 months: A 5.5 (14.16) 15; B 25.3 (59) 17; 4.35 (7.3) 17
Quality of life
ICIQ-SF score (mean (SD) N)
1 month: A 7.5 (5) 15; B 14 (3.6) 17; C 9.6 (6.3) 17
3 months: A 5.4 (5.2) 15; B 6.9 (5.8) 17; C 7.2 (6.4) 17
6 months: A 3.7 (5.3) 15; B 4.8 (5.3) 17; C 5.3 (5.5) 17
SF-36
Results not reported: “There were no differences between groups on the various domains
of the SF-36 (p > 0.05)”
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Laurienzo 2013 (Continued)
Random sequence generation (selection
bias)
Low risk “The patients were randomized (computer generated list using
Randomizer, v4)”
Allocation concealment (selection bias) Unclear risk “The patients were randomized (computer generated list using
Randomizer, v4)”
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Unclear risk “PFMR was performed in the preoperative period by the same
physiotherapist.”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 9 (2 failed to attend all sessions, 2 desistance, 1 adjuvant radio-
therapy, 1 post-operative urethral stenosis, 1 urinary fistula, 1
unsuitable for surgery due to cardiovascular risk, 1 inadequate
follow-up). Unclear from which group
Selective reporting (reporting bias) High risk Results of SF-36 not reported
Financial support Low risk “Sao Paulo State Foundation for Research Support - FAPESP
(number 08/54585-1)”
Approved by medical ethics committee Low risk “After approval by the ethical committee and internal review
board, 58 consecutive males were included in this analysis”
Informed consent Low risk “All subjects received and signed an informed consent form”
ITT analysis Low risk Data presented for all men randomised and not excluded. No
differential dropout apparent
Liu 2008
Methods Randomised controlled clinical trial
Participants Recruitment: post-operative
Included: men with UI after radical prostatectomy
Randomised: N = 24
Interventions Group A (12) intervention: extra-corporeal magnetic innervation (ExMI), the frequency
of the pulse field was 10 Hz for 10 minutes, followed by a 3 minute rest and a second
treatment of 50 Hz for 20 minutes. This was done twice a week
Group B (12) control: PFMT alone, instructions given to carry out 20 mins x 3 a day
Duration of treatment: six weeks
Length of follow up: 1, 3 and 6 months
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Liu 2008 (Continued)
Outcomes Main outcome measures: quality of life scale and the ICI-Q-SF
1 month: both scores were decreased with no significant differences between the groups
At 3 and 6 months: both scores decreased with group A having a significantly lower
(better) score than group B (P < 0.05)
Notes Information from abstract, awaiting translation of paper
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote “randomly assigned”. No additional in-
formation provided
Allocation concealment (selection bias) Unclear risk No description. Therefore judged to be unclear
risk
Blinding of participants (performance bias) High risk Blinding not possible
Blinding of personnel (performance bias) High risk Blinding not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk All 24 patients included in the final analysis
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk Not reported. Therefore judged to be unclear risk
Approved by medical ethics committee Low risk Hospital board, local military university hospital
Informed consent Unclear risk Not reported. Therefore judged to be unclear risk
ITT analysis Unclear risk Not specified. Therefore judged to be unclear risk
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Manassero 2007
Methods Randomised: prospective randomised controlled trial
Method of allocation: computer generated random numbers
Blinding: blinded outcome assessors, not instructors
Dropouts: 12 excluded as the couldn’t attend regularly for PFMT; 33 continent after
surgery and were not randomised; 13 lost to follow-up in the control group (5 social
reasons and 8 non-responders)
Intention to treat: no
Participants Recruitment: post-operative
Included: men incontinent (UI > 2g/24 hour pad test), post-radical prostatectomy who
were able to attend hospital
Excluded: those with a history of preoperative incontinence, significant perioperative
complications, rectal lesion, infection, psychiatric neurological disorders, inability to
contract PF muscles or weak contraction with increased detrusor activity
Mean age: A 66.8 (6.3 years), B 67.9 (5.5 years)
Interventions Group A (54) intervention: PFMT re-education program, verbal feedback
The training program involved active PFE. Verbal feedback of the contraction was used
to instruct the patients to correctly and selectively contract their pelvic muscles while
relaxing the abdominal muscles. The strength of the pelvic floor muscles was measured
by digital anal control using a score of 0 to 5 ( 0 = no contraction, 5 = good contraction
against strong resistance)
Initially home practice comprised 45 contractions (3 sessions of 15) per day at home,
progressively increasing the number until 90 per day. This was taught by two experienced
urologists
Group B (53) control: no treatment
Duration of treatment: up to a year or until incontinence ceased
Length of follow-up: 1, 3, 6 and 12 months
Outcomes UI at -
1 month: A 83.3% (45/54), B 97.5% (39/40), P = 0.04
3 months: A 53.7% (29/54), B 77.5% (31/40), P = 0.03
6 months: A 33.3% (18/54), B 60% (24/40), P = 0.01
12 months: A 16.6% (9/54), B 52.5% (21/40), P < 0.01
Subjective assessment of continence using VAS: P = 0.01 at 12 months
Quality of lIfe (single question): P = 0.03 at 12 months
Notes ITT analysis used for data entry, assuming that all 13 men who dropped out of the
control group were dry, because of differential dropout of 13 men from B versus none
from A with no explanation for difference between groups
If unable to contract anal sphincter or strength 2 or less, not randomised. These men
were given ES treatment at home with anal probe
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated random numbers
102Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Manassero 2007 (Continued)
Allocation concealment (selection bias) Low risk Stratified on volume of urine lost on pad
test
Blinding of participants (performance bias) High risk Blinding of intervention not possible
Blinding of personnel (performance bias) High risk Blinidng of intervention not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinded outcome assessors
Incomplete outcome data (attrition bias)
All outcomes
High risk Differential dropout of 13 from control
group, ITT analysis used for data entry by
review authors
Selective reporting (reporting bias) Unclear risk Outcomes in methods reported
Financial support Unclear risk Not reported. Therefore judged to be un-
clear risk
Approved by medical ethics committee Low risk “The study was approved by the Medical
Centre Institutional Review Board”
Informed consent Low risk “All men provided informed consent”
ITT analysis Low risk Assumed from patient flow chart
Marchiori 2010
Methods RCT
Participants Time of recruitment: post-operative
Population: men with incontinence after retropubic radical prostatectomy, open or
laparoscopic
Included: moderate to severe incontinence at 30 days after catheter removal
Excluded: lack of cooperation, pre-operative incontinence, early recovery of continence
Age (mean): A 67; B 66.5
Dropouts: “Survey questionnaire were correctly filled in and returned by fewer than
10% of the patients”
Baseline characteristics: comparable at baseline
Interventions Time of intervention: post-operative treatment
A (166): one-to-one guided PFMT + biofeedback during first session, second session
involved 10 sets of pelvic floor electrical stimulation lasting 15 mins each, instructed to:
carry out three sets of 30 contractions a day at home for the first month after catheter
removal (16 days after surgery)
B (166): received oral and written information on pelvic floor anatomy and on PFME,
instructed to: perform three sets of 30 contractions a day at home for the first month
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Marchiori 2010 (Continued)
after catheter removal (16 days after surgery) and continue for duration of
All men received oral and written information on pelvic floor anatomy and on PFME,
pelvic floor muscle endurance assessed by digital anal control + PFMT consisting of 3
sets of 30 contractions daily for the first month after catheter removal
Duration of treatment
Follow up: 3 months, 6 months and 12 months
Outcomes Primary outcome (number of men with UI)
Number of incontinent men (defined as 0 or 2 minipads daily)
3 months: A 36/166; B 81/166
6.5 months: A 1/166; B 28/166
12 months: A 0/166; B 0/166
Other outcomes
Median time of continence recovery, days:
A 44 ± 2, B 76 ± 4, P ≤ 0.01
Quality of life
ICIQ-male: Results not reported
RAND 36-Item Health Survey questionnaire: results not reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Prospectively randomized” Sequence generation not reported
Allocation concealment (selection bias) Unclear risk “Prospectively randomized”
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) High risk Blinding to intervention not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
High risk Not reported for primary outcome
Selective reporting (reporting bias) High risk No reporting of primary outcome
Financial support Unclear risk Not reported. Therefore judged to be unclear risk
Approved by medical ethics committee Unclear risk Not reported. Therefore judged to be unclear risk
Informed consent Unclear risk Not reported. Therefore judged to be unclear risk
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Marchiori 2010 (Continued)
ITT analysis Unclear risk Not reported. Therefore judged to be unclear risk
Mariotti 2009
Methods Randomised: yes
Participants Randomised post-operatively
Included: radical prostatectomy, all men after catheter removal
Age: Group A mean 61.86 years, Group B, 61.43 years
Interventions Intervention post-operative
Group A (30) intervention: PFMT plus ES and biofeedback twice a week for 6 weeks
ES - a surface electrode was inserted into the anus and pulsed, the intensity was adequate
to induce visual lifting of the levator ani and pubococcygeus muscle, considering the
level of comfort to the patient
Biofeedback - via surface electrodes both perineal and abdominally
Group B (30) control: instructions to conduct PFMT - verbal and written instructions
at catheter removal and follow-up visits
Duration of treatment: 6 weeks
Length of follow up: 3 and 6 months
Outcomes 24 hour pad test: g/24hrs, mean (SD)
3 months: A 16.67 (30.55), B 136.67 (152.62), P = 0.000
6 months: A 3.47 (14.67), B 27.83 (55.98), P = 0.0004
ICS-male questionnaire, number of men incontinent, n/N
3 months: A 6/30, B 20/30
6 months: A 1/30, B 10/30
Time to regain continence: A 8 (6.49) weeks, B 13.88 (8.32) weeks, P = 0.003
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Consecutive patients
Allocation concealment (selection bias) Unclear risk Quote - “Randomized fashion”
Blinding of participants (performance bias) High risk Blinding not possible
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be unclear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported. Therefore judged to be unclear risk
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Mariotti 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No dropouts
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk Not reported. Therefore judged to be unclear risk
Approved by medical ethics committee Unclear risk Not reported. Therefore judged to be unclear risk
Informed consent Low risk “All patients signed an informed consent before randomization”
ITT analysis Unclear risk Not specified. Therefore judged to be unclear risk
Martini 2011
Methods RCT (abstract only)
Participants Time of recruitment: pre-operative
Population:70 consecutivemenundergoing a laparoscopic radical prostatectomy (whole
population, with or without UI)
Included: men undergoing RP for clinically localized prostate cancer T1 to T3
Excluded: history of incontinence or overactive bladder, central or peripheral neurologic
disease and cognitive impairment
Age (mean, SD): not reported
Dropouts: 5 lost to follow up, unclear from which group
Baseline characteristics: not reported
Interventions Time of intervention: pre-operative (post-operative treatment for all men)
A (24): PFMT: 5 sessions of guidedPFMTfor 2 to 3weeks pre-operatively and continued
post-operatively
B (25): post-operative standard care, written instructions for PFMT
All men underwent clinical examination of pelvic muscles function using digital perineal
testing according to “AIPDA score” and evaluation of voiding symptoms
Duration of treatment:
Follow up: 1, 3 and 6 months
Outcomes Primary outcome (number of men with UI)
Number of incontinent men (need to wear a pad)
No useable data
Other outcomes
24 hour pad test
Pad use
Bladder diary
Quality of life
Instrument unspecified
Notes No useable data
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Martini 2011 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “randomised”
Allocation concealment (selection bias) Unclear risk Not reported. Therefore judged to be unclear risk
Blinding of participants (performance bias) High risk Blinding to treatment not possible
Blinding of personnel (performance bias) Unclear risk Not reported. Therefore judged to be unclear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk “Five patients lost at follow up”. Not clear why there were drop-
outs or from which group
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk Not reported. Therefore judged to be unclear risk
Approved by medical ethics committee Unclear risk Not reported. Therefore judged to be unclear risk
Informed consent Unclear risk Not reported. Therefore judged to be unclear risk
ITT analysis Unclear risk Not specified. Therefore judged to be unclear risk
Mathewson-Chapman 97
Methods Randomised: yes, block procedure
Method of allocation: not reported
Blinding: none
Dropouts: 2, not accounted for
Intention to treat: not clear
Participants Recruitment: pre-operative
Included: all men undergoing radical prostatectomy
N = 53 men
Randomised pre-operatively
Interventions Pre and post-operative intervention
Group A (27) intervention: pre-operatively received further instruction and practice with
PME protocol home exercises and biofeedback (anal probe) (Incare 8900); practiced at
home 3 times a week, starting with daily 15 PFMT and increasing by 10 every 4 weeks
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Mathewson-Chapman 97 (Continued)
to a maximum of 35 PFMT
Group B (24) control: post-operatively no further interventions until week 5 when pelvic
muscle strength was assessed
Both: pre-operatively, both groups received 30 minutes’ prostate education programme
and baseline ’perineal muscle evaluation’ (not defined); as well all were taught to contract
the perineal muscle and hold for a few seconds prior to standing, lifting or coughing and
limit the amount of tea, chocolate, alcohol and over-the-counter medications
Length of follow-up: 12 weeks
Outcomes Main outcome: urine loss measured by 24 hour pad test, frequency of micturitions (self-
recorded bladder diary), number of pads used; days to achieve continence from baseline
Secondary outcomes: perineal muscle strength (method not described)
Continence definition: self-report of return of continence
Data collection: 3 day bladder diaries at weeks 2, 5, 9 and 12. 24 hour pad test at weeks
5 and 12
Notes Inclusion of other modalities such as caffeine limitation and using perineal muscles
during any event which increased abdominal stress may have masked any treatment
benefit
Extra information obtained from thesis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Block procedure
Allocation concealment (selection bias) Unclear risk No description. Therefore judged to be un-
clear risk
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be un-
clear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description. Therefore judged to be un-
clear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Two dropouts
Selective reporting (reporting bias) Low risk Outcomes in methods reported
Financial support Unclear risk Not reported
Approved by medical ethics committee Low risk “Permission to conduct this study was
obtained from the Univerisity of Florida
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Health Center Institutional Review Board
(IRB).”
Informed consent Low risk “The informed consent was explained to
each subject, andhis signaturewas obtained
to confirm consent to participate in the
study”
ITT analysis Unclear risk Not specified. Therefore judged to be un-
clear risk
Moore 1999
Methods Randomised: yes
Method of allocation: sealed envelopes
Blinding: physiotherapist blinded to results of control group
Dropouts: 5
Participants Recruitment: post-operative
Included: men incontinent post-radical prostatectomy. Median duration of UI 8 weeks
post-surgery, range 4 to 200 weeks
N = 63 men (53 completed study)
Randomised to 3 groups
Interventions Post-operative intervention
Intervention
Group A (18) intervention: PFMT alone
Group B (19) intervention: PFMT plus rectal electrical stimulation treated by one phys-
iotherapist 30 minutes twice a week for 12 weeks
Intervention groups also did home exercises 3 times/day gradually working up to 30
minutes per session lying, standing, sitting; strength, endurance, speed and control with
maximum contractions of 5 to 10 seconds, 10 to 20 second relaxation and 12 to 20
repetitions; submaximum contractions at 65% to 75% of maximum strength with hold
20 to 30 seconds and equal rest time, 8 to 10 repetitions; speed was sets of quick repetitive
contractions in a 10 second time span; control involved gradual recruitment tomaximum
contraction in 3 stages with 5 second hold at each stage and a slow release with rest 15
to 30 seconds
Group C (21) control: oral and written information about PFMT pre and post-opera-
tively (standard treatment)
Length of follow-up: 24 weeks
Outcomes Main outcome: urine loss measured by 24 hour pad test
Secondary outcomes: quality of life measures (Incontinence Impact Questionnaire, Eu-
ropean Organization for the research and treatment of Cancer-EORTC QLQ C-30,
version 2), physical symptom inventory (adapted from Herr 1994)
Continence definition: ≤ 2 g urine/24 hours
Data collection: baseline, 12, 16, 24 weeks after baseline
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Moore 1999 (Continued)
Notes Intervention perhaps administered too early - all subjects improved at the same rate;
wide range of severity of urinary incontinence at study entry and size of SD of pad test
results also may have resulted in Type II error
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Participants were assigned
using a computer-generated random-num-
ber list placed in sealed envelopes at the end
of the assessment visit, with patient and re-
searcher opening the sealed envelope”
Allocation concealment (selection bias) Low risk “Participants were assigned
using a computer-generated random-num-
ber list placed in sealed envelopes at the end
of the assessment visit, with patient and re-
searcher opening the sealed envelope”
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Low risk Physiotherapist blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported. Therefore judged to be un-
clear risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk 5 (3 from group B, 2 from group A), 3
bladder neck contractures, 1 rectal pain
when performing exercises, 1 vacation for
4 months). No differential dropout
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Low risk “Funding for the research project was re-
ceived from the Oncology Nurses’ Soci-
ety, Canadian Nurses’ Foundation, Caritas
Health, Alberta Physiotherapy Association,
EdnaMinton Foundation, and the Univer-
sity of Alberta”
Approved by medical ethics committee Low risk “approved by the University of Alberta and
CaritasHealthGroup ethics review boards”
Informed consent Low risk “All patients signed informed consent”
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Moore 1999 (Continued)
ITT analysis High risk Intention-to-treat-analysis not performed
Moore 2004
Methods Randomised: yes (order of product testing: in threes to treatment block of 4 periods (1
no device, 3 with devices)
Block, multiple period cross-over design using Latin square configuration
Method of allocation: sealed envelopes. Blinding: research assistant not involved in study
chose envelope; but research assistant and participants could not be blinded to interven-
tion
Dropouts: none
Intention to treat: not discussed
Participants Recruitment: post-operative
Included: men incontinent post-radical prostatectomy who required continuous pad
protection for stress incontinence
Inclusion criteria: normal perineal and penile sensation, intact penile skin, sufficient
manual dexterity
Exclusion criteria: overactive bladder, neurological disorders affecting sensation or cir-
culation, cognitive impairment
N = 12 men
Interventions Post-operative intervention
Each participant had 4 periods (each lasted 1 day)
Group A: no device
Group B: C3 device
Group C: U-Tex device
Group D: Cunningham clamp
Outcomes Main outcome: 4 hour pad test
Secondary outcomes: resistive index, cavernosal flow
None of the devices completely eliminated urine loss when applied at a comfortable
pressure. Each device showed improvement in terms of urine lost, with Cunningham
clamp having the lowest mean loss
Cunningham clamp significantly lowered flow, but ranked positively by participants
Notes Unable to blind participants and research assistant to intervention
Sample size calculation given and required size achieved
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A computer-generated randomized list of
device assignments was prepared by one of
the investigators” Block, multiple period
crossover design using Latin square config-
uration
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Moore 2004 (Continued)
Allocation concealment (selection bias) Low risk Sealed envelopes, research assistant not in-
volved in study chose envelope
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) High risk Blinding to intervention not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “A research assistant not directly involved
with recruitment or data collection entered
the data”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No dropouts
Selective reporting (reporting bias) Low risk Outcomes reported
Financial support Low risk “This study was supported by the Univer-
sity of Alberta Internal Allocations Fund
and Department of Radiology, University
of Alberta Hospital.”
Approved by medical ethics committee Low risk “The Institutional reviewBoard at theUni-
versity of Alberta approved the study”
Informed consent Low risk “the study was explained and informed
consent obtained”
ITT analysis Unclear risk Not specified. Therefore judged to be un-
clear risk
Moore 2008
Methods Randomised: yes
Method of allocation: computer generated list of numbers; group allocation placed in
sealed opaque envelopes; openedby subject after initial post-operation instruction session
with therapist
Blinding: data entry by clerk blinded to group; therapist blinded to outcome of non-
intervention group; pads weighed by third party
Dropouts: control = 7; treatment = 12
Participants Recruitment: post-operative (but approached before surgery)
Included: men incontinent after radical prostatectomy (> 8 grams urine lost on 24 hour
pad test) at 4 weeks post-surgery
N = 217 men from 3 centres with early stage prostate cancer
Inclusion criteria: English speaking, living within 1 hour drive of research centre
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Moore 2008 (Continued)
Interventions Post-operative intervention
Group A (106) intervention: maximum 24 weekly, 30 minute treatment protocol (30
min biofeedback-assisted PFMT) and home exercise protocol of 2 to 3 times a day
Group B (99) control: verbal and written information on PFME and weekly telephone
contact by a urology nurse
Both: at 4 weeks post-surgery, both groups received standardised verbal and written
instruction about PFMT and recovery after radical prostatectomy by one dedicated
physiotherapist or registered nurse at each site
Length of follow-up: 12 months
Outcomes Main outcome: grams of urine loss on 24 hour pad test (> 8 g defined as incontinence)
Definition of continence: < 8 g of urine loss on 24 hour pad test; subjective continence
defined as yes or no
Secondary outcome: IPSS, IIQ-7 (Incontinence Impact Questionnaire), voiding diary,
and subjective continence
All measures obtained at baseline (pre-operatively) and at 4, 8, 12, 28 weeks and 1 year
post-operatively
24 hour pad test, mean (SD) N
12 weeks: A 115 (300) 93, B 72 (144) 82
16 weeks: A 76 (259) 94, B 61 (194) 80
28 weeks: A 45 (142) 87, B 35 (101) 74
12 months: A 47 (215) 89, B 8 (10) 78
Dry at 8 weeks: A 20/101 (20%), B 20/88 (23%)
Dry at 12 weeks: A 30/93 (32%), B 23/82 (28%)
Dry at 16 weeks: A 41/94 (44%), B 32/80 (40%)
Dry at 28 weeks: A 41/87 (47%). B 37/74 (50%)
Dry at 12 months: A 53/89 60%, B 47/78 60% (< 8 g on pad test)
No significant differences between groups on continence or on symptom and quality of
life measures or diary at any time point post-operatively
Cost: A: CAD 400; B 240
Adverse events: none in either group
The majority of men reported a low impact of incontinence as per the IIQ-7 and fewer
LUTS at 12 months than at baseline on the IPSS. The majority were very satisfied with
treatment and support from the continence nurse
Notes Groups comparable at pre-operation baseline on PSA, Gleason score, IPPS, IIQ, pad
test and voiding diary
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated list of random num-
bers, random blocked allocation to groups
Allocation concealment (selection bias) Low risk Group allocation placed in sealed opaque
envelopes; opened by participant after ini-
tial post-operation instruction session with
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Moore 2008 (Continued)
therapist
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Low risk Therapist blinded to outcome of non-inter-
vention group; pads weighed by third party
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Data entry by clerk blinded to group
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Dropouts: control = 7; treatment = 12; no
differential dropout
Selective reporting (reporting bias) Unclear risk Protocol not available. Therefore judged to
be unclear risk
Financial support Low risk “Funded by the Alberta Heritage Foun-
dation for Medical Research, the North-
ernAlbertaUrology Foundation, andPfizer
Corporation (unrestricted)”
Approved by medical ethics committee Low risk “Healthcare ethics approval was obtained
at all sites”
Informed consent Low risk “After the consent form was signed, base-
line data were collected”
ITT analysis Low risk Patient flow chart give details of patient
dropouts and withdrawals
Morihiro 2011
Methods RCT abstract only
Participants Time of recruitment: not reported
Population: men having laparoscopic radical prostatectomy
Included: patients who underwent laparoscopic radical prostatectomy performed by a
single surgeon
Excluded: not reported
Age (mean, SD): not reported
Dropouts: not reported
Baseline characteristics: comparable at baseline
Interventions Time of intervention: post-operative treatment for all men
A (20): PFMT + sacral surface therapeutic ES (ssTES), ssTES 2 times a day for 15
minutes each, lasting 1 month after catheter removal (day 5)
B (14): PFMT only, carried out alone
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Morihiro 2011 (Continued)
Duration of treatment: 1 month
Follow-up: 1 month, 3 months, 6 months and 12 months post-operatively
Outcomes Primary outcome (number of men with UI)
Number of incontinent men (defined as requirement for a pad to keep clothing dry)
6 months: A 3/20; B 6/14
12 months: A 0/20; B 5/14
Other outcomes
Recovery rate of urinary continence (defined as no requirement for a pad to keep clothing
dry)
6 months: A 17/20, B 8/14
12 months: A 20/20, B 9/14, P = 0.007
Quality of life
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “randomly assigned”
Allocation concealment (selection bias) Unclear risk “randomly assigned”
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be unclear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not enough information. Therefore judged to be unclear risk
Selective reporting (reporting bias) Unclear risk Protocol not available. Therefore judged to be unclear risk
Financial support Low risk None
Approved by medical ethics committee Low risk “ethics committee of Kitasato university of medicine”
Informed consent Low risk Yes
ITT analysis Unclear risk No description. Therefore judged to be unclear risk
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Nowak 2007
Methods Randomised: yes
Participants Recruitment: pre-operative
Included: men undergoing radical prostatectomy
Aged: 59 to 72 years
Interventions Group A intervention: extra-corporeal magnetic innervation (ExMI) based pelvic floor
device
Group B control: PFMT alone
Treatment initiated one week after catheter removal
Duration of treatment: 10 weeks
Length of follow-up: 12 months
Outcomes On first day following catheter removal 16.8% of patients were continent
Subsequent follow-up data unclear if N = 105 or 88 subjects. Group numbers not stated
UI at -
4 weeks: A 49%, B 56%
3 months: A 36%, B 50%
6 months; A 18%, B 32%
Twenty minute pad test at 12 months, significantly better in Group A at 12 months, P
=0.004
QoL score and urinary symptom inventory also carried out, numbers not given
Notes No useable data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “randomized”
Allocation concealment (selection bias) Unclear risk No description. Therefore judged to be unclear risk
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be unclear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk One patient withdrew from Group A for non-medical reasons
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk No description. Therefore judged to be unclear risk
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Nowak 2007 (Continued)
Approved by medical ethics committee Unclear risk No description. Therefore judged to be unclear risk
Informed consent Unclear risk No description. Therefore judged to be unclear risk
ITT analysis Unclear risk Not specified. Therefore judged to be unclear risk
Opsomer 1994
Methods Randomised: yes
Method of allocation: method not described
Blinding: none
Dropouts: 4
Intention to treat: not specified
Participants Recruitment: post-operative
Included:men incontinent post-radical prostatectomy 6weeks after six week after surgery
N = 43 (39 completed study)
Interventions Post-operative intervention
Group A (21) intervention: PFMT plus biofeedback plus ES directed by physiotherapist
Group B (22) control: PFME on their own without medical supervision
Length of follow-up: 12 weeks
Outcomes Main outcome: urine loss measured by pad test
No statistical difference between groups as to recovery of continence
Notes Abstract only - unable to contact author for further data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description. Therefore judged to be un-
clear risk
Allocation concealment (selection bias) Unclear risk “Randomised”
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be un-
clear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description. Therefore judged to be un-
clear risk
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Opsomer 1994 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Four dropouts
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk No description. Therefore judged to be un-
clear risk
Approved by medical ethics committee Unclear risk No description. Therefore judged to be un-
clear risk
Informed consent Unclear risk No description. Therefore judged to be un-
clear risk
ITT analysis Unclear risk Not specified. Therefore judged to be un-
clear risk
Overgard 2008
Methods Randomised: yes
Participants Recruitment: Pre-operative
Included: radical prostatectomy, all men
Age: Group A 48 to 68 years, Group B 49 to 72 years
Interventions Intervention: post operative
Group A (38) intervention: instructions on PFMT and physiotherapy, 45 minutes
weekly. Patients were instructed to perform 3 sets of contractions daily at home, in either
a supine, sitting or standing position. Digital anal palpation to teach correct contractions,
as well as oral and written instructions
DVD of instructions given to those living too far from hospital
Group B (42) control: instructions on PFMT alone
Duration of treatment: up to 1 year
Length of follow-up: 3, 6 and 12 months
Outcomes Self-reported continence (not using pads)
3 months: A 16/35 (46%), B 17/40 (43%), P = 0.73
6 months: A 27/34 (79%), B 22/38 (58%), P = 0.061
12 months: A 33/36 (92%), B 28/39 (72%), P = 0.028
24 hour pad test: g/24hrs, mean (range)
3 months: A 17 (0-282), B 7 (0-46), P = 0.53
6 months: A 9 (0-203), B 2 (0-12), P = 0.73
12 months: A 2 (0-55), B 1 (0-14), P = 0.95
PFM strength (anal squeeze pressure, cm H2O), mean (SD)
3 months: A 50.7 (23.9), B 55.7 (25.6), P = 0.398
6 months: A 56.1 (21.7), B 65.8 (27.0), P = 0.117
12 months: A 64.0 (24.0), B 71.5 (26.2), P = 0.237.
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Overgard 2008 (Continued)
Notes No SDs
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Norwegian University performed the computerised randomisa-
tion procedure immediately after pre-operative test
Allocation concealment (selection bias) Low risk Norwegian University performed the computerised randomisa-
tion procedure immediately after pre-operative test. Urologist
no prior knowledge of randomisation procedure
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) High risk Blinding to intervention not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
High risk Drop out rate was 6% Four lost to follow up in physiotherapy
group, one lost in instructions only group
Selective reporting (reporting bias) Low risk Outcomes in methods reported
Financial support Low risk “Theworkwas fundedbyTheNorwegianFund for Postgraduate
Training in Physiotherapy and The Norwegian Cancer Society”
Approved by medical ethics committee Low risk “The study was approved by the Regional Committee for Med-
ical and Health Research Ethics”
Informed consent Low risk “Eighty-five men provided written informed consent”
ITT analysis Low risk Assumed from patient flow chart
Parekh 2003
Methods Randomised: yes
Method of allocation: not described
Blinding: none
Dropouts: 1 from each of the control and treatment groups. Reasons not described
Intention to treat: yes, dropouts categorised as incontinent
Participants Recruitment: pre-operative
Included: all men scheduled for radical prostatectomy
N = 38 patients with localized carcinoma of the prostate
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Parekh 2003 (Continued)
Interventions Pre and post-operative interventions
Group A (19) intervention: 2 treatment sessions pre-operatively. Session 1 consisted of
PFMT in a hook lying position
Session 2 was on an exercise ball. Teaching methods varied and included verbal cues,
visualization with an anatomical model, palpation or biofeedback with rectal probe. Post-
operatively, PFMT was reviewed and participants were seen every 3 weeks for 3 months
by a physiotherapist
Home exercise for 6months ormore for those requiring further physical therapy guidance
Group B (19) control: no formal education on PFMT pre-operatively, telephone or face
to face follow-up at least monthly
Length of follow-up: 12 months
Outcomes Main outcome: urine loss measured by number of pads used daily
Continence definition: 0 pads or 1 precautionary pad used
Data collection: UI questionnaires at 6, 12, 16, 20, 28, and 52 weeks
Greater number of the intervention group gained continence earlier than the control
group at 3 months (only point of statistical difference). Minimal long-term effect as
continence rates the same at 1 year
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Patients were enrolled in prospective, ran-
domized fashion into a treatment or a con-
trol group”
Allocation concealment (selection bias) Unclear risk “Randomly assigned”
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) High risk Blinding to intervention not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported. Therefore judged to be un-
clear risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 dropout from each arm. Categorised as
incontinent
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk Not reported. Therefore judged to be un-
clear risk
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Parekh 2003 (Continued)
Approved by medical ethics committee Unclear risk Not reported. Therefore judged to be un-
clear risk
Informed consent Unclear risk Not reported. Therefore judged to be un-
clear risk
ITT analysis Unclear risk Not reported. Therefore judged to be un-
clear risk
Park 2012
Methods RCT
Participants Time of recruitment: post-operative
Population: 121 men who underwent radical prostatectomy (whole population, with
or without UI)
Included: elderly male patients aged≥ 65 years, clinically localized prostate cancer (cT1
to T2), Eastern Cooperative Oncology Group performance status of 0 or 1, and written
informed consent
Excluded: adjuvant or neoadjuvant therapy, severe postoperative complications, a history
of intrapelvic surgery, diseases that can affect voiding function, and limitations for exercise
intervention, such as patients with serious cardiovascular events or spinal or articular
disease
Age (mean, SD): A 69.1 (5.7); B 69.4 (7.2)
Dropouts: A: 7 (1 orthopaedic surgery for a pre-existing ankle problem, 1 transurethral
surgery for urethral stricture, 4 non-compliance with follow-up due to a long distance
from the centre to the home or personal affairs, 1 new employment after surgery)
B: 8 (1 ophthalmologic surgery for a cataract, 2 adjuvant radiotherapy, 4 non-compliance
with follow-up due to a long distance from the center to the home or personal affairs, 1
new employment after surgery)
Not differential dropout
Baseline characteristics: comparable at baseline
Interventions Time of intervention: post-operative treatment for all men
A (26): patients performed Kegel exercises twice weekly, together with other types of
exerciseswhich included resistance training andpelvic flexibility. The intervention started
3 weeks after surgery and lasted 12 weeks
B (23): ‘In the control group, only kegel exercises were performed’
Duration of treatment: 15 weeks
Follow-up: 1 week before surgery, 3 weeks and 15 weeks after surgery
Outcomes Primary outcome (number of men with UI)
Cumulative number of incontinent men [defined as > 1 g on 24 hour pad test)
15 weeks: A 7/26; B 13/23
Other outcomes
Cumulative number of continent men [defined as < 1 g on 24 hour pad test)
15 weeks: A 19/26; B 10/23, P = 0.035
Urine loss in grams using 24 hour pad test (mean (SD) N)
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Park 2012 (Continued)
1 week before surgery: A 0 (NR) 26; B 0 (NR) 23
3 weeks post-operatively: A 60 (NR) 26; B 83 (NR) 23
15 weeks: A 12 (NR) 26; B 46 (NR) 23
Quality of life
ICIQ score (mean (SD) N)
1 week before surgery: A 4 (NR) 26; B 3 (NR) 23
3 weeks post-operatively: A 10 (NR) 26; B 10 (NR) 23
15 weeks: A 6 (NR) 26; B 10 (NR) 23
SF-36 physical composite score (mean (SD) N)
1 week before surgery: A 57 (NR) 26; B 54 (NR) 23
3 weeks post-operatively: A 45 (NR) 26; B 44 (NR) 23
15 weeks: A 57 (NR) 26; B 48 (NR) 23
SF-36 mental composite score (mean (SD) N)
1 week before surgery: A 45 (NR) 26; B 44.6 (NR) 23
3 weeks post-operatively: A 44 (NR) 26; B 43 (NR) 23
15 weeks: A 49 (NR) 26; B 46 (NR) 23
Beck Depression Inventory (mean (SD) N)
1 week before surgery: A 9 (NR) 26; B 7.4 (NR) 23
3 weeks post-operatively: A 8 (NR) 26; B 9 (NR) 23
15 weeks: A 6 (NR) 26; B 9 (NR) 23
NR = Not reported
Notes Details of the combined exercise regime
Post-operative weeks 1 to 4
1) Education about post-operative symptoms
2) Performing Kegel exercises, recognizing the parapelvic muscles
3) Pelvic floor flexibility fitness: performing pelvic exercises while sitting on a ball
Post-operative weeks 5 to 8 (ball exercises)
1) Performing pelvic exercises while sitting on a ball
2) Performing lower extremity exercises while placing a ball on the wall
3) Lifting a heel on the ball while standing face-to-face with the wall
4) Lifting up and down on the ball while spreading and bending legs
5) Performing flank exercises while having a ball in the hand
6) Squeezing the ball with the adductor muscles while lying on a table
Post-operative weeks 9-12 (elastic band exercises)
1) Lifting the object with an elastic band lateral, anterior, and posterior to the patient’s
arms
2) Lifting the legs and then spreading them while attaching an elastic band to the foot
Further information provided by author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A random number generator was used to determine the ran-
domization allocation in a 1:1 ratio”
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Park 2012 (Continued)
Allocation concealment (selection bias) Low risk “Sealed envelope, sequentially numbered, and opened by the
trial nurse”
Blinding of participants (performance bias) High risk Blinding of participants was not possible
Blinding of personnel (performance bias) High risk Blinding not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk An independent assessor performed serial measurements
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk A: 7 (1 orthopaedic surgery for a pre-existing ankle problem,
1 transurethral surgery for urethral stricture, 4 non-compliance
with follow-up due to a long distance from the centre to the
home or personal affairs, 1 new employment after surgery)
B: 8 (1 ophthalmologic surgery for a cataract, 2 adjuvant radio-
therapy, 4 non-compliance with follow up due to a long distance
from the center to the home or personal affairs, 1 new employ-
ment after surgery)
No differential dropout
Selective reporting (reporting bias) Low risk Results of outcomes reported
Financial support Low risk Unconditional funding from the “Medical Research Institute,
Pusan National University Hospital, Busan, Korea.”
Approved by medical ethics committee Low risk “Our institutional review board approved this prospective, ran-
domized, controlled trial”
Informed consent Low risk Patients signed “written informed consent”
ITT analysis High risk No
Perissinotto 2008
Methods Randomised: yes.
Method of allocation: consecutive patients
Participants Pre-operative randomisation
Included: all men undergoing radical prostatectomy
Pre-operative intervention
Age: not given
Interventions Group A (N not given) intervention: early pelvic floor rehabilitation program at home
twice dally, Kegel exercises
Group B (N not given) control: no formal PFMT
Duration of treatment: for six months or until continence was achieved
Length of follow-up: at 3 and 6 months
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Perissinotto 2008 (Continued)
Outcomes PFM strength: P = 0.002
Quality of life using ICIQ-SF not significant
24 hour pad test not significant
Notes No useable data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Consecutive patients. No additional infor-
mation provided. Therefore judged to be
unclear risk
Allocation concealment (selection bias) Unclear risk Randomised controlled trial.No additional
information provided. Therefore judged to
be unclear risk
Blinding of participants (performance bias) Unclear risk No description. Therefore judged to be un-
clear risk
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be un-
clear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description. Therefore judged to be un-
clear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No description. Therefore judged to be un-
clear risk
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Low risk “FAPESP” (Sao Paulo Research Founda-
tion)
Approved by medical ethics committee Low risk “COMITE DE ESTICA E PESQUISA -
UNICAMP”
Informed consent Low risk Yes
ITT analysis Unclear risk Not specified
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Porru 2001
Methods Randomised: yes
Method of allocation: not described
Blinding: report stated that urologist performing digital evaluation of pelvic floor muscle
contraction was blinded to the study group
Dropouts: intervention 2, control 1. Reason reported was non-attendance at all clinic
appointments
Intention to treat: none
Participants Recruitment: pre-operative
Included: all men undergoing TURP
N = 58 men (55 completed study) with benign prostatic hypertrophy randomised to 2
groups
Interventions Pre and post-operative intervention
Group A (30) intervention: initial visit before surgery, digital evaluation of pelvic muscle
contraction strength. Verbal instruction, feedback and reinforcement on contraction
was given to teach selective contraction of anal sphincter and relaxation of abdominal
muscles. Verbal and written instruction given for home PFMT. Weekly digital anal
reassessment and grading of pelvic muscle contraction by the therapist. Instructed to
practice contractions 45 times per day (3 groups of 15 contractions)
Group B (28) control: not specified
Both A and B: voiding diaries initiated after catheter removal
Length of follow-up: 4 weeks. Data collection at catheter removal and weekly for 4 weeks
Outcomes Main outcome: urine loss (incontinence episodes) measured by 48 hour bladder diaries
completed weekly
Secondary outcomes
Muscle contraction strength by digital evaluation Scale 0 to 4 (0 = none, 4 = strong)
Pressure flow: urine flowmetry pre-operatively and 1 month post-operatively
Symptoms: AUA (American Urological Association) symptom score preoperatively and
30 days after surgery
Quality of life: ICS male questionnaire
Significant increase in muscle strength in intervention group by week 4
Both groups showed improvement in symptom score and quality of life post-operatively,
no significant difference between groups
Significantly better satisfaction with life in intervention group A compared to control B
at 4 weeks
Significant difference in voiding intervals between the groups at weeks 2 and 3, but not
week 4
No difference in uroflowmetry
Significantly less incontinence in the intervention group A at weeks 1, 2 and 3. No
difference at week 4
Concluded that PFMT quickens the return to normal voiding post-TURP
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
125Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Porru 2001 (Continued)
Random sequence generation (selection
bias)
Unclear risk No description
Allocation concealment (selection bias) Unclear risk B - ’randomised’
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Low risk Urologist performing digital evaluation of
pelvic floormuscle contractionwas blinded
to the study group
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “One urologist, who was blinded to the
study group of the patients, performed only
the digital evaluation of the pelvic floor
muscle contraction and established and re-
ported the grading during all the visits”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Dropouts due to non-attendance at all
clinic appointments (A 2, B 1)
Selective reporting (reporting bias) Low risk Results reported for outcomes stated in
methods
Financial support Unclear risk No description. Therefore judged to be un-
clear risk
Approved by medical ethics committee Unclear risk No description. Therefore judged to be un-
clear risk
Informed consent Low risk “Informed consent was given by all pa-
tients”
ITT analysis Unclear risk Not specified
Ribeiro 2008
Methods Randomised: yes
Participants Post-operative intervention
Included: radical prostatectomy, all men after catheter removal
Age: 51 to 76 years
Interventions Group A (36) intervention: PFMT plus BF weekly for 3 months
Group B (37) control: PFMT oral instructions only
Duration of treatment: weekly until continent or to a maximum of 3 months
Length of follow-up: 3 months after treatment finished
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Ribeiro 2008 (Continued)
Outcomes UI severity (24 hour pad test weights)
1 month (N, mean, SD): A 96 g (160) 36, B 355 (423) 37, P = 0.007
3 months: A 51 (119), 36, B 197 (269) 37
6 months: A 40 (77), 36, B 80 (176) 37
ICI-SF score: 3 months:A 3.4 (3.7), 36, B 6.8 (5.6) 37, P = 0.022
6 months: A 2.7 (3.5), 36, B 4.3 (5.5) 37, P = 0.339
PFM Strength, A versus B: 1 month, P = 0.006; 3 months P < 0.001; 6 months P = 0.
799
Quality of life (IIQ): 3 months: A 1.6 (2.7), 36, B 4.3 (6.2) 37
Notes Groups comparable at baseline before operation on age, BMI, voiding symptoms and
PFMT strength
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description. Therefore judged to be unclear risk
Allocation concealment (selection bias) Unclear risk “Randomised controlled trial”
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) High risk Blinding not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk 19: A:10 (2 refused further follow-up, 7 post-operative compli-
cations, 1 radiotherapy); B: 9 (6 refused further follow-up, 2
post-operative complications, 1 radiotherapy). No differential
dropout
Selective reporting (reporting bias) Low risk Outcomes in methods reported
Financial support Low risk Grant FAPESP 2003/07656-7 (Sao PauloResearch Foundation)
Approved by medical ethics committee Low risk “institutional review board approval”
Informed consent Low risk “All patients signed an informed consent before randomization”
ITT analysis Low risk Assumed from patient flow chart
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Robinson 2008
Methods Randomisation: yes
Participants Recruitment: pre-operatively
Included: all men undergoing radical prostatectomy
Groups comparable at baseline
Age range 39 to 74 years
Pre-operative UI 9%
Interventions Group A (62) intervention: brief verbal instruction in PFMT before operation and offer
of one biofeedback session at 2 months after surgery (uptake 33%) plus PFMT for four
weeks with biofeedback
Group B (64) control: brief verbal instruction in PFMT before operation and offer of
one biofeedback session at 2 months after surgery (uptake 46%)
Outcomes No urinary outcomes provided
No between group differences in intensity and distress of lower urinary tract symptoms
nor in impact on health-related quality of life
Notes No useable data
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation list
Allocation concealment (selection bias) Low risk The co-project director who supervised the intervention was re-
sponsible for recruitment, but did not have access to the ran-
domisation list
The co-project director who supervised data collection was re-
sponsible for concealment of the randomisation list and alloca-
tion to the next available assignment on the list to participants
sequentially as they enrolled
Blinding of participants (performance bias) High risk Participants were advised by the research assistant of their group
assignment
Blinding of personnel (performance bias) High risk Questionnaires were filled in by research assistants either in per-
son or by telephone interview
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk No significant difference between groups in the number of par-
ticipants who either withdrew prematurely or were dropped
from the study. Questionnaires with > 20% data missing were
excluded from analysis. In remainder mean substitution was in-
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putted for missing data
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Low risk “This study was supported by the American Cancer Society
(TPRB-98-118-01-PBP) and a Rutgers College of Nursing Fac-
ulty Research Development Award”
Approved by medical ethics committee Low risk “Recruitment was initiated in January 1998 after approval of the
parent study was obtained from the institutional review boards
of both medical centres and the university”
Informed consent Low risk “Written informed consent was obtained by a research assistant”
ITT analysis Low risk “Data analysis was by intention-to-treat”
Robinson 2009
Methods Randomisation: randomly assigned via sealed envelopes
Participants Number of men 54 but no numbers in groups
Recuitment: post-operatively
Included: radical prostatectomy, all with UI who were 50 + years, English speaking and
were within a 50 mile radius of treatment centre
Age: mean 59.5 (6.3) years
Interventions Group A intervention: routine brief verbal and written PFMT plus one PFMT session
and 3 weekly nurse phone calls
Group B intervention: routine brief verbal and written PFMT plus four BF enhanced
PFMT sessions and 4 weekly nurse phone calls
Group C control: routine brief verbal and written PFMT
Duration of treatment: 3 months
Length of follow-up: 9 months
Outcomes Urine stream interruption test (PFM strength)
Mishell Uncertainty in Illness Scale
Broome Pelvic Muscle self-Efficacy Scale
UI frequency (3 day bladder diary)
24 hour pad test (volume of urine lost)
Male Urogenital Distress Inventory (UI distress)
Male Urinary Symptom Impact Questionnaire (QoL)
Notes No useable data in abstract
Risk of bias
Bias Authors’ judgement Support for judgement
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Robinson 2009 (Continued)
Random sequence generation (selection
bias)
Low risk Via sealed envelopes
Allocation concealment (selection bias) Unclear risk No description. Therefore judged to be un-
clear risk
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be un-
clear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description. Therefore judged to be un-
clear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No description. Therefore judged to be un-
clear risk
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Low risk “NIH/NINR”
Approved by medical ethics committee Low risk “Yes”
Informed consent Low risk “Following informed consent”
ITT analysis Unclear risk Not specified. Therefore judged to be un-
clear risk
Seleme 2008
Methods Randomisation: yes, single blind
Method of allocation: using coloured cards
Participants Post-operative intervention
Included: men with UI eight weeks after radical prostatectomy
Exclusion: previous radiotherapy, anterior transurethral resection, diabetes mellitus and
urethral obstruction after surgery
Age: median 63.7 years, range 46 to 83 years
Interventions A (44) intervention: verbal instruction and information on PFMT plus information on
life style changes. Additional 15 physiotherapy sessions consisting of intensive PFMT
with BF and ES
B (32) control: verbal instruction and information on PFMT plus information on life
style changes
Duration of treatment: no description
Length of follow-up: 6 months
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Seleme 2008 (Continued)
Outcomes Incontinence Quality of life (I-QoL, higher score better), mean (SD)
Directly after treatment: A 44.23 (14.61), B 37.53 (9.94)
At 6 months: A 80.32 (7.01), B 51.69 (16.17), P = 0.001
At 6 months for Group A (44) intervention only:
1 hour pad test: mean urine loss before treatment 54.2 g and after treatment 8.8 g (P >
0.001)
VAS severity of UI: before treatment 9.3, after treatment 1.3 (P > 0.001)
Notes Unexplained disparity between numbers in randomised groups
No results for Group B control for pad test or VAS
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Coloured cards
Allocation concealment (selection bias) Unclear risk Method of selection unknown
Blinding of participants (performance bias) High risk Blinding not possible
Blinding of personnel (performance bias) High risk Blinding not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported. Therefore judged to be un-
clear risk
Incomplete outcome data (attrition bias)
All outcomes
High risk No information for Group B control for
both the one hour pad test and the VAS
severity of UI
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Low risk “None”
Approved by medical ethics committee Low risk “Medical Ethical Committee of Nossa Sen-
hora das Gracas Hospital in Curitiba,
Brazil”
Informed consent Low risk “after signing informed consent”
ITT analysis Unclear risk Not reported. Therefore judged to be un-
clear risk
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Tibaek 2007
Methods Randomisation: yes, mathematical table, grouped in blocks of 10
Method of allocation: sealed envelopes by independent third party
Blinding: Slingle blind. Independent physiotherapist undertook initial assessment and
4 week outcome assessment
Dropouts: 9 before intervention (4, training too time consuming; 1, didn’t have TURP;
4, operated elsewhere)
Setting: Hospital, Denmark
Participants Pre-operative intervention
Included: TURP, all men
Exclusion: prostate cancer, previous lower urinary tract surgery, neurological disease
Age: A 70 (58 to 77) years, B 68 (52 to 79) years
Interventions Group A (26) intervention: 1 hour individual session with physiotherapist to teach
correct contraction for PFMT, three 1 hour group lessons and home training programme
Group B (23) control: no pre-operative physiotherapy. Information about anatomy and
physiology and verbal instructions for 2 to 3 days after TURP in the ward
Duration of treatment: 4 weeks after surgery
Length of follow-up: 2 and 4 weeks and 3 months after operation
Outcomes Compliance: A 24/26 attended all 4 training sessions
Use of urinary pads per 24 hours, at 4 weeks: A 4/26, B 4/21. At 3 months: A 3/26, B
5/22
UI (pad test weight g/24hrs):
4 weeks (N, Median, range): A 26, 12 (0 to 374), B 23, 4 (0 to 56), P = 0.755
Danish Prostatic Symptom Scale: 3 months (N, median, range): A 26, 3 (0 to 24), B 23,
4.5 (0 to 51), P = 0.754
Also data on muscle function, muscle strength, static endurance and dynamic endurance
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Mathematical table, grouped in blocks of
10
Allocation concealment (selection bias) Low risk Sealed envelopes by independent third
party
Blinding of participants (performance bias) High risk Not possible to blind to intervention
Blinding of personnel (performance bias) Unclear risk Independent physiotherapist undertook
initial assessment and 4 week outcome as-
sessment
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Tibaek 2007 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description. Therefore judged to be un-
clear risk
Incomplete outcome data (attrition bias)
All outcomes
High risk Nine dropped out before intervention
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Low risk None
Approved by medical ethics committee Low risk “This study was approved by the ethical
committee inCopenhagenCounty and fol-
lowed the Declaration of Helsinki”
Informed consent Low risk “Informed consent was obtained from the
patients”
ITT analysis Unclear risk Not specified
Tienforti 2012
Methods RCT
Participants Time of recruitment: pre-operative
Population:men undergoing radical prostatectomy (whole population, with or without
UI)
Included: men who underwent open retropubic radical prostatectomy for clinically
localized prostate cancer (cT1a to cT2b), able to regularly attend an ambulatory schedule
Excluded: prior diseases with a possible impact on urinary continence, preoperative
radiotherapy and any medical condition that could limit participation in the training
programme
Age (mean, range): A 67 (60 to 74); B 64 (52 to 74)
Dropouts: 1 from A (intolerance to procedure using rectal probe), 1 from B (surgical
complication)
Not differential dropout
Baseline characteristics: comparable at baseline
Interventions Time of intervention: pre-operative
A (16): on the day before RP + the day after catheter removal, patients received guided
PFMT+biofeedback + information about the anatomy of pelvic floormuscles andwrong
execution was corrected, also given oral and written instructions on Kegel exercises to be
performed at home, instructed to: perform three sets daily for 10 mins, each contraction
lasting 5 seconds with 5 seconds of relaxation, contract their pelvic floor while lying,
sitting and standing, frequency recorded in training diary, After RP visits at monthly
intervals after catheter removal involving assisted biofeedback andmotivation for 20min
B (16): after catheter removal, men received standard care, oral and written instructions
from urologist on PFMT, Instructed to: start PFMT (e.g. 2 to 3 weeks after surgery),
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Tienforti 2012 (Continued)
control visits at 3 + 6 months after catheter removal
All men were given oral and written instructions post-operatively to perform PFMT at
home, 3 sets daily of 10 min each
Duration of treatment: monthly visits as long as patient required pads, including safety
pads
Follow up: at least 6 months after catheter removal
Outcomes Primary outcome (number of men with UI)
Number of incontinent men (defined as ICIQ-UI > 0)
1 month: A 10/16; B 16/16, P = 0.02
3 months: A 8/16; B 15/16, P = 0.01
6 months: A 6/16; B 15/16, P = 0.002
Other outcomes
Number of continent men (efined as ICIQ-UI = 0)
1 month: A 6/16; B 0/16, P = 0.02
3 months: A 8/16; B 1/16, P = 0.01
6 months : A 10/16; B 1/16, P = 0.002
Mean number of incontinence episodes per week/24 hours (mean (SD) N)
1 month: A 1.43 (0.82) 16; B 14 (0.82) 16, P = N.S
3 months: A 0.57 (1.47) 16; B 2 (1.47) 16, P = 0.01
6 months: A 0.43 (1.33) 16; B 1.86 (1.33) 16, P = 0.005
Mean number of pads used per week/24 hours (mean (SD) N)
1 month: A 0.46 (0.67) 16; B 0.94 (0.67) 16 P = NS
3 months: A 0.23 (0.63) 16; B 0.91 (0.63) 16 P = 0.005
6 months: A 0.2 (0.57) 16; B 0.66 (0.57) 16 P = 0.03
Quality of life
Mean ICIQ-OAB score (mean (SD) N)
1 month: A 11.5 (3.6) 16; B 14 (3.6) 16, P = NS
3 months: A 11 (0.92) 16; B 11.7 (0.92) 16, P = 0.04
6 months: A 9 (4.1) 16; B 13 (4.1) 16, P = 0.01
Mean UCLA-PCI score (mean (SD) N)
1 month: A 330 (?) 16; B 260 (?) 16, P = NS
3 months: A 400 (500) 16; B 270 (338) 16, P = 0.006
6 months: A 430 (487) 26; B 275 (311) 16, P = 0.003
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Generated by computer andwas stratified with a 1:1 allocation”
Allocation concealment (selection bias) Unclear risk Not reported
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Tienforti 2012 (Continued)
Blinding of participants (performance bias) High risk “Participants were unblinded to treatment assignment”
Blinding of personnel (performance bias) Low risk “Surgeons and person scoring the evaluation questionnaires were
blinded throughout the duration of the study”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “nurse scoring the evaluation questionnaires was blinded” to
randomisation
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 from A (intolerance to procedure) 1 from B (surgical compli-
cation). Not differential dropout
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk Not reported
Approved by medical ethics committee Low risk “Work was carried out in accordance with the ethical standards
of the appropriate institutional committee on human experi-
mentation and with the last revision of the Helsinki Declaration
Informed consent Low risk “All eligible patients gave informed signed consent”
ITT analysis Low risk Assumed from patient flow diagram
Tobia 2008
Methods Randomised: yes
Participants Recruitment: pre-operative
Included: all men, radical prostatectomy
Age: 45 to 75 years
Interventions Group A (19) intervention: PFMT
Group B (19) control: no PFMT
length of follow-up: 2, 4 and 8 weeks
Outcomes Dry at 2 weeks: A 9/19, B 9/19
Dry at 4 weeks: A 9/19, B 9/19
Dry at 8 weeks: A 15/19, B 17/19, P = 0.374
No significant differences for age (P = 0.674), PSA (P = 0.208), Gleason score pre (P =
0.762) and post-operation (P = 0.824)
Notes Awaiting translation for more information.
Risk of bias
Bias Authors’ judgement Support for judgement
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Tobia 2008 (Continued)
Random sequence generation (selection
bias)
Unclear risk No description. Therefore judged to be unclear risk
Allocation concealment (selection bias) Unclear risk No description. Therefore judged to be unclear risk
Blinding of participants (performance bias) High risk No description, Spanish language
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be unclear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information. Therefore judged to be unclear risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk No dropouts. Therefore judged to be unclear risk
Selective reporting (reporting bias) Unclear risk Spanish language
Financial support Unclear risk Unable to be determined
Approved by medical ethics committee Unclear risk Unable to be determined
Informed consent Unclear risk Unable to be determined
ITT analysis Unclear risk Unable to be determined
van Kampen 1998
Methods Randomised: yes
Method of allocation: stratified randomisation with sealed envelopes. Stratified by grams
of urine loss (< 50 , > 50, < 250, > 250 g)
Blinding: yes (outcome assessor not involved with the study)
Dropouts: 5
Intention to treat: yes
Participants Recruitment: post-operative
Included:men incontinent post-radical prostatectomy 15 days after surgery after catheter
removal
N = 102 eligible, 98 completed
Interventions Post-operative intervention
Group A (50) intervention: 1 session of PFMT in hospital before discharge and then saw
the physiotherapist for 1 to 2 weeks for as long as UI persisted; 90 daily home exercises
sitting, standing and lying; 7 men unable to contract PFM or with weak contraction
received electrical stimulation by anal probe
Group B (52) control: No formal PFMT instruction but saw the therapist at 1 to 2 weeks
and received placebo stimulation and information about aetiology of UI
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van Kampen 1998 (Continued)
Both A and B: received bladder training to increase bladder capacity
Length of follow-up: 12 months
Outcomes Main outcome: urine loss measured by 24 and 1 hour pad tests; 24 hour pad test done
daily until continence achieved; 1 hour pad test when loss of < 2 g of urine to confirm
continence
Secondary outcomes:
Subjective UI by visual analogue scale
Fluid Volume Chart
Quality of Life - questionnaire designed for study
Continence definition:
Numbers cured defined as < 2 g urine loss on 24 and 1 hour pad tests
Data collection: subject assessment of continence preoperatively (during screening), and
at 1, 6 and 12 months. Daily weighing of pads by participants (24 hour pad test)
Notes Pragmatic study; policy of management left to clinical judgment as to which protocols
to add to PFMT regime. 63 of the eligible subjects were unable to participate because
of geographical reasons; demographics and post-operative variables did not differ from
the 102 subjects who were in the treatment groups
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified by grams of urine loss (< 50 , >
50, < 250, > 250 g)
Allocation concealment (selection bias) Low risk A - stratified randomisation with sealed en-
velopes
Blinding of participants (performance bias) Unclear risk The control group “received placebo elec-
trotherapy that could not affect the pelvic-
floor muscle function.”
Blinding of personnel (performance bias) Unclear risk “The patients in both groups were treated
by the same therapist (MVK) until they be-
came continent, within a period of 1 year”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessor not involved with the
study
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Dropouts: 5
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Low risk “supported by a grant from the Fund of
Scientific Research, Flanders, Belgium”
137Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
van Kampen 1998 (Continued)
Approved by medical ethics committee Unclear risk Not specified
Informed consent Low risk “All patients included in the study gave
written informed consent”
ITT analysis Low risk “The groupswere analysed on an intention-
to-treat basis”
Wille 2003
Methods Randomised: yes
Method of allocation: not described
Blinding: not mentioned
Dropouts: numbers participating at 3 and 12 months identified (for pad test, N = 116
at baseline, 79 at 3 months and 124 at 12 months), reason for dropouts not described
Participants Recruitment: pre-operative
Included: all men undergoing radical prostatectomy
N = 139 randomised (number in each group at various data collection points varied)
Interventions Post-operative intervention
Group A (47): PFMT alone
Group B (46): PFMT + ES; PFMT as above plus instructed by dedicated in ES via
surface anal electrode and bio-impulser (biphasic pulse with 1 second bursts, 5 second
pulse width, 2 second pulse trains
Group C (46): PFMT + ES + biofeedback. As above plus biofeedback (anal probe) 15
minutes twice daily for 3 months
All groups A and B and C: PFMT by physiotherapist, 20-30 minute sessions for 3
days, instructed to perform exercises twice daily for 3 months plus 3 week rehabilitation
program after discharge. Regular interaction with health professional for 6 weeks after
surgery, encouraged to performed treatment for 3 months post-surgery
Length of follow-up: 12 months
Outcomes Main outcome: urine loss measure by continence questionnaire and 20 minute provoca-
tive pad test
Continence definition: reported use of 0 to 1 pads on questionnaire (subjective) or loss
of less than 1 gram of urine on pad test
Data collection: baseline (after catheter removal), 3 months and 12 months post-opera-
tively
Willingness to undergo surgery again: A 73%, B 83%, C 73%
Quality of life EORCTQLQ-C30: scores for physical; role; emotional; social; and global
quality of life were not significantly different between the groups at 3 or 12 months (no
SDs provided)
No significant differences in continence rates between the three groups at baseline, 3
months or 12 months (objective)
Notes
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Wille 2003 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Prospective randomized trial” Method of
sequence generation not specified
Allocation concealment (selection bias) Unclear risk “Prospective randomized trial” Method of
sequence generation not specified
Blinding of participants (performance bias) High risk Blinding to intervention not possible
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be un-
clear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk “Results at baseline after catheter removal,
at 3 and 12 months postoperatively were
available for 139, 120 and 128 (question-
naires at three different time points) and
116, 79 and 124 (pad test at three dif-
ferent time points) patients, respectively”.
However, no information about individual
groups
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Unclear risk Not reported. Therefore judged to be un-
clear risk
Approved by medical ethics committee Unclear risk Not reported. Therefore judged to be un-
clear risk
Informed consent Low risk “Informed consent was obtained”
ITT analysis Unclear risk Not reported. Therefore judged to be un-
clear risk
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Yamanishi 2006
Methods Randomised: yes.
Blinding: double blind
Dropouts: 1 due to pain in the intervention group
Participants Randomisation: postoperative
Included: radical prostatectomy, all with severe post-operative UI of > 100 g after catheter
removal
Age: mean 65.7 (7.0) years
Pre-operative intervention
Interventions All patients instructed pre-operatively PFMT by nurses and continued after catheter
removal
A (26) intervention: oral PFMT plus electrical stimulation for 15 minutes twice daily
(50 Hz square waves, 300 µsec pulse duration, maximum output 70 mA (5 sec on, 5 sec
off duty cycle)
B (30) control: oral PFMT plus sham stimulation (output 3 mA, 2 sec on, 13 sec off
duty cycle)
Duration of treatment: until continent or 12 months
Length of follow-up: 1, 3, 6 and 12 months after treatment
Dropouts: A 4/26, B 5/30 (including 2+4 with adverse effects)
Outcomes Number of incontinent men
1 month: A 18/26, B 29/30
3 months: A 10/24, B 25/29
6 months: A 5/23, B 15/26
12 months: A 3/22, B 8/25
24 hour pad test weights (mean ml, SD, N)
1 month: A 210 (261) 26, B 423 (357) 30
3 months: A 81 (140) 24, B 232 (339) 29
6 months: A 20 (49) 23, B 132 (293) 26
12 months: A 18 (49) 22, B 98 (277) 25
Time until continent in months (mean, SD, N): A 2.71 (2.6) 22, B 6.82 (3.9) 25, P =
0.0006
ICIQ-SF (mean score SD N; 0 to 21, higher = worse)
1 month: A 10.6 (6) 26, B 14.9 (4.9) 30
3 months: A 5.8 (5.7) 24, B 11.2 (5.7) 29
6 months: A 4.3 (6.2) 23, B 8.2 (5.3) 26
12 months: A 4.2 (6.2) 22, B 5.6 (6.5) 25
ICIQ-QoL score (mean score SD N; 0 to 21; 0 to 10, higher = worse)
1 month: A 4.2 (3.5) 26, B 6 (3) 30
3 months: A 2.2 (2.3) 24, B 3.7 (2.9) 29
6 months: A 1.6 (3.1) 23, B 2.5 (2.2) 26
12 months: A 1.5 (3.1) 22, B 1.9 (2.5) 25
Adverse effects: A 2/26, B 4/30 (discomfort or anal pain)
Notes
Risk of bias
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Yamanishi 2006 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk By computer
Allocation concealment (selection bias) Low risk “None of the patients, doctors or medi-
cal staff knew which type of stimulation
had been assigned until the key code was
opened”
Blinding of participants (performance bias) Low risk Men were blinded to the intervention
(sham, low energy stimulation in control
group
Blinding of personnel (performance bias) Low risk Blinding of doctors, nurses and medical
staff
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinding of assessors, medical staff
Incomplete outcome data (attrition bias)
All outcomes
Low risk It is reported that “In the active ES group 2
patients discontinued after 2 and3months,
respectively, due to urethral stricture at the
bladder neck. In the sham group 1 patient
discontinued treatment at 7 months be-
cause of an increase in prostate specific anti-
gen and he then underwent radiation ther-
apy”. However, there is no evidence that
dropout was related to trial interventions
Selective reporting (reporting bias) Unclear risk Protocol not available
Financial support Low risk “None”
Approved by medical ethics committee Low risk “Local ethical committee approval” was ob-
tained
Informed consent Low risk “written informed consent from each sub-
ject was obtained”
ITT analysis Unclear risk Not reported. Therefore judged to be un-
clear risk
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Yokoyama 2004
Methods Randomised: yes
Method of allocation: not stated
Blinding: not mentioned
Dropouts: it appears that there are no dropouts but this is not specifically mentioned
Participants Recruitment: post-operative
Included: 36 men with urinary incontinence, >100g on 24hour pad test, one day after
catheter removal
Mean age: Group A 67.2 years, Group B 68.2 years, Group C 66.2 years
Interventions A (12) intervention: anal electrode for 15 minutes twice a day for 1 month
B (12) intervention: extra-corporeal magnetic innervation, neocontrol system, treatment
sessions 20 minutes, twice a week for 2 weeks
C (12) control: PFMT, digital anal teaching of correct contractions, then verbal and
written instructions for home practice
Length of follow-up: 2, 3, 4, 5 and 6 months
Outcomes 24 hour pad test weight (grams)
3 months: A 34 g, B 7.3 g, C 50 g.
6 months: for all groups less than 10 g
Quality of life measured by I-QOL: improvement in all groups over time, no statistically
significant difference between the groups
Remaining UI at 6 months: A 2/12, B 1/12, C 2/12
Notes Adverse effects: None in any of the groups, no discomfort or irritation from anal probe
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description. Therefore judged to be un-
clear risk
Allocation concealment (selection bias) Unclear risk Randomly assigned
Blinding of participants (performance bias) Unclear risk No description. Therefore judged to be un-
clear risk
Blinding of personnel (performance bias) Unclear risk No description. Therefore judged to be un-
clear risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description. Therefore judged to be un-
clear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Numbers not given
Selective reporting (reporting bias) Unclear risk Protocol not available
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Yokoyama 2004 (Continued)
Financial support Unclear risk Not reported
Approved by medical ethics committee Low risk “The local ethics committee approved the
protocol procedure”
Informed consent Low risk “Each patient provided written informed
consent”
ITT analysis Unclear risk Not reported. Therefore judged to be un-
clear risk
Zhang 2007
Methods Randomised: yes
Method of allocation: not stated
Blinding: none
Dropouts: two did not complete the control follow-up assessment because they believed
the control group was not helpful
Participants 58 men approached, 33 consented, 3 dropouts
Recruitment: post-operative
Included: all incontinent men 6 months after radical prostatectomy
Interventions GroupA (14) intervention: PFMTplus BF using rectal electrical sensor, initial 45minute
session with physical therapist then written instructions to carry out at home three
times a day for 10 minutes. Plus support group, 6 meetings in 3 months with a health
psychologist
Group B (15) control: PFMT plus BF using rectal electrical sensor, initial 45 minute
session with physical therapist then written instructions to carry out at home three times
a day for 10 minutes
Outcomes Length of follow-up: 3 months
Frequency of PFMT: 4 to 7 times per week A 12/14, B 6/13, P = 0.077
Use of pad or brief: A 7/14 (50%), B 11/13 (85%), P = 0.057
Not able to control urge to urinate and prevent leakage: A 4/14, B 8/13, P = 0.085
Nocturia per week (mean): A 13, B 15.08, P = 0.484
VAS for severity of UI: A 3.21, B 4.65, P = 0.057 (t = -1.902)
QoL measured by Illness Intrusiveness Questionnaires (IIRS): A 10.96, B 17.27, P = 0.
037 Mann Whitney U = 48.5
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description. Therefore judged to be un-
clear risk
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Zhang 2007 (Continued)
Allocation concealment (selection bias) Unclear risk “Randomised”
Blinding of participants (performance bias) High risk Group therapy (unable to blind to inter-
vention)
Blinding of personnel (performance bias) Unclear risk A research assistant, who was a doctoral
candidate in medical anthropology, col-
lected data under supervision
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not specified. Therefore judged to be un-
clear risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Two dropouts in the control group
Selective reporting (reporting bias) Low risk Outcomes reported
Financial support Low risk “This study was supported by an American
Cancer Society pilot research grant and the
Frances Payne Bolton School of Nursing at
Case Western Reserve University”
Approved by medical ethics committee Unclear risk Not reported. Therefore judged to be un-
clear risk
Informed consent Unclear risk “33 patients consented to participate”
ITT analysis Unclear risk Not reported. Therefore judged to be un-
clear risk
ExMI = extra-corporeal magnetic innervation; g = gram(s); PFMT = pelvic floor muscle training; TURP = transurethral resection of
the prostate; UI = urinary incontinence
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bennett 1997 Insufficient information to assess study for inclusion. Abstract only, no data included. Attempts to contact
the author for data unsuccessful
Bocker 2002 Data from study that included male postprostatectomy and female post-polio patients. Translation obtained
as reported in German. Data from the two groups were not separated and therefore not in a usable form
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(Continued)
Burkert 2011 Not measuring incontinence
Ceresoli 2002 Insufficient information to assess study for inclusion. Attempts to contact the author for data unsuccessful
Chang 1998 Data from study which involved post-TURP patients. Two groups, treatment and control. Not randomly
assigned to groups, first 25 consecutively assigned to control, next 25 to intervention
Cornel 2005 Descriptive study. No control group
Cornu 2011 RCT. PFMT + Duloxetine (drug) versus PFMT + placebo
Crevenna 2003 Descriptive pilot study. No control group
Dieperink 2013 Intervention after radiotherapy only
Eren 2013 RCT, 58 men after RP. Pharmacological intervention: Duloxetine + PFMT versus PFMT alone
Filocamo 2007 RCT, 112 men after RP. Pharmacological intervention: Duloxetine + PFMT versus PFMT alone
Griebling 1999 Insufficient information to assess study for inclusion.Data reported in paper presentation and in later published
report did not contain sufficient detail of analysis to include in tables of comparison. Attempts to contact
authors not successful in providing further data
Hotston 2006 Pharmacological intervention
Ip 2004 Education intervention (refrigerator magnet) not an intervention included in review
Kahihara 2006 A comparative study. Early versus delayed PFMT no randomisation
Lin 2012 Measuring erectile dysfunction only
McGlynn 2004 Descriptive study of change in education delivery approach. No control group
Mishel 2002 Data not separated for men who received radiotherapy and those who underwent prostate surgery
Nehra 2001 Insufficient information to assess study for inclusion. Abstract only. Attempts to contact authors for further
data unsuccessful. Possibly ongoing trial but no further data available
Ottenbacher 2013 RCT but of written information about diet and general exercise
Pemberton 2006 Comparative study of different types of urinary sheath
Prota 2012 Measuring erectile dysfunction, no useable data
Pulker 2002 Descriptive study. No control group
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(Continued)
Ribeiro 2013 Not prostatectomy
Ricci 2004 NEWa Measuring “sensory urgency” only, not incontinence
Robinson 2012 Measuring the validity of a specific test, no useable data
Salinas Casado 1991 Descriptive study. No control group. Article in Spanish with English abstract
Salinas Casado 1996 Descriptive study. No control group. Article in Spanish with English abstract
Seki 2005 Descriptive study. No control group
Shen 2012 NEWa Not looking at incontinence. Translation obtained as reported in Chinese
Traeger 2013 Data for men who received radiotherapy not separated from those who underwent prostate surgery
Yang 2010 NEWa Not randomised. Translation obtained as reported in Chinese
Yao 2012 Not RCT. Physiotherapist-guided PFMT versus control (retrospective analysis)
Zahariou 2009 Not randomised
Zermann 1999 Descriptive study. No control group
Zhang 2009 Data for men who received radiotherapy not separated from those who underwent surgery
Estim = Electrical stimulation
ExMI = Extra-corporeal magnetic innervation
TURP = Transurethral resection of the prostate
Characteristics of studies awaiting assessment [ordered by study ID]
Crivellaro 2011
Methods Not enough information
Participants 73 men after retropubic radical prostatectomy
Interventions Ultrasound-guided biofeedback versus biofeedback using verbal instructions and digital biofeedback
Outcomes
Notes Authors to be contacted regarding whether assignment was randomised
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Delmastro 2010
Methods Open label RCT
Participants Men scheduled for radical prostatectomy
Interventions Preoperative intensive PFMT with or without proprioceptive training
Outcomes Anal examination to assess pelvic floormuscle function; subjective and objective voiding and incontinence parameters;
four tests of pelvic floor muscle function; PGI-I; ICIQ-male score
Notes Further information needed from authors
Lilli 2006 NEW
Methods Unclear if randomised, further information from authors required
Participants Time of recruitment: pre-operative
Population:Men having a radical prostatectomy (whole population, with or without UI)
Included: Men who were candidates for retropubic radical prostatectomy
Excluded:Acquired or congenital disability, cardiovascular diseases requiring the administration of drugs that interfere
with voiding, e.g. diuretics and/or alphalytics, problems relating to vesico-sphincteral innervations, episodes of
unstable or transitory continence during their lifetime, any type of neuropathy, other cancers, and psychoaffective
disturbances such as depression or insomnia
Age (mean, SD): A 68 (?); B 68 (?)
Dropouts:Not reported
Baseline characteristics: Comparable at baseline
Interventions Time of intervention: Pre-operative
A (45): 20 mins of PFMT + biofeedback daily for 15 weeks before surgery, instructed to: carry out exercises during
increased abdominal pressure (coughing, extending the abdomen, raising the head and keeping it raised), instructed
how to carry out rapid, brief contractions without increasing abdominal activity and how to perform slow contractions
B (45): Instructed to start PFMT at home 15 weeks before surgery
After surgery and removal of catheter, all men were instructed to carry out four series of PF contractions at home on
a daily basis for six months
Duration of treatment: 6 months
Follow up: 1 month, 3 months and 6 months after surgery
Outcomes Primary outcome (number of men with UI):
Number of incontinent men (defined as use of pads):
Pre-operative: A 0/45; B 0/45
1 month: A 42/45; B 42/45
3 months: A 30/45; B 33/45
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Lilli 2006 NEW (Continued)
6 months: A 13/45; B 15/45
Other outcomes:
Number of continent men (defined as completely dry without the use of pads):
Pre-operative: A 45/45; B 45/45
1 month: A 3/45; B 3/45
3 months: A 15/45; B 12/45
6 months: A 32/45; B 30/45
Notes Unclear if randomised
Simeit 2010 NEW
Methods RCT
Participants Men with urinary incontinence after radical prostatectomy
Interventions A: PFMT
B: PFMT with additional ’BBS trainer’
Outcomes Quality of life (EORTC questionnaire), impact of incontinence
Notes Awaiting German translation
Zellner 2011 NEW
Methods RCT
Participants Men after radical prostatectomy
Interventions A: PFMT + biofeedback + electrical stimulation
B: Whole body vibration
C: Guided PFMT
Outcomes International Prostate Symptom Score (IPSS), the enclosed question about quality of life (IPSS-QL), pad test, pelvic
floor strength, maximum uroflow, micturition volume, serum testosterone and blood glucose
Notes Awaiting German translation
Zhang 2013
Methods RCT
Participants 127 Men with incontinence after “cancer treatment” Radical prostatectomy?
Interventions A: Biofeedback + PFMT + 6 biweekly sessions of problem-solving therapy delivered through a support group, B:
Biofeedback + PFMT + 6 biweekly sessions of Problem-solving therapy delivered through telephone contact, C (?):
Standard care
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Zhang 2013 (Continued)
Outcomes Number of incontinent men [need for wearing a pad]
Notes Further information required about participants + no useable data
Characteristics of ongoing studies [ordered by study ID]
Burnett 2012
Trial name or title Health Interventions in Men Undergoing Radical Prostatectomy- A Randomized Controlled Clinical Trial
Methods RCT
Participants Men undergoing radical prostatectomy
Interventions Intensive fitness intervention
Outcomes Expanded Prostate Cancer Index (EPIC)-26, RAND-12 Questionnaire, body weight change, body mass
index (BMI) change, blood pressure (BP) change, International Index of Erectile Function (IIEF), Quality
of Erection Questionnaire (QEQ)
Starting date December 2012
Contact information Arthur L Burnett, Johns Hopkins Hospital, Baltimore, United States
Notes
Burnett 2013
Trial name or title Study of Non-Invasive Viberect Penile Vibratory Stimulation Regimen to Enhance Recovery of Erectile
Function/Rigidity and Urinary Control/Continence After Nerve Sparing Radical Prostatectomy (RP) for
Clinically Localized Prostate Cancer
Methods RCT
Participants Men with Urinary Incontinence
Interventions Post-operative use of Viberect device 3 days after catheter removal, daily usage for 7-10 minutes versus no
treatment
Outcomes Recovery of erectile function following radical prostatectomy, IIEF, recovery of continence, EPIC urinary and
and sexual domain, AUA, EHS EDITS and TSS questionnaires
Starting date April 2013
Contact information Arthur L. Burnett, M.D., Johns Hopkins University
149Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Burnett 2013 (Continued)
Notes
Fode 2012 NEW
Trial name or title Mechanical Nerve Stimulation in the Treatment of Post Prostatectomy Incontinence
Methods RCT
Participants Men with urinary incontinence more than 1 year after radical prostatectomy
Interventions Medical vibrator used daily for 6 weeks
Outcomes 24 hour pad test, Micturition diary, Validated symptom score ICI-Q, IPSS
Starting date June 2012
Contact information Copenhagen University Hospital at Herlev
Notes
Goode 2014
Trial name or title Perioperative Post-Prostatectomy Incontinence Home Telehealth Program (ProsTel)
Methods RCT
Participants Men undergoing radical prostatectomy
Interventions Guided PFMT using a telehealth device (home messaging unit)
Outcomes Time to continence using ICIQ-SF, EPIC-UI, HRQOL, IIQ-SF, IPSS, patient satisfaction questionnaire,
Estimated Percent improvement, Global perception of Improvement
Starting date January 2012
Contact information Department of Veterans Affairs
Notes
Mina 2013
Trial name or title A Multicentre, Pilot Randomized Controlled Trial to Examine the Effects of Prehabilitation on Functional
Outcomes After Radical Prostatectomy
Methods RCT
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Mina 2013 (Continued)
Participants Men undergoing radical prostatectomy
Interventions Behavioral: Prehabilitation (PREHAB)
Outcomes Adherence toPrehabilitationProgram,Recruitment,Contamination, StudyRetention, Physical Fitness,Qual-
ity of Life, Psychosocial Wellbeing, Physical Activity, Treatment Complications, Post-operative length of stay
Starting date November 2013
Contact information Daniel Santa Mina, University Health Network, Toronto, Ontario, Canada
Notes
Ng 2011
Trial name or title Trial study of the efficacy of intensive preoperative pelvic floor muscle training to decrease post-prostatectomy
urinary incontinence
Methods RCT
Participants Men with urinary incontinence after radical prostatectomy
Interventions Preoperative guided PFMT 3 weeks before surgery versus PFMT on the day of admission for surgery
Outcomes Pad test, IIQ-7, SF 12
Starting date February 2011
Contact information Sau-loi NG, Queen Mary Hospital, Hong Kong
Notes
Terrone 2007
Trial name or title Prevention of Urinary Incontinence After Prostatectomy
Methods RCT
Participants Men undergoing radical prostatectomy
Interventions BioFeedback; Functional Electrical Stimulation; Pelvic Floor Muscle training exercises
Outcomes 24-hour PAD test: Complete continence
Starting date February 2007
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Terrone 2007 (Continued)
Contact information Carlo Cisari, Azienda Ospedaliero Universitaria Maggiore della Carita
Notes
Zopf 2012
Trial name or title Implementation and scientific evaluation of rehabilitative sports groups for prostate cancer patients: study
protocol of the ProRehab Study
Methods “Patient preference RCT”?
Participants Men after radical prostatectomy
Interventions exercise intervention - rehabilitative sports group
Outcomes “quality of life using EORTC-QLQ-C30/PR 25, incontinence using pad test and erectile dysfunction using
IIEF”
Starting date
Contact information German Sport University Cologne
Notes
Estim = Electrical stimulation
ExMI = Extra-corporeal magnetic innervation
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D A T A A N D A N A L Y S E S
Comparison 1. Treatment of UI after radical: PFMT ± biofeedback versus no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of incontinent men 9 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 less than 3 months 7 980 Risk Ratio (M-H, Random, 95% CI) 0.95 [0.84, 1.08]
1.2 within 3-6 months 7 895 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.83, 1.10]
1.3 within 6-12 months 5 792 Risk Ratio (M-H, Random, 95% CI) 0.91 [0.73, 1.14]
1.4 after 12 months 3 665 Risk Ratio (M-H, Random, 95% CI) 0.85 [0.60, 1.22]
2 Number of incontinence
episodes per day
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 less than 3 months 2 400 Mean Difference (IV, Fixed, 95% CI) -1.09 [-1.39, -0.78]
2.2 within 3-6 months 1 227 Mean Difference (IV, Fixed, 95% CI) -0.20 [-1.40, 1.00]
2.3 within 6-12 months 1 217 Mean Difference (IV, Fixed, 95% CI) -0.20 [-1.33, 0.93]
2.4 after first year 1 211 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.82, 1.02]
3 Number of men using pads 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 less than 3 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 within 3-6 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 within 6-12 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.4 after 12 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Pad changes over 24 hours 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.4 after first year 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Urinary Incontinence Score
(ICIQ-SF)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.4 after first year 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Quality of life related to urinary
incontinence
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6.1 less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.4 after first year 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Adverse events 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8 24 hour pad test (grams of urine
lost)
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
8.1 less than 3 months 2 214 Mean Difference (IV, Fixed, 95% CI) 22.29 [-33.12, 77.
70]
8.2 within 3-6 months 2 213 Mean Difference (IV, Fixed, 95% CI) 11.87 [-40.77, 64.
52]
8.3 within 6-12 months 2 194 Mean Difference (IV, Fixed, 95% CI) 11.23 [-22.35, 44.
82]
8.4 after first year 1 167 Mean Difference (IV, Fixed, 95% CI) 39.0 [-5.72, 83.72]
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9 1 hour pad test (grams of urine
lost)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
9.1 less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.4 after first year 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Number of men not carrying
out pelvic floor muscle
contractions at 12 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 2. Treatment of UI after radical: electric or magnetic energy versus no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of incontinent men 4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 less than 3 months 2 96 Risk Ratio (M-H, Fixed, 95% CI) 0.77 [0.60, 0.98]
1.2 within 3-6 months 1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.48 [0.29, 0.79]
1.3 within 6-12 months 2 83 Risk Ratio (M-H, Fixed, 95% CI) 0.37 [0.18, 0.73]
1.4 after 12 months 3 413 Risk Ratio (M-H, Fixed, 95% CI) 0.26 [0.09, 0.74]
2 Adverse effects 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3 24 hour pad test (grams of urine
lost)
2 325 Mean Difference (IV, Fixed, 95% CI) -16.94 [-58.21, 24.
33]
3.1 less than 3 months 2 96 Mean Difference (IV, Fixed, 95% CI) -27.82 [-116.97, 61.
33]
3.2 within 3-6 months 2 93 Mean Difference (IV, Fixed, 95% CI) 5.12 [-86.19, 96.43]
3.3 within 6-12 months 2 89 Mean Difference (IV, Fixed, 95% CI) -1.95 [-64.03, 60.
13]
3.4 after first year 1 47 Mean Difference (IV, Fixed, 95% CI) -80.0 [-190.50, 30.
50]
4 Urinary Incontinence Score
(ICIQ-short form UI score)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.4 after first year 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Urinary Incontinence Quality of
Life Score (ICIQ-short form)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.4 after first year 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Time until continent (months) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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Comparison 4. Treatment of UI after radical: combinations of treatments versus no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of incontinent men at <
3 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 PFMT + anal Estim +
Biofeedback vs no treatment
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number of incontinent men
within 3-6 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 PFMT + anal Estim +
Biofeedback vs no treatment
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Number of incontinence
episodes per day at > 3 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 PFMT + anal Estim +
BFB
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Adverse effects 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 PFMT + anal Estim +
BFB
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 5. Treatment of UI after radical: one active treatment versus another active treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of incontinent men at <
3 months
2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 PFMT + Anal EStim vs
PFMT alone
2 177 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.83, 1.12]
2 Number of incontinent men
within 3 to 6 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 PFMT + BF + support
group vs PFMT + BF
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Number of incontinent men
within 6 to 12 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 FES vs ExMI 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Number of incontinence
episodes at < 3 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 PFMT + anal EStim vs
PFMT alone
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Quality of Life Score (severity of
UI) within 3 to 6 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 PFMT + BF + support
group vs PFMT + BF
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Quality of Life Score (I-QoL)
within 6-12 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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6.1 PFMT + BF + EStim vs
PFMT
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Quality of Life Score (ICI-Q-SF)
within 6-12 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7.1 PFMT + ExMI vs PFMT 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Adverse events 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 PFMT + Anal EStim vs
PFMT alone
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 1 hour pad test (grams of urine
lost): at < 3 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
9.1 PFMT + anal EStim vs
PFMT alone
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 PFMT + perineal EStim
vs PFMT alone
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 PFMT + perineal EStim
vs PFMT + anal EStim
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 24 hour pad test (grams of
urine lost): at < 3 months
2 Mean Difference (IV, Fixed, 95% CI) Totals not selected
10.1 PFMT + anal EStim vs
PFMT alone
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.2 PFMT + visual BF vs
PFMT + oral BF
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 24 hour pad test (grams of
urine lost): within 3 to 6
months
2 Mean Difference (IV, Fixed, 95% CI) Totals not selected
11.1 PFMT + anal EStim vs
PFMT alone
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.2 PFMT + visual BF vs
PFMT + oral BF
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 24 hour pad test (grams of
urine lost): within 3 to 6
months
3 Mean Difference (IV, Fixed, 95% CI) Totals not selected
12.1 PFMT + anal EStim vs
PFMT alone
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.2 PFMT + visual BF vs
PFMT + oral BF
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.3 ExMI vs PFMT alone 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Pad changes over 24 hours
within 3 to 6 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
13.1 ExMI vs PFMT alone 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Number of men not carrying
out sufficient PFMT within 3
to 6 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
14.1 PFMT + BF + support
group vs PFMT + BF
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Comparison 6. Prevention of UI after radical: PFMT ± biofeedback versus no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of incontinent men 8 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 less than 3 months 7 663 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.83, 1.06]
1.2 within 3-6 months 7 697 Risk Ratio (M-H, Random, 95% CI) 0.85 [0.75, 0.97]
1.3 within 6-12 months 6 640 Risk Ratio (M-H, Random, 95% CI) 0.51 [0.35, 0.75]
1.4 after 12 months 2 373 Risk Ratio (M-H, Random, 95% CI) 0.32 [0.20, 0.51]
2 Pad changes over 24 hours 1 Mean Difference (IV, Random, 95% CI) Totals not selected
2.1 less than 3 months 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
2.2 within 3-6 months 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
2.3 within 6 - 12 months 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
3 1 hour pad test (grams of urine
lost)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 Less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 24 hour pad test (gm/24hrs) 4 Mean Difference (IV, Random, 95% CI) Subtotals only
4.1 less than 3 months 3 424 Mean Difference (IV, Random, 95% CI) -78.19 [-211.46, 55.
07]
4.2 within 3-6 months 2 373 Mean Difference (IV, Random, 95% CI) -73.28 [-196.42, 49.
86]
4.3 within 6-12 months 2 373 Mean Difference (IV, Random, 95% CI) -14.50 [-18.36, -10.
64]
4.4 after first year 2 378 Mean Difference (IV, Random, 95% CI) -1.0 [-1.81, -0.19]
5 Number of incontinence
episodes per day
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.4 after first year 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Urinary Incontinence Score
(ICI-short form)
2 Mean Difference (IV, Random, 95% CI) Subtotals only
6.1 less than 3 months 1 32 Mean Difference (IV, Random, 95% CI) 6.5 [3.45, 9.55]
6.2 within 3-6 months 2 105 Mean Difference (IV, Random, 95% CI) -1.21 [-5.99, 3.56]
6.3 within 6-12 months 2 105 Mean Difference (IV, Random, 95% CI) -0.69 [-3.19, 1.81]
7 Quality of Life Score (IIQ) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7.1 less than 3 months 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 within 6-12 months 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.4 after first year 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Pelvic floor muscle strength (anal
squeeze pressure, cm H2O)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
8.1 less than 3 months 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.4 after first year 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Number of men not carrying out
sufficient PFMT
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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9.1 less than 3 months 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 within 3-6 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 within 6-12 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.4 after 12 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Number of men having surgery
for incontinence
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 7. Prevention of UI after radical: electric or magnetic energy versus no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 1 hour pad test (grams of urine
lost)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 ICIQ-SF score 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 9. Prevention of UI after radical: combinations of treatments versus no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of incontinent men
within 3 to 6 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 PFMT + anal Estim
+ Biofeedback versus no
treatment/sham treatment
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number of incontinent men
within 6 to 12 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 PFMT + anal Estim
+ biofeedback versus no
treatment
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 24 hour pad test (grams of urine
lost) within 3 to 6 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 PFMT + anal Estim
+ Biofeedback versus no
treatment/sham treatment
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 24 hour pad test (grams of urine
lost) 6 to 12 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 PFMT + anal Estim
+ Biofeedback versus no
treatment/sham treatment
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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5 Time until continent (months) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 PFMT + anal Estim
+ Biofeedback versus no
treatment/sham treatment
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 10. Prevention of UI after radical: one active treatment versus another active treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of incontinent men at <
3months
3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 PFMT pre and post op vs
PFMT post op
2 289 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.69, 1.06]
1.2 PFMT + Biofeedback +
transcutaneous Estim versus
Estim only
1 54 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.61, 1.26]
1.3 PFMT + Biofeedback +
transcutaneous Estim versus
post-op PFMT
1 54 Risk Ratio (M-H, Fixed, 95% CI) 0.80 [0.57, 1.11]
1.4 Post-op transcutaneous
Estim versus post-op PFMT
1 52 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.67, 1.22]
2 Number of incontinent men
within 3 to 6 months
4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 PFMT pre and post op vs
PFMT post op
2 290 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.54, 1.04]
2.2 post-op PFMT +
biofeedback + transcutaneous
Estim vs post-op Estim
1 54 Risk Ratio (M-H, Fixed, 95% CI) 1.55 [0.96, 2.49]
2.3 PFMT + general exercise
versus PFMT alone
1 49 Risk Ratio (M-H, Fixed, 95% CI) 0.48 [0.23, 0.99]
2.4 Post-op PFMT +
transcutaneous Estim +
Biofeedback versus post-op
PFMT
1 54 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.76, 1.57]
2.5 Post-op transcutaneous
electrical stimulation versus
post-op PFMT
1 52 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.43, 1.16]
3 Number of incontinent men
within 6 to 12 months
2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 PFMT pre and post op vs
PFMT post op
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 post-op PFMT +
Biofeedback + transcutaneous
Estim vs post-op Estim
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Post-op PFMT +
transcutaneous Estim +
Biofeedback versus post-op
PFMT
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
159Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
3.4 Post-op transcutaneous
Estim versus post-op PFMT
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Number of incontinent men
after 12 months
4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 PFMT pre and post op vs
PFMT post op
3 367 Risk Ratio (M-H, Fixed, 95% CI) 1.32 [0.78, 2.25]
4.2 PFMT + Penile vibration
pre and post op versus PFMT
pre and post op
1 58 Risk Ratio (M-H, Fixed, 95% CI) 1.4 [0.25, 7.77]
5 No. with severe incontinence
(e.g. pad test weight >150g) at
< 3 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 PFMT pre and post op vs
PFMT post op
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 No. with severe incontinence
(e.g. pad test weight >150g) at
3 to 6 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 PFMT pre and post op vs
PFMT post op
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 20 minute pad test (grams
of urine lost): within 3 to 6
months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7.1 PFMT + anal EStim vs
PFMT alone
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 PFMT + anal EStim + BF
vs PFMT alone
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 PFMT + anal EStim vs
PFMT + anal EStim + BF
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 20 minute pad test (grams of
urine lost): within 6 to 12
months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
8.1 PFMT + anal EStim vs
PFMT alone
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 PFMT + anal EStim + BF
vs PFMT alone
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 PFMT + anal EStim vs
PFMT + anal EStim + BF
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 1 hour pad test (grams of urine
lost) at less than 3 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
9.1 Pre-op PFMT + Estim
versus pre-op PFMT
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 1 hour pad test (grams of urine
lost) within 3-6 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
10.1 Pre-op PFMT + electrical
stimulation versus pre-op
PFMT
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 1 hour pad test within 6-12
months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
11.1 Pre-op PFMT + electrical
stimulation versus pre-op
PFMT
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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12 24 hour pad test (grams of
urine lost) at less than 3 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
12.1 PFMT + Biofeedback +
transcutaneous Estim versus
Estim only
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.2 Post-operative PFMT
+ transcutaneous Estim
+ Biofeedback versus
post-operative PFMT
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.3 Post-operative
transcutaneous electrical
stimulation versus
post-operative PFMT
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 24 hour pad test (grams of
urine lost) within 3-6 months
2 Mean Difference (IV, Fixed, 95% CI) Totals not selected
13.1 PFMT + Biofeedback +
transcutaneous Estim versus
Estim only
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.2 Postoperative PFMT +
biofeedback + transcutaneous
Estim versus postoperative
PFMT
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.3 Post-operative
transcutaneous Estim only
versus post-operative PFMT
only
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.4 PFMT + general exercise
versus PFMT alone
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 24 hour pad test (grams of
urine lost) within 6-12 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
14.1 PFMT + transcutaneous
Estim + biofeedback versus
Estim only
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.2 Post-op PFMT +
transcutaneous Estim +
Biofeedback versus post-op
PFMT
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.3 Post-op transcutaneous
Estim versus post-op PFMT
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Quality of Life Score (ICS male
short form) at < 3 months
2 Mean Difference (IV, Fixed, 95% CI) Totals not selected
15.1 PFMT pre and post op
vs PFMT post op
2 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
16 Urinary Incontinence Quality
of Life Score (ICIQ - short
form) within 3-6 months
3 Mean Difference (IV, Fixed, 95% CI) Totals not selected
16.1 Pre-op PFMT + electrical
stimulation versus pre-op
PFMT
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
16.2 PFMT + general exercise
versus PFMT alone
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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16.3 PFMT pre and post op
vs PFMT post op
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Urinary Incontinence Quality
of Life Score (ICIQ-short
form) within 6-12 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
17.1 Pre-op PFMT + electrical
stimulation versus pre-op
PFMT
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 King’s health Questionnaire
after 12 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
18.1 General Health 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.2 Role limitations 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.3 Physical limitations 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.4 Social limitations 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.5 Personal 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.6 Emotional 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.7 Sleep/energy disturbance 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18.8 Symptom severity 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 Health status measure SF-36
within 3-6 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
19.1 Physical composite score 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
19.2 Mental Composite score 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 Adverse events 2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
20.1 PFMT pre and post op
vs PFMT post op
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20.2 PFMT + Penile vibration
pre and post op versus PFMT
pre and post op
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 11. Treatment of UI after TURP: PFMT ± biofeedback versus no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of incontinent men 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 less than 3 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 within 3-6 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 within 6-12 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 after 12 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number of incontinence
episodes per day
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.4 after first year 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Number of men using pads 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 less than 3 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 within 3-6 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 within 6-12 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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3.4 after 12 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Urinary Incontinence Score
(ICI-short form)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.4 after first year 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Quality of life related to urinary
incontinence
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 less than 3 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 within 3-6 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 within 6-12 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.4 after first year 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Number of men not carrying out
pelvic floor muscle contractions
at 12 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 16. Prevention of UI after TURP: pre or post-operative PFMT ± biofeedback versus no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of incontinent men 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 less than 3 months 2 105 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.21, 1.77]
1.2 within 3-6 months 1 48 Risk Ratio (M-H, Fixed, 95% CI) 0.51 [0.14, 1.89]
2 Health status measure SF-36
within 3-6 months
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Physical component 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Physical functioning 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Body pain 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.4 General Health 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.5 Physical role limitation 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.6 Mental health component 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.7 Mental role limitation 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.8 Vitality 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.9 Mental health 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.10 Social functioning 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Comparison 21. Containment of urinary incontinence from any cause: external penile compression devices (penile
clamps) versus no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of men satisfied with
device
Other data No numeric data
2 Mean urine loss (grams of urine
on pad test)
Other data No numeric data
3 Penile Doppler blood flow
(mean systolic velocity)
Other data No numeric data
4 Penile Doppler blood flow
(mean resistence to flow index)
Other data No numeric data
Analysis 1.1. Comparison 1 Treatment of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 1 Number of incontinent men.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 1 Treatment of UI after radical: PFMT biofeedback versus no treatment
Outcome: 1 Number of incontinent men
Study or subgroup
PFMT +/-
biofeed-
back Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 less than 3 months
Franke 1998 6/13 3/10 1.2 % 1.54 [ 0.50, 4.69 ]
Glazener RP 2011 172/200 176/198 29.0 % 0.97 [ 0.90, 1.04 ]
Goode 2009 59/70 64/68 25.3 % 0.90 [ 0.80, 1.01 ]
Manassero 2007 45/54 39/53 17.8 % 1.13 [ 0.93, 1.38 ]
Moore 1999 12/18 14/21 6.5 % 1.00 [ 0.64, 1.56 ]
Moore 2008 63/93 59/82 18.3 % 0.94 [ 0.77, 1.14 ]
van Kampen 1998 5/48 23/52 1.9 % 0.24 [ 0.10, 0.57 ]
Subtotal (95% CI) 496 484 100.0 % 0.95 [ 0.84, 1.08 ]
Total events: 362 (PFMT +/- biofeedback), 378 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 15.23, df = 6 (P = 0.02); I2 =61%
Test for overall effect: Z = 0.76 (P = 0.45)
2 within 3-6 months
0.02 0.1 1 10 50
Favours PFMT Favours control
(Continued . . . )
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(. . . Continued)
Study or subgroup
PFMT +/-
biofeed-
back Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Dubbelman 2004 17/33 20/33 8.8 % 0.85 [ 0.55, 1.31 ]
Franke 1998 1/7 1/8 0.3 % 1.14 [ 0.09, 15.08 ]
Glazener RP 2011 158/197 158/197 52.9 % 1.00 [ 0.91, 1.10 ]
Manassero 2007 29/54 31/53 13.5 % 0.92 [ 0.66, 1.28 ]
Moore 1999 8/18 7/21 2.8 % 1.33 [ 0.60, 2.95 ]
Moore 2008 53/94 48/80 20.9 % 0.94 [ 0.73, 1.21 ]
van Kampen 1998 2/48 12/52 0.9 % 0.18 [ 0.04, 0.77 ]
Subtotal (95% CI) 451 444 100.0 % 0.96 [ 0.83, 1.10 ]
Total events: 268 (PFMT +/- biofeedback), 277 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 7.38, df = 6 (P = 0.29); I2 =19%
Test for overall effect: Z = 0.65 (P = 0.51)
3 within 6-12 months
Floratos 2002 4/28 0/14 0.6 % 4.66 [ 0.27, 80.84 ]
Glazener RP 2011 144/191 157/194 52.3 % 0.93 [ 0.84, 1.04 ]
Manassero 2007 18/54 24/53 16.1 % 0.74 [ 0.46, 1.19 ]
Moore 2008 46/87 37/74 28.7 % 1.06 [ 0.78, 1.43 ]
van Kampen 1998 2/48 9/49 2.2 % 0.23 [ 0.05, 1.00 ]
Subtotal (95% CI) 408 384 100.0 % 0.91 [ 0.73, 1.14 ]
Total events: 214 (PFMT +/- biofeedback), 227 (Control)
Heterogeneity: Tau2 = 0.02; Chi2 = 6.43, df = 4 (P = 0.17); I2 =38%
Test for overall effect: Z = 0.82 (P = 0.41)
4 after 12 months
Glazener RP 2011 148/196 151/195 49.1 % 0.98 [ 0.87, 1.09 ]
Manassero 2007 9/54 21/53 17.9 % 0.42 [ 0.21, 0.83 ]
Moore 2008 36/89 31/78 33.0 % 1.02 [ 0.70, 1.48 ]
Subtotal (95% CI) 339 326 100.0 % 0.85 [ 0.60, 1.22 ]
Total events: 193 (PFMT +/- biofeedback), 203 (Control)
Heterogeneity: Tau2 = 0.06; Chi2 = 6.26, df = 2 (P = 0.04); I2 =68%
Test for overall effect: Z = 0.89 (P = 0.38)
0.02 0.1 1 10 50
Favours PFMT Favours control
165Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.2. Comparison 1 Treatment of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 2 Number of incontinence episodes per day.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 1 Treatment of UI after radical: PFMT biofeedback versus no treatment
Outcome: 2 Number of incontinence episodes per day
Study or subgroup
PFMT +/-
biofeed-
back Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Glazener RP 2011 139 3.3 (3.8) 139 3.9 (4.5) 9.7 % -0.60 [ -1.58, 0.38 ]
Goode 2009 58 1.86 (0.56) 64 3 (1.17) 90.3 % -1.14 [ -1.46, -0.82 ]
Subtotal (95% CI) 197 203 100.0 % -1.09 [ -1.39, -0.78 ]
Heterogeneity: Chi2 = 1.06, df = 1 (P = 0.30); I2 =5%
Test for overall effect: Z = 6.99 (P < 0.00001)
2 within 3-6 months
Glazener RP 2011 117 3.3 (5.2) 110 3.5 (4) 100.0 % -0.20 [ -1.40, 1.00 ]
Subtotal (95% CI) 117 110 100.0 % -0.20 [ -1.40, 1.00 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.33 (P = 0.74)
3 within 6-12 months
Glazener RP 2011 107 3.1 (4.7) 110 3.3 (3.7) 100.0 % -0.20 [ -1.33, 0.93 ]
Subtotal (95% CI) 107 110 100.0 % -0.20 [ -1.33, 0.93 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.35 (P = 0.73)
4 after first year
Glazener RP 2011 105 3 (3.8) 106 2.9 (3) 100.0 % 0.10 [ -0.82, 1.02 ]
Subtotal (95% CI) 105 106 100.0 % 0.10 [ -0.82, 1.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.21 (P = 0.83)
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Analysis 1.3. Comparison 1 Treatment of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 3 Number of men using pads.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 1 Treatment of UI after radical: PFMT biofeedback versus no treatment
Outcome: 3 Number of men using pads
Study or subgroup
PFMT +/-
biofeed-
back Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 less than 3 months
Glazener RP 2011 101/177 108/177 0.94 [ 0.79, 1.11 ]
2 within 3-6 months
Glazener RP 2011 74/161 83/164 0.91 [ 0.72, 1.14 ]
3 within 6-12 months
Glazener RP 2011 67/154 71/156 0.96 [ 0.75, 1.23 ]
4 after 12 months
Glazener RP 2011 63/159 68/161 0.94 [ 0.72, 1.22 ]
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Analysis 1.4. Comparison 1 Treatment of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 4 Pad changes over 24 hours.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 1 Treatment of UI after radical: PFMT biofeedback versus no treatment
Outcome: 4 Pad changes over 24 hours
Study or subgroup
PFMT +/-
biofeed-
back Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Floratos 2002 28 1.2 (1.1) 14 0.9 (1) 0.30 [ -0.36, 0.96 ]
2 within 3-6 months
Floratos 2002 28 0.8 (1) 14 0.4 (0.5) 0.40 [ -0.05, 0.85 ]
3 within 6-12 months
Floratos 2002 28 0.4 (0.7) 14 0.2 (0.4) 0.20 [ -0.13, 0.53 ]
4 after first year
-1 -0.5 0 0.5 1
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Analysis 1.5. Comparison 1 Treatment of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 5 Urinary Incontinence Score (ICIQ-SF).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 1 Treatment of UI after radical: PFMT biofeedback versus no treatment
Outcome: 5 Urinary Incontinence Score (ICIQ-SF)
Study or subgroup
PFMT +/-
biofeed-
back Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Glazener RP 2011 198 6.3 (4.2) 198 7.2 (4.9) -0.90 [ -1.80, 0.00 ]
2 within 3-6 months
Glazener RP 2011 197 5.4 (4.2) 197 5.6 (4.6) -0.20 [ -1.07, 0.67 ]
3 within 6-12 months
Glazener RP 2011 186 5.1 (4.2) 194 5.6 (4.6) -0.50 [ -1.39, 0.39 ]
4 after first year
Glazener RP 2011 196 4.9 (4.1) 195 5.4 (4.5) -0.50 [ -1.35, 0.35 ]
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Analysis 1.6. Comparison 1 Treatment of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 6 Quality of life related to urinary incontinence.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 1 Treatment of UI after radical: PFMT biofeedback versus no treatment
Outcome: 6 Quality of life related to urinary incontinence
Study or subgroup
PFMT +/-
biofeed-
back Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Glazener RP 2011 198 2 (2.3) 198 2.5 (2.8) -0.50 [ -1.00, 0.00 ]
2 within 3-6 months
Glazener RP 2011 194 1.5 (2.1) 196 1.8 (2.5) -0.30 [ -0.76, 0.16 ]
3 within 6-12 months
Glazener RP 2011 186 1.4 (1.9) 194 1.8 (2.5) -0.40 [ -0.85, 0.05 ]
4 after first year
Glazener RP 2011 193 1.4 (2) 193 1.7 (2.3) -0.30 [ -0.73, 0.13 ]
-1 -0.5 0 0.5 1
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Analysis 1.7. Comparison 1 Treatment of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 7 Adverse events.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 1 Treatment of UI after radical: PFMT biofeedback versus no treatment
Outcome: 7 Adverse events
Study or subgroup
PFMT +/-
biofeed-
back Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Goode 2009 0/70 0/68 Not estimable
0.01 0.1 1 10 100
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Analysis 1.8. Comparison 1 Treatment of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 8 24 hour pad test (grams of urine lost).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 1 Treatment of UI after radical: PFMT biofeedback versus no treatment
Outcome: 8 24 hour pad test (grams of urine lost)
Study or subgroup
PFMT +/-
biofeed-
back Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Moore 1999 18 87 (123) 21 104 (176) 34.5 % -17.00 [ -111.31, 77.31 ]
Moore 2008 93 115 (300) 82 72 (144) 65.5 % 43.00 [ -25.48, 111.48 ]
Subtotal (95% CI) 111 103 100.0 % 22.29 [ -33.12, 77.70 ]
Heterogeneity: Chi2 = 1.02, df = 1 (P = 0.31); I2 =2%
Test for overall effect: Z = 0.79 (P = 0.43)
2 within 3-6 months
Moore 1999 18 74 (131) 21 67 (137) 39.1 % 7.00 [ -77.24, 91.24 ]
Moore 2008 94 76 (259) 80 61 (194) 60.9 % 15.00 [ -52.44, 82.44 ]
Subtotal (95% CI) 112 101 100.0 % 11.87 [ -40.77, 64.52 ]
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.44 (P = 0.66)
3 within 6-12 months
Moore 1999 17 70 (114) 16 54 (103) 20.6 % 16.00 [ -58.05, 90.05 ]
Moore 2008 87 45 (142) 74 35 (101) 79.4 % 10.00 [ -27.68, 47.68 ]
Subtotal (95% CI) 104 90 100.0 % 11.23 [ -22.35, 44.82 ]
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.66 (P = 0.51)
4 after first year
Moore 2008 89 47 (215) 78 8 (10) 100.0 % 39.00 [ -5.72, 83.72 ]
Subtotal (95% CI) 89 78 100.0 % 39.00 [ -5.72, 83.72 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.71 (P = 0.087)
Test for subgroup differences: Chi2 = 1.05, df = 3 (P = 0.79), I2 =0.0%
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Analysis 1.9. Comparison 1 Treatment of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 9 1 hour pad test (grams of urine lost).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 1 Treatment of UI after radical: PFMT biofeedback versus no treatment
Outcome: 9 1 hour pad test (grams of urine lost)
Study or subgroup
PFMT +/-
biofeed-
back Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Floratos 2002 28 6.5 (11.4) 14 3 (4.1) 3.50 [ -1.24, 8.24 ]
2 within 3-6 months
Floratos 2002 28 3.7 (9.9) 14 1.3 (2.4) 2.40 [ -1.48, 6.28 ]
3 within 6-12 months
Floratos 2002 28 3.1 (8.1) 14 0 (0) Not estimable
4 after first year
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Analysis 1.10. Comparison 1 Treatment of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 10 Number of men not carrying out pelvic floor muscle contractions at 12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 1 Treatment of UI after radical: PFMT biofeedback versus no treatment
Outcome: 10 Number of men not carrying out pelvic floor muscle contractions at 12 months
Study or subgroup
PFMT +/-
biofeed-
back Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Glazener RP 2011 63/191 91/189 0.69 [ 0.53, 0.88 ]
0.5 0.7 1 1.5 2
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Analysis 2.1. Comparison 2 Treatment of UI after radical: electric or magnetic energy versus no treatment,
Outcome 1 Number of incontinent men.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 2 Treatment of UI after radical: electric or magnetic energy versus no treatment
Outcome: 1 Number of incontinent men
Study or subgroup
PFMT +
extra
stimulation Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 less than 3 months
Yamanishi 2006 18/26 29/30 66.9 % 0.72 [ 0.55, 0.93 ]
Moore 1999 11/19 14/21 33.1 % 0.87 [ 0.53, 1.42 ]
Subtotal (95% CI) 45 51 100.0 % 0.77 [ 0.60, 0.98 ]
Total events: 29 (PFMT + extra stimulation), 43 (Control)
Heterogeneity: Chi2 = 0.50, df = 1 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 2.15 (P = 0.032)
2 within 3-6 months
Yamanishi 2006 10/24 25/29 100.0 % 0.48 [ 0.29, 0.79 ]
Subtotal (95% CI) 24 29 100.0 % 0.48 [ 0.29, 0.79 ]
Total events: 10 (PFMT + extra stimulation), 25 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.88 (P = 0.0040)
3 within 6-12 months
Morihiro 2011 3/20 6/14 33.4 % 0.35 [ 0.10, 1.17 ]
Yamanishi 2006 5/23 15/26 66.6 % 0.38 [ 0.16, 0.87 ]
Subtotal (95% CI) 43 40 100.0 % 0.37 [ 0.18, 0.73 ]
Total events: 8 (PFMT + extra stimulation), 21 (Control)
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 2.84 (P = 0.0045)
4 after 12 months
Marchiori 2010 0/166 0/166 Not estimable
Morihiro 2011 0/20 5/14 46.1 % 0.06 [ 0.00, 1.09 ]
Yamanishi 2006 3/22 8/25 53.9 % 0.43 [ 0.13, 1.41 ]
Subtotal (95% CI) 208 205 100.0 % 0.26 [ 0.09, 0.74 ]
Total events: 3 (PFMT + extra stimulation), 13 (Control)
Heterogeneity: Chi2 = 1.59, df = 1 (P = 0.21); I2 =37%
Test for overall effect: Z = 2.51 (P = 0.012)
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Analysis 2.2. Comparison 2 Treatment of UI after radical: electric or magnetic energy versus no treatment,
Outcome 2 Adverse effects.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 2 Treatment of UI after radical: electric or magnetic energy versus no treatment
Outcome: 2 Adverse effects
Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Yamanishi 2006 2/26 4/30 0.58 [ 0.11, 2.90 ]
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Analysis 2.3. Comparison 2 Treatment of UI after radical: electric or magnetic energy versus no treatment,
Outcome 3 24 hour pad test (grams of urine lost).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 2 Treatment of UI after radical: electric or magnetic energy versus no treatment
Outcome: 3 24 hour pad test (grams of urine lost)
Study or subgroup
PFMT +
extra
stimulation Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Moore 1999 19 156 (168) 21 104 (176) 15.0 % 52.00 [ -54.64, 158.64 ]
Yamanishi 2006 26 210 (261) 30 423 (357) 6.5 % -213.00 [ -375.43, -50.57 ]
Subtotal (95% CI) 45 51 21.4 % -27.82 [ -116.97, 61.33 ]
Heterogeneity: Chi2 = 7.14, df = 1 (P = 0.01); I2 =86%
Test for overall effect: Z = 0.61 (P = 0.54)
2 within 3-6 months
Moore 1999 19 202 (242) 21 67 (137) 11.2 % 135.00 [ 11.41, 258.59 ]
Yamanishi 2006 24 81 (140) 29 232 (339) 9.3 % -151.00 [ -286.50, -15.50 ]
Subtotal (95% CI) 43 50 20.4 % 5.12 [ -86.19, 96.43 ]
Heterogeneity: Chi2 = 9.34, df = 1 (P = 0.002); I2 =89%
Test for overall effect: Z = 0.11 (P = 0.91)
3 within 6-12 months
Moore 1999 19 98 (132) 21 54 (103) 31.2 % 44.00 [ -29.92, 117.92 ]
Yamanishi 2006 23 20 (49) 26 132 (293) 13.0 % -112.00 [ -226.39, 2.39 ]
Subtotal (95% CI) 42 47 44.2 % -1.95 [ -64.03, 60.13 ]
Heterogeneity: Chi2 = 5.04, df = 1 (P = 0.02); I2 =80%
Test for overall effect: Z = 0.06 (P = 0.95)
4 after first year
Yamanishi 2006 22 18 (49) 25 98 (277) 14.0 % -80.00 [ -190.50, 30.50 ]
Subtotal (95% CI) 22 25 14.0 % -80.00 [ -190.50, 30.50 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.42 (P = 0.16)
Total (95% CI) 152 173 100.0 % -16.94 [ -58.21, 24.33 ]
Heterogeneity: Chi2 = 23.28, df = 6 (P = 0.00071); I2 =74%
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Chi2 = 1.76, df = 3 (P = 0.62), I2 =0.0%
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Analysis 2.4. Comparison 2 Treatment of UI after radical: electric or magnetic energy versus no treatment,
Outcome 4 Urinary Incontinence Score (ICIQ-short form UI score).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 2 Treatment of UI after radical: electric or magnetic energy versus no treatment
Outcome: 4 Urinary Incontinence Score (ICIQ-short form UI score)
Study or subgroup
PFMT +
extra
stimulation Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Yamanishi 2006 26 10.6 (6) 30 14.9 (4.9) -4.30 [ -7.20, -1.40 ]
2 within 3-6 months
Yamanishi 2006 24 5.8 (5.7) 29 11.2 (5.7) -5.40 [ -8.48, -2.32 ]
3 within 6-12 months
Yamanishi 2006 23 4.3 (6.2) 26 8.2 (5.3) -3.90 [ -7.15, -0.65 ]
4 after first year
Yamanishi 2006 22 4.2 (6.2) 25 5.6 (6.5) -1.40 [ -5.03, 2.23 ]
-10 -5 0 5 10
Favours PFMT + Estim Favours no treatment
176Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.5. Comparison 2 Treatment of UI after radical: electric or magnetic energy versus no treatment,
Outcome 5 Urinary Incontinence Quality of Life Score (ICIQ-short form).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 2 Treatment of UI after radical: electric or magnetic energy versus no treatment
Outcome: 5 Urinary Incontinence Quality of Life Score (ICIQ-short form)
Study or subgroup
PFMT +
extra
stimulation Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Yamanishi 2006 26 4.2 (3.5) 30 6 (3) -1.80 [ -3.52, -0.08 ]
2 within 3-6 months
Yamanishi 2006 24 2.2 (2.3) 29 3.7 (2.9) -1.50 [ -2.90, -0.10 ]
3 within 6-12 months
Yamanishi 2006 23 1.6 (3.1) 26 2.5 (2.2) -0.90 [ -2.42, 0.62 ]
4 after first year
Yamanishi 2006 22 1.5 (3.1) 25 1.9 (2.5) -0.40 [ -2.02, 1.22 ]
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Analysis 2.6. Comparison 2 Treatment of UI after radical: electric or magnetic energy versus no treatment,
Outcome 6 Time until continent (months).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 2 Treatment of UI after radical: electric or magnetic energy versus no treatment
Outcome: 6 Time until continent (months)
Study or subgroup
PFMT +
extra
stimulation Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Yamanishi 2006 22 2.71 (2.6) 25 6.82 (3.9) -4.11 [ -5.99, -2.23 ]
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Analysis 4.1. Comparison 4 Treatment of UI after radical: combinations of treatments versus no treatment,
Outcome 1 Number of incontinent men at < 3 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 4 Treatment of UI after radical: combinations of treatments versus no treatment
Outcome: 1 Number of incontinent men at < 3 months
Study or subgroup
PFMT + anal
Estim + BFB Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT + anal Estim + Biofeedback vs no treatment
Goode 2009 58/70 64/68 0.88 [ 0.78, 0.99 ]
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Analysis 4.2. Comparison 4 Treatment of UI after radical: combinations of treatments versus no treatment,
Outcome 2 Number of incontinent men within 3-6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 4 Treatment of UI after radical: combinations of treatments versus no treatment
Outcome: 2 Number of incontinent men within 3-6 months
Study or subgroup
PFMT + anal
Estim + BFB Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT + anal Estim + Biofeedback vs no treatment
Opsomer 1994 3/20 1/19 2.85 [ 0.32, 25.07 ]
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Analysis 4.3. Comparison 4 Treatment of UI after radical: combinations of treatments versus no treatment,
Outcome 3 Number of incontinence episodes per day at > 3 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 4 Treatment of UI after radical: combinations of treatments versus no treatment
Outcome: 3 Number of incontinence episodes per day at > 3 months
Study or subgroup
PFMT + anal
Estim + BFB Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + anal Estim + BFB
Goode 2009 54 1.71 (0.54) 64 3 (1.17) -1.29 [ -1.61, -0.97 ]
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Analysis 4.4. Comparison 4 Treatment of UI after radical: combinations of treatments versus no treatment,
Outcome 4 Adverse effects.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 4 Treatment of UI after radical: combinations of treatments versus no treatment
Outcome: 4 Adverse effects
Study or subgroup Intervention Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT + anal Estim + BFB
Goode 2009 2/70 0/68 4.86 [ 0.24, 99.39 ]
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Analysis 5.1. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 1 Number of incontinent men at < 3 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 1 Number of incontinent men at < 3 months
Study or subgroup Treatment A Treatment B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT + Anal EStim vs PFMT alone
Goode 2009 58/70 59/70 82.7 % 0.98 [ 0.85, 1.14 ]
Moore 1999 11/19 12/18 17.3 % 0.87 [ 0.52, 1.44 ]
Subtotal (95% CI) 89 88 100.0 % 0.96 [ 0.83, 1.12 ]
Total events: 69 (Treatment A), 71 (Treatment B)
Heterogeneity: Chi2 = 0.24, df = 1 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 0.50 (P = 0.62)
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Analysis 5.2. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 2 Number of incontinent men within 3 to 6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 2 Number of incontinent men within 3 to 6 months
Study or subgroup Treatment A Treatment B Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT + BF + support group vs PFMT + BF
Zhang 2007 7/14 11/13 0.59 [ 0.33, 1.05 ]
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Analysis 5.3. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 3 Number of incontinent men within 6 to 12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 3 Number of incontinent men within 6 to 12 months
Study or subgroup Treatment A Treatment B Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 FES vs ExMI
Yokoyama 2004 2/12 1/12 2.00 [ 0.21, 19.23 ]
0.001 0.01 0.1 1 10 100 1000
Favours A Favours B
Analysis 5.4. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 4 Number of incontinence episodes at < 3 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 4 Number of incontinence episodes at < 3 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + anal EStim vs PFMT alone
Goode 2009 54 1.71 (0.54) 58 1.86 (0.56) -0.15 [ -0.35, 0.05 ]
-0.5 -0.25 0 0.25 0.5
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Analysis 5.5. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 5 Quality of Life Score (severity of UI) within 3 to 6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 5 Quality of Life Score (severity of UI) within 3 to 6 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + BF + support group vs PFMT + BF
Zhang 2007 14 3.21 (2.04) 15 4.65 (2.04) -1.44 [ -2.93, 0.05 ]
-4 -2 0 2 4
Favours A Favours B
Analysis 5.6. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 6 Quality of Life Score (I-QoL) within 6-12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 6 Quality of Life Score (I-QoL) within 6-12 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + BF + EStim vs PFMT
Seleme 2008 44 -80.32 (7.01) 32 -51.69 (16.17) -28.63 [ -34.60, -22.66 ]
-50 -25 0 25 50
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Analysis 5.7. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 7 Quality of Life Score (ICI-Q-SF) within 6-12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 7 Quality of Life Score (ICI-Q-SF) within 6-12 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + ExMI vs PFMT
Liu 2008 12 6.7 (1.2) 12 8.3 (1.6) -1.60 [ -2.73, -0.47 ]
-4 -2 0 2 4
Favours A Favours B
Analysis 5.8. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 8 Adverse events.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 8 Adverse events
Study or subgroup
PFMT +/-
biofeed-
back Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT + Anal EStim vs PFMT alone
Goode 2009 2/70 0/70 5.00 [ 0.24, 102.30 ]
0.005 0.1 1 10 200
Favours experimental Favours control
183Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 5.9. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 9 1 hour pad test (grams of urine lost): at < 3 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 9 1 hour pad test (grams of urine lost): at < 3 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + anal EStim vs PFMT alone
Hoffman 2005 59 89.6 (89.5) 60 90 (111.8) -0.40 [ -36.76, 35.96 ]
2 PFMT + perineal EStim vs PFMT alone
Hoffman 2005 59 85.3 (100.6) 60 90 (111.8) -4.70 [ -42.90, 33.50 ]
3 PFMT + perineal EStim vs PFMT + anal EStim
Hoffman 2005 59 85.3 (100.6) 59 89.6 (89.5) -4.30 [ -38.66, 30.06 ]
-20 -10 0 10 20
Favours A Favours B
Analysis 5.10. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 10 24 hour pad test (grams of urine lost): at < 3 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 10 24 hour pad test (grams of urine lost): at < 3 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + anal EStim vs PFMT alone
Moore 1999 19 156 (168) 18 87 (123) 69.00 [ -25.53, 163.53 ]
2 PFMT + visual BF vs PFMT + oral BF
Joseph 2000 6 59 (98) 5 31 (40) 28.00 [ -57.90, 113.90 ]
-200 -100 0 100 200
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Analysis 5.11. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 11 24 hour pad test (grams of urine lost): within 3 to 6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 11 24 hour pad test (grams of urine lost): within 3 to 6 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + anal EStim vs PFMT alone
Moore 1999 19 202 (242) 18 74 (131) 128.00 [ 3.49, 252.51 ]
2 PFMT + visual BF vs PFMT + oral BF
Joseph 2000 5 4 (6) 5 0 (0) Not estimable
-200 -100 0 100 200
Favours A Favours B
185Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 5.12. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 12 24 hour pad test (grams of urine lost): within 3 to 6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 12 24 hour pad test (grams of urine lost): within 3 to 6 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + anal EStim vs PFMT alone
Moore 1999 19 98 (132) 17 70 (114) 28.00 [ -52.37, 108.37 ]
2 PFMT + visual BF vs PFMT + oral BF
Joseph 2000 4 6 (10) 3 0 (0) Not estimable
3 ExMI vs PFMT alone
Koo 2009 16 9 (28) 16 45 (28) -36.00 [ -55.40, -16.60 ]
-200 -100 0 100 200
Favours A Favours B
Analysis 5.13. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 13 Pad changes over 24 hours within 3 to 6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 13 Pad changes over 24 hours within 3 to 6 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 ExMI vs PFMT alone
Koo 2009 16 0.1 (0.42) 16 0.6 (0.42) -0.50 [ -0.79, -0.21 ]
-1 -0.5 0 0.5 1
Favours A Favours B
186Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 5.14. Comparison 5 Treatment of UI after radical: one active treatment versus another active
treatment, Outcome 14 Number of men not carrying out sufficient PFMT within 3 to 6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 5 Treatment of UI after radical: one active treatment versus another active treatment
Outcome: 14 Number of men not carrying out sufficient PFMT within 3 to 6 months
Study or subgroup Treatment A Treatment B Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT + BF + support group vs PFMT + BF
Zhang 2007 2/14 7/13 0.27 [ 0.07, 1.05 ]
0.005 0.1 1 10 200
Favours A Favours B
Analysis 6.1. Comparison 6 Prevention of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 1 Number of incontinent men.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 6 Prevention of UI after radical: PFMT biofeedback versus no treatment
Outcome: 1 Number of incontinent men
Study or subgroup PFMT +/- BF Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 less than 3 months
Bales 2000 38/47 38/50 18.1 % 1.06 [ 0.86, 1.31 ]
Burgio 2006 49/54 51/53 30.7 % 0.94 [ 0.85, 1.04 ]
Filocamo 2005 145/150 147/150 37.5 % 0.99 [ 0.95, 1.02 ]
Mathewson-Chapman 97 8/27 10/24 2.5 % 0.71 [ 0.34, 1.50 ]
Parekh 2003 6/19 12/19 2.5 % 0.50 [ 0.24, 1.05 ]
Tienforti 2012 10/16 16/16 8.0 % 0.64 [ 0.43, 0.93 ]
Tobia 2008 5/19 2/19 0.6 % 2.50 [ 0.55, 11.33 ]
Subtotal (95% CI) 332 331 100.0 % 0.93 [ 0.83, 1.06 ]
0.5 0.7 1 1.5 2
Favours treatment Favours control
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(. . . Continued)
Study or subgroup PFMT +/- BF Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Total events: 261 (PFMT +/- BF), 276 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 14.83, df = 6 (P = 0.02); I2 =60%
Test for overall effect: Z = 1.10 (P = 0.27)
2 within 3-6 months
Bales 2000 20/47 19/50 6.8 % 1.12 [ 0.69, 1.82 ]
Burgio 2006 32/53 40/51 19.8 % 0.77 [ 0.59, 1.00 ]
Filocamo 2005 115/150 129/150 56.1 % 0.89 [ 0.80, 0.99 ]
Mathewson-Chapman 97 1/27 0/24 0.2 % 2.68 [ 0.11, 62.81 ]
Overgard 2008 19/35 23/40 9.4 % 0.94 [ 0.63, 1.41 ]
Parekh 2003 4/19 7/19 1.5 % 0.57 [ 0.20, 1.63 ]
Tienforti 2012 8/16 15/16 6.3 % 0.53 [ 0.32, 0.88 ]
Subtotal (95% CI) 347 350 100.0 % 0.85 [ 0.75, 0.97 ]
Total events: 199 (PFMT +/- BF), 233 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 6.92, df = 6 (P = 0.33); I2 =13%
Test for overall effect: Z = 2.39 (P = 0.017)
3 within 6-12 months
Bales 2000 3/47 2/50 4.4 % 1.60 [ 0.28, 9.13 ]
Burgio 2006 22/51 30/50 26.4 % 0.72 [ 0.49, 1.06 ]
Filocamo 2005 35/150 102/150 29.2 % 0.34 [ 0.25, 0.47 ]
Overgard 2008 7/34 16/38 15.2 % 0.49 [ 0.23, 1.04 ]
Parekh 2003 3/19 4/19 6.7 % 0.75 [ 0.19, 2.91 ]
Tienforti 2012 6/16 15/16 18.1 % 0.40 [ 0.21, 0.76 ]
Subtotal (95% CI) 317 323 100.0 % 0.51 [ 0.35, 0.75 ]
Total events: 76 (PFMT +/- BF), 169 (Control)
Heterogeneity: Tau2 = 0.11; Chi2 = 11.24, df = 5 (P = 0.05); I2 =56%
Test for overall effect: Z = 3.38 (P = 0.00071)
4 after 12 months
Filocamo 2005 16/150 49/148 84.2 % 0.32 [ 0.19, 0.54 ]
Overgard 2008 3/36 11/39 15.8 % 0.30 [ 0.09, 0.97 ]
Subtotal (95% CI) 186 187 100.0 % 0.32 [ 0.20, 0.51 ]
Total events: 19 (PFMT +/- BF), 60 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 4.74 (P < 0.00001)
0.5 0.7 1 1.5 2
Favours treatment Favours control
188Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 6.2. Comparison 6 Prevention of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 2 Pad changes over 24 hours.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 6 Prevention of UI after radical: PFMT biofeedback versus no treatment
Outcome: 2 Pad changes over 24 hours
Study or subgroup PFMT +/- BF Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 less than 3 months
Mathewson-Chapman 97 27 1.1 (2.1) 24 2.04 (2.7) -0.94 [ -2.28, 0.40 ]
2 within 3-6 months
Mathewson-Chapman 97 27 0.6 (1.6) 24 1.8 (2.7) -1.20 [ -2.44, 0.04 ]
3 within 6 - 12 months
Mathewson-Chapman 97 27 0.6 (1.6) 24 1.8 (2.7) -1.20 [ -2.44, 0.04 ]
-4 -2 0 2 4
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Analysis 6.3. Comparison 6 Prevention of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 3 1 hour pad test (grams of urine lost).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 6 Prevention of UI after radical: PFMT biofeedback versus no treatment
Outcome: 3 1 hour pad test (grams of urine lost)
Study or subgroup
Favours
[experi-
mental] Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Less than 3 months
Laurienzo 2013 17 29.5 (35.8) 15 17.6 (38.5) 11.90 [ -13.97, 37.77 ]
2 Within 3-6 months
Laurienzo 2013 17 11.8 (28.4) 15 14.3 (34.4) -2.50 [ -24.53, 19.53 ]
3 Within 6-12 months
Laurienzo 2013 17 25.3 (59) 15 5.5 (14.16) 19.80 [ -9.15, 48.75 ]
-100 -50 0 50 100
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Analysis 6.4. Comparison 6 Prevention of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 4 24 hour pad test (gm/24hrs).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 6 Prevention of UI after radical: PFMT biofeedback versus no treatment
Outcome: 4 24 hour pad test (gm/24hrs)
Study or subgroup PFMT +/- BF Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 less than 3 months
Filocamo 2005 150 53.6 (41) 150 63.8 (38.1) 41.8 % -10.20 [ -19.16, -1.24 ]
Mathewson-Chapman 97 27 120.4 (249.2) 24 126 (215.6) 30.3 % -5.60 [ -133.18, 121.98 ]
Ribeiro 2008 36 96 (160) 37 355 (423) 27.9 % -259.00 [ -404.97, -113.03 ]
Subtotal (95% CI) 213 211 100.0 % -78.19 [ -211.46, 55.07 ]
Heterogeneity: Tau2 = 11030.98; Chi2 = 11.12, df = 2 (P = 0.004); I2 =82%
Test for overall effect: Z = 1.15 (P = 0.25)
2 within 3-6 months
Filocamo 2005 150 13.2 (13.9) 150 32.2 (29.5) 57.3 % -19.00 [ -24.22, -13.78 ]
Ribeiro 2008 36 51 (119) 37 197 (269) 42.7 % -146.00 [ -240.99, -51.01 ]
Subtotal (95% CI) 186 187 100.0 % -73.28 [ -196.42, 49.86 ]
Heterogeneity: Tau2 = 6886.42; Chi2 = 6.85, df = 1 (P = 0.01); I2 =85%
Test for overall effect: Z = 1.17 (P = 0.24)
3 within 6-12 months
Filocamo 2005 150 3.4 (4.8) 150 17.8 (23.7) 99.6 % -14.40 [ -18.27, -10.53 ]
Ribeiro 2008 36 40 (77) 37 80 (176) 0.4 % -40.00 [ -102.04, 22.04 ]
Subtotal (95% CI) 186 187 100.0 % -14.50 [ -18.36, -10.64 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.65, df = 1 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 7.36 (P < 0.00001)
4 after first year
Filocamo 2005 150 1.4 (2.3) 148 2.4 (4.5) 100.0 % -1.00 [ -1.81, -0.19 ]
Overgard 2008 38 2 (0) 42 1 (0) Not estimable
Subtotal (95% CI) 188 190 100.0 % -1.00 [ -1.81, -0.19 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.41 (P = 0.016)
-200 -100 0 100 200
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Analysis 6.5. Comparison 6 Prevention of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 5 Number of incontinence episodes per day.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 6 Prevention of UI after radical: PFMT biofeedback versus no treatment
Outcome: 5 Number of incontinence episodes per day
Study or subgroup
PFMT +/-
biofeed-
back Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Tienforti 2012 16 1.43 (0.82) 16 2 (0.82) -0.57 [ -1.14, 0.00 ]
2 within 3-6 months
Tienforti 2012 16 0.57 (1.47) 16 2 (1.47) -1.43 [ -2.45, -0.41 ]
3 within 6-12 months
Tienforti 2012 16 0.43 (1.33) 16 1.86 (1.33) -1.43 [ -2.35, -0.51 ]
4 after first year
-4 -2 0 2 4
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Analysis 6.6. Comparison 6 Prevention of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 6 Urinary Incontinence Score (ICI-short form).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 6 Prevention of UI after radical: PFMT biofeedback versus no treatment
Outcome: 6 Urinary Incontinence Score (ICI-short form)
Study or subgroup PFMT +/- BF Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 less than 3 months
Laurienzo 2013 17 14 (3.6) 15 7.5 (5) 100.0 % 6.50 [ 3.45, 9.55 ]
Subtotal (95% CI) 17 15 100.0 % 6.50 [ 3.45, 9.55 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.17 (P = 0.000030)
2 within 3-6 months
Laurienzo 2013 17 6.9 (5.8) 15 5.4 (5.2) 44.7 % 1.50 [ -2.31, 5.31 ]
Ribeiro 2008 36 3.4 (3.7) 37 6.8 (5.6) 55.3 % -3.40 [ -5.57, -1.23 ]
Subtotal (95% CI) 53 52 100.0 % -1.21 [ -5.99, 3.56 ]
Heterogeneity: Tau2 = 9.50; Chi2 = 4.79, df = 1 (P = 0.03); I2 =79%
Test for overall effect: Z = 0.50 (P = 0.62)
3 within 6-12 months
Laurienzo 2013 17 4.8 (5.3) 15 3.7 (5.3) 33.8 % 1.10 [ -2.58, 4.78 ]
Ribeiro 2008 36 2.7 (3.5) 37 4.3 (5.5) 66.2 % -1.60 [ -3.71, 0.51 ]
Subtotal (95% CI) 53 52 100.0 % -0.69 [ -3.19, 1.81 ]
Heterogeneity: Tau2 = 1.30; Chi2 = 1.56, df = 1 (P = 0.21); I2 =36%
Test for overall effect: Z = 0.54 (P = 0.59)
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Analysis 6.7. Comparison 6 Prevention of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 7 Quality of Life Score (IIQ).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 6 Prevention of UI after radical: PFMT biofeedback versus no treatment
Outcome: 7 Quality of Life Score (IIQ)
Study or subgroup PFMT +/- BF Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
2 within 3-6 months
Ribeiro 2008 36 1.6 (2.7) 37 4.3 (6.2) -2.70 [ -4.88, -0.52 ]
3 within 6-12 months
4 after first year
-4 -2 0 2 4
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Analysis 6.8. Comparison 6 Prevention of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 8 Pelvic floor muscle strength (anal squeeze pressure, cm H2O).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 6 Prevention of UI after radical: PFMT biofeedback versus no treatment
Outcome: 8 Pelvic floor muscle strength (anal squeeze pressure, cm H2O)
Study or subgroup PFMT +/- BF Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
2 within 3-6 months
Overgard 2008 35 -50.7 (23.9) 40 -55.7 (25.6) 5.00 [ -6.21, 16.21 ]
3 within 6-12 months
Overgard 2008 34 -56.1 (21.7) 38 -65.8 (27) 9.70 [ -1.56, 20.96 ]
4 after first year
Overgard 2008 36 -64 (24) 39 -71.5 (26.2) 7.50 [ -3.86, 18.86 ]
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Analysis 6.9. Comparison 6 Prevention of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 9 Number of men not carrying out sufficient PFMT.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 6 Prevention of UI after radical: PFMT biofeedback versus no treatment
Outcome: 9 Number of men not carrying out sufficient PFMT
Study or subgroup PFMT +/- BF Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 less than 3 months
2 within 3-6 months
Overgard 2008 3/35 18/40 0.19 [ 0.06, 0.59 ]
3 within 6-12 months
Overgard 2008 12/34 21/36 0.61 [ 0.36, 1.03 ]
4 after 12 months
Overgard 2008 30/36 26/36 1.15 [ 0.90, 1.48 ]
0.02 0.1 1 10 50
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Analysis 6.10. Comparison 6 Prevention of UI after radical: PFMT ± biofeedback versus no treatment,
Outcome 10 Number of men having surgery for incontinence.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 6 Prevention of UI after radical: PFMT biofeedback versus no treatment
Outcome: 10 Number of men having surgery for incontinence
Study or subgroup PFMT +/- BF Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Filocamo 2005 2/150 3/148 0.66 [ 0.11, 3.88 ]
0.02 0.1 1 10 50
Favours experimental Favours control
Analysis 7.1. Comparison 7 Prevention of UI after radical: electric or magnetic energy versus no treatment,
Outcome 1 1 hour pad test (grams of urine lost).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 7 Prevention of UI after radical: electric or magnetic energy versus no treatment
Outcome: 1 1 hour pad test (grams of urine lost)
Study or subgroup EStim Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Less than 3 months
Laurienzo 2013 17 25.5 (35.4) 15 17.6 (38.5) 7.90 [ -17.84, 33.64 ]
2 Within 3-6 months
Laurienzo 2013 17 9.6 (18.8) 15 14.3 (34.4) -4.70 [ -24.27, 14.87 ]
3 Within 6-12 months
Laurienzo 2013 17 4.35 (7.3) 15 5.5 (14.16) -1.15 [ -9.11, 6.81 ]
-100 -50 0 50 100
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Analysis 7.2. Comparison 7 Prevention of UI after radical: electric or magnetic energy versus no treatment,
Outcome 2 ICIQ-SF score.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 7 Prevention of UI after radical: electric or magnetic energy versus no treatment
Outcome: 2 ICIQ-SF score
Study or subgroup EStim Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Less than 3 months
Laurienzo 2013 17 9.6 (6.3) 15 7.5 (5) 2.10 [ -1.82, 6.02 ]
2 Within 3-6 months
Laurienzo 2013 17 7.2 (6.4) 15 5.4 (5.2) 1.80 [ -2.22, 5.82 ]
3 Within 6-12 months
Laurienzo 2013 17 5.3 (5.5) 15 3.7 (5.3) 1.60 [ -2.15, 5.35 ]
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Analysis 9.1. Comparison 9 Prevention of UI after radical: combinations of treatments versus no treatment,
Outcome 1 Number of incontinent men within 3 to 6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 9 Prevention of UI after radical: combinations of treatments versus no treatment
Outcome: 1 Number of incontinent men within 3 to 6 months
Study or subgroup Intervention
No
treatment
control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT + anal Estim + Biofeedback versus no treatment/sham treatment
Mariotti 2009 6/30 20/30 0.30 [ 0.14, 0.64 ]
0.01 0.1 1 10 100
Favours intervention Favours no treatment
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Analysis 9.2. Comparison 9 Prevention of UI after radical: combinations of treatments versus no treatment,
Outcome 2 Number of incontinent men within 6 to 12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 9 Prevention of UI after radical: combinations of treatments versus no treatment
Outcome: 2 Number of incontinent men within 6 to 12 months
Study or subgroup Intervention
No
treatment
control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT + anal Estim + biofeedback versus no treatment
Mariotti 2009 1/30 10/30 0.10 [ 0.01, 0.73 ]
0.002 0.1 1 10 500
Favours intervention Favours no treatment
Analysis 9.3. Comparison 9 Prevention of UI after radical: combinations of treatments versus no treatment,
Outcome 3 24 hour pad test (grams of urine lost) within 3 to 6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 9 Prevention of UI after radical: combinations of treatments versus no treatment
Outcome: 3 24 hour pad test (grams of urine lost) within 3 to 6 months
Study or subgroup Intervention
No
treatment
control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + anal Estim + Biofeedback versus no treatment/sham treatment
Mariotti 2009 30 6.7 (30.6) 30 136.7 (152.6) -130.00 [ -185.69, -74.31 ]
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Analysis 9.4. Comparison 9 Prevention of UI after radical: combinations of treatments versus no treatment,
Outcome 4 24 hour pad test (grams of urine lost) 6 to 12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 9 Prevention of UI after radical: combinations of treatments versus no treatment
Outcome: 4 24 hour pad test (grams of urine lost) 6 to 12 months
Study or subgroup Intervention
No
treatment
control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + anal Estim + Biofeedback versus no treatment/sham treatment
Mariotti 2009 30 3.5 (14.7) 30 27.8 (56) -24.30 [ -45.02, -3.58 ]
-100 -50 0 50 100
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Analysis 9.5. Comparison 9 Prevention of UI after radical: combinations of treatments versus no treatment,
Outcome 5 Time until continent (months).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 9 Prevention of UI after radical: combinations of treatments versus no treatment
Outcome: 5 Time until continent (months)
Study or subgroup Intervention
No
treatment
control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + anal Estim + Biofeedback versus no treatment/sham treatment
Mariotti 2009 30 2 (1.6) 30 3.5 (2.1) -1.50 [ -2.44, -0.56 ]
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Analysis 10.1. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 1 Number of incontinent men at < 3months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 1 Number of incontinent men at < 3months
Study or subgroup Treatment A Treatment B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT pre and post op vs PFMT post op
Centemero 2009 33/59 47/59 57.5 % 0.70 [ 0.54, 0.91 ]
Geraerts 2013 37/85 35/86 42.5 % 1.07 [ 0.75, 1.52 ]
Subtotal (95% CI) 144 145 100.0 % 0.86 [ 0.69, 1.06 ]
Total events: 70 (Treatment A), 82 (Treatment B)
Heterogeneity: Chi2 = 3.79, df = 1 (P = 0.05); I2 =74%
Test for overall effect: Z = 1.39 (P = 0.16)
2 PFMT + Biofeedback + transcutaneous Estim versus Estim only
Ahmed 2012 18/28 19/26 100.0 % 0.88 [ 0.61, 1.26 ]
Subtotal (95% CI) 28 26 100.0 % 0.88 [ 0.61, 1.26 ]
Total events: 18 (Treatment A), 19 (Treatment B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.70 (P = 0.49)
3 PFMT + Biofeedback + transcutaneous Estim versus post-op PFMT
Ahmed 2012 18/28 21/26 100.0 % 0.80 [ 0.57, 1.11 ]
Subtotal (95% CI) 28 26 100.0 % 0.80 [ 0.57, 1.11 ]
Total events: 18 (Treatment A), 21 (Treatment B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.34 (P = 0.18)
4 Post-op transcutaneous Estim versus post-op PFMT
Ahmed 2012 19/26 21/26 100.0 % 0.90 [ 0.67, 1.22 ]
Subtotal (95% CI) 26 26 100.0 % 0.90 [ 0.67, 1.22 ]
Total events: 19 (Treatment A), 21 (Treatment B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
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Analysis 10.2. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 2 Number of incontinent men within 3 to 6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 2 Number of incontinent men within 3 to 6 months
Study or subgroup Treatment A Treatment B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT pre and post op vs PFMT post op
Centemero 2009 24/59 37/59 71.2 % 0.65 [ 0.45, 0.93 ]
Geraerts 2013 15/86 15/86 28.8 % 1.00 [ 0.52, 1.92 ]
Subtotal (95% CI) 145 145 100.0 % 0.75 [ 0.54, 1.04 ]
Total events: 39 (Treatment A), 52 (Treatment B)
Heterogeneity: Chi2 = 1.36, df = 1 (P = 0.24); I2 =26%
Test for overall effect: Z = 1.74 (P = 0.082)
2 post-op PFMT + biofeedback + transcutaneous Estim vs post-op Estim
Ahmed 2012 20/28 12/26 100.0 % 1.55 [ 0.96, 2.49 ]
Subtotal (95% CI) 28 26 100.0 % 1.55 [ 0.96, 2.49 ]
Total events: 20 (Treatment A), 12 (Treatment B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.80 (P = 0.073)
3 PFMT + general exercise versus PFMT alone
Park 2012 7/26 13/23 100.0 % 0.48 [ 0.23, 0.99 ]
Subtotal (95% CI) 26 23 100.0 % 0.48 [ 0.23, 0.99 ]
Total events: 7 (Treatment A), 13 (Treatment B)
Heterogeneity: not applicable
Test for overall effect: Z = 2.00 (P = 0.046)
4 Post-op PFMT + transcutaneous Estim + Biofeedback versus post-op PFMT
Ahmed 2012 20/28 17/26 100.0 % 1.09 [ 0.76, 1.57 ]
Subtotal (95% CI) 28 26 100.0 % 1.09 [ 0.76, 1.57 ]
Total events: 20 (Treatment A), 17 (Treatment B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.47 (P = 0.63)
5 Post-op transcutaneous electrical stimulation versus post-op PFMT
Ahmed 2012 12/26 17/26 100.0 % 0.71 [ 0.43, 1.16 ]
Subtotal (95% CI) 26 26 100.0 % 0.71 [ 0.43, 1.16 ]
Total events: 12 (Treatment A), 17 (Treatment B)
Heterogeneity: not applicable
Test for overall effect: Z = 1.36 (P = 0.17)
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Analysis 10.3. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 3 Number of incontinent men within 6 to 12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 3 Number of incontinent men within 6 to 12 months
Study or subgroup Treatment A Treatment B Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT pre and post op vs PFMT post op
Geraerts 2013 8/86 5/85 1.58 [ 0.54, 4.64 ]
2 post-op PFMT + Biofeedback + transcutaneous Estim vs post-op Estim
Ahmed 2012 1/28 6/26 0.15 [ 0.02, 1.20 ]
3 Post-op PFMT + transcutaneous Estim + Biofeedback versus post-op PFMT
Ahmed 2012 1/28 9/26 0.10 [ 0.01, 0.76 ]
4 Post-op transcutaneous Estim versus post-op PFMT
Ahmed 2012 6/26 9/26 0.67 [ 0.28, 1.60 ]
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Analysis 10.4. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 4 Number of incontinent men after 12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 4 Number of incontinent men after 12 months
Study or subgroup Treatment A Treatment B Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT pre and post op vs PFMT post op
Dijkstra-Eshuis 2013 20/58 9/45 50.6 % 1.72 [ 0.87, 3.42 ]
Geraerts 2013 7/81 7/83 34.5 % 1.02 [ 0.38, 2.79 ]
Ghanem 2013 2/50 3/50 15.0 % 0.67 [ 0.12, 3.82 ]
Subtotal (95% CI) 189 178 100.0 % 1.32 [ 0.78, 2.25 ]
Total events: 29 (Treatment A), 19 (Treatment B)
Heterogeneity: Chi2 = 1.42, df = 2 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 1.04 (P = 0.30)
2 PFMT + Penile vibration pre and post op versus PFMT pre and post op
Fode 2014 3/30 2/28 100.0 % 1.40 [ 0.25, 7.77 ]
Subtotal (95% CI) 30 28 100.0 % 1.40 [ 0.25, 7.77 ]
Total events: 3 (Treatment A), 2 (Treatment B)
Heterogeneity: not applicable
Test for overall effect: Z = 0.38 (P = 0.70)
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Analysis 10.5. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 5 No. with severe incontinence (e.g. pad test weight >150g) at < 3 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 5 No. with severe incontinence (e.g. pad test weight >150g) at < 3 months
Study or subgroup Treatment A Treatment B Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT pre and post op vs PFMT post op
Centemero 2009 15/59 20/59 0.75 [ 0.43, 1.32 ]
0.5 0.7 1 1.5 2
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Analysis 10.6. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 6 No. with severe incontinence (e.g. pad test weight >150g) at 3 to 6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 6 No. with severe incontinence (e.g. pad test weight >150g) at 3 to 6 months
Study or subgroup Treatment A Treatment B Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT pre and post op vs PFMT post op
Centemero 2009 10/59 19/59 0.53 [ 0.27, 1.03 ]
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Analysis 10.7. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 7 20 minute pad test (grams of urine lost): within 3 to 6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 7 20 minute pad test (grams of urine lost): within 3 to 6 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + anal EStim vs PFMT alone
Wille 2003 26 4.7 (10) 27 9.74 (22.1) -5.04 [ -14.22, 4.14 ]
2 PFMT + anal EStim + BF vs PFMT alone
Wille 2003 26 4.45 (12.4) 27 9.74 (22.1) -5.29 [ -14.89, 4.31 ]
3 PFMT + anal EStim vs PFMT + anal EStim + BF
Wille 2003 26 4.7 (10) 26 4.45 (12.4) 0.25 [ -5.87, 6.37 ]
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Analysis 10.8. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 8 20 minute pad test (grams of urine lost): within 6 to 12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 8 20 minute pad test (grams of urine lost): within 6 to 12 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + anal EStim vs PFMT alone
Wille 2003 39 0.39 (0.5) 41 3.7 (9) -3.31 [ -6.07, -0.55 ]
2 PFMT + anal EStim + BF vs PFMT alone
Wille 2003 44 0.43 (0.66) 41 3.7 (9) -3.27 [ -6.03, -0.51 ]
3 PFMT + anal EStim vs PFMT + anal EStim + BF
Wille 2003 39 0.39 (0.5) 44 0.43 (0.66) -0.04 [ -0.29, 0.21 ]
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Analysis 10.9. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 9 1 hour pad test (grams of urine lost) at less than 3 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 9 1 hour pad test (grams of urine lost) at less than 3 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pre-op PFMT + Estim versus pre-op PFMT
Laurienzo 2013 17 25.5 (35.4) 17 29.5 (35.8) -4.00 [ -27.93, 19.93 ]
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Analysis 10.10. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 10 1 hour pad test (grams of urine lost) within 3-6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 10 1 hour pad test (grams of urine lost) within 3-6 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pre-op PFMT + electrical stimulation versus pre-op PFMT
Laurienzo 2013 17 9.6 (18.8) 17 11.8 (28.4) -2.20 [ -18.39, 13.99 ]
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Analysis 10.11. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 11 1 hour pad test within 6-12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 11 1 hour pad test within 6-12 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pre-op PFMT + electrical stimulation versus pre-op PFMT
Laurienzo 2013 17 4.35 (7.3) 17 25.3 (59) -20.95 [ -49.21, 7.31 ]
-100 -50 0 50 100
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Analysis 10.12. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 12 24 hour pad test (grams of urine lost) at less than 3 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 12 24 hour pad test (grams of urine lost) at less than 3 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + Biofeedback + transcutaneous Estim versus Estim only
Ahmed 2012 28 263 (145.87) 26 383 (145.87) -120.00 [ -197.87, -42.13 ]
2 Post-operative PFMT + transcutaneous Estim + Biofeedback versus post-operative PFMT
Ahmed 2012 28 263 (145.87) 26 533 (316.53) -270.00 [ -403.13, -136.87 ]
3 Post-operative transcutaneous electrical stimulation versus post-operative PFMT
Ahmed 2012 26 383 (145.87) 26 533 (316.53) -150.00 [ -283.97, -16.03 ]
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Analysis 10.13. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 13 24 hour pad test (grams of urine lost) within 3-6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 13 24 hour pad test (grams of urine lost) within 3-6 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + Biofeedback + transcutaneous Estim versus Estim only
Ahmed 2012 28 83 (145.87) 26 132 (145.87) -49.00 [ -126.87, 28.87 ]
2 Postoperative PFMT + biofeedback + transcutaneous Estim versus postoperative PFMT
Ahmed 2012 28 83 (145.87) 26 260 (216.53) -177.00 [ -276.23, -77.77 ]
3 Post-operative transcutaneous Estim only versus post-operative PFMT only
Ahmed 2012 26 132 (145.87) 26 260 (216.53) -128.00 [ -228.35, -27.65 ]
4 PFMT + general exercise versus PFMT alone
Park 2012 26 12.2 (14.5) 23 46.3 (31) -34.10 [ -47.94, -20.26 ]
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Analysis 10.14. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 14 24 hour pad test (grams of urine lost) within 6-12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 14 24 hour pad test (grams of urine lost) within 6-12 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT + transcutaneous Estim + biofeedback versus Estim only
Ahmed 2012 28 36 (95.87) 26 98 (105.87) -62.00 [ -116.01, -7.99 ]
2 Post-op PFMT + transcutaneous Estim + Biofeedback versus post-op PFMT
Ahmed 2012 28 36 (95.87) 26 123 (116.53) -87.00 [ -144.16, -29.84 ]
3 Post-op transcutaneous Estim versus post-op PFMT
Ahmed 2012 26 97.8 (105.87) 26 123 (116.53) -25.20 [ -85.72, 35.32 ]
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Analysis 10.15. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 15 Quality of Life Score (ICS male short form) at < 3 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 15 Quality of Life Score (ICS male short form) at < 3 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 PFMT pre and post op vs PFMT post op
Centemero 2009 59 14.6 (6.36) 59 18.3 (6.36) -3.70 [ -6.00, -1.40 ]
Laurienzo 2013 17 9.6 (6.3) 17 14 (3.6) -4.40 [ -7.85, -0.95 ]
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Analysis 10.16. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 16 Urinary Incontinence Quality of Life Score (ICIQ - short form) within 3-6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 16 Urinary Incontinence Quality of Life Score (ICIQ - short form) within 3-6 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pre-op PFMT + electrical stimulation versus pre-op PFMT
Laurienzo 2013 17 7.2 (6.4) 17 6.9 (5.8) 0.30 [ -3.81, 4.41 ]
2 PFMT + general exercise versus PFMT alone
Park 2012 26 6 (2.5) 23 10 (2.52) -4.00 [ -5.41, -2.59 ]
3 PFMT pre and post op vs PFMT post op
Centemero 2009 59 8.1 (7.04) 59 12.2 (7.04) -4.10 [ -6.64, -1.56 ]
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Analysis 10.17. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 17 Urinary Incontinence Quality of Life Score (ICIQ-short form) within 6-12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 17 Urinary Incontinence Quality of Life Score (ICIQ-short form) within 6-12 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pre-op PFMT + electrical stimulation versus pre-op PFMT
Laurienzo 2013 17 5.3 (5.5) 17 4.8 (5.3) 0.50 [ -3.13, 4.13 ]
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Analysis 10.18. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 18 King’s health Questionnaire after 12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 18 King’s health Questionnaire after 12 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 General Health
Dijkstra-Eshuis 2013 56 24.48 (50.7) 46 29.64 (50.7) -5.16 [ -24.93, 14.61 ]
2 Role limitations
Dijkstra-Eshuis 2013 56 21.36 (22.2) 46 17.73 (22.2) 3.63 [ -5.03, 12.29 ]
3 Physical limitations
Dijkstra-Eshuis 2013 56 16.49 (15.45) 46 13.48 (15.45) 3.01 [ -3.02, 9.04 ]
4 Social limitations
Dijkstra-Eshuis 2013 56 7.98 (24.8) 46 4.15 (24.8) 3.83 [ -5.84, 13.50 ]
5 Personal
Dijkstra-Eshuis 2013 56 18.72 (4.4) 46 19.62 (4.4) -0.90 [ -2.62, 0.82 ]
6 Emotional
Dijkstra-Eshuis 2013 56 5.08 (7) 46 4.24 (7) 0.84 [ -1.89, 3.57 ]
7 Sleep/energy disturbance
Dijkstra-Eshuis 2013 56 9.13 (39) 46 6.13 (39) 3.00 [ -12.21, 18.21 ]
8 Symptom severity
Dijkstra-Eshuis 2013 56 14.62 (86.1) 46 10.93 (86.1) 3.69 [ -29.89, 37.27 ]
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Analysis 10.19. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 19 Health status measure SF-36 within 3-6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 19 Health status measure SF-36 within 3-6 months
Study or subgroup Treatment A Treatment B
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Physical composite score
Park 2012 26 -57 (3.7) 23 -48 (4) -9.00 [ -11.17, -6.83 ]
2 Mental Composite score
Park 2012 26 -49 (1.6) 23 -46 (1.45) -3.00 [ -3.85, -2.15 ]
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Analysis 10.20. Comparison 10 Prevention of UI after radical: one active treatment versus another active
treatment, Outcome 20 Adverse events.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 10 Prevention of UI after radical: one active treatment versus another active treatment
Outcome: 20 Adverse events
Study or subgroup Treatment A Treatment B Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PFMT pre and post op vs PFMT post op
Dijkstra-Eshuis 2013 0/56 0/46 Not estimable
2 PFMT + Penile vibration pre and post op versus PFMT pre and post op
Fode 2014 5/30 0/38 13.84 [ 0.80, 240.77 ]
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Analysis 11.1. Comparison 11 Treatment of UI after TURP: PFMT ± biofeedback versus no treatment,
Outcome 1 Number of incontinent men.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 11 Treatment of UI after TURP: PFMT biofeedback versus no treatment
Outcome: 1 Number of incontinent men
Study or subgroup PFMT Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 less than 3 months
Glazener TURP 2011 142/205 132/208 1.09 [ 0.95, 1.25 ]
2 within 3-6 months
Glazener TURP 2011 140/199 129/201 1.10 [ 0.96, 1.26 ]
3 within 6-12 months
Glazener TURP 2011 133/197 131/202 1.04 [ 0.90, 1.20 ]
4 after 12 months
Glazener TURP 2011 126/194 125/203 1.05 [ 0.91, 1.23 ]
0.5 0.7 1 1.5 2
Favours PFMT Favours Control
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Analysis 11.2. Comparison 11 Treatment of UI after TURP: PFMT ± biofeedback versus no treatment,
Outcome 2 Number of incontinence episodes per day.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 11 Treatment of UI after TURP: PFMT biofeedback versus no treatment
Outcome: 2 Number of incontinence episodes per day
Study or subgroup
PFMT +/-
biofeed-
back Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Glazener TURP 2011 182 1.31 (2.2) 184 1.4 (2.5) -0.09 [ -0.57, 0.39 ]
2 within 3-6 months
Glazener TURP 2011 184 1.1 (2) 181 1.4 (2.6) -0.30 [ -0.78, 0.18 ]
3 within 6-12 months
Glazener TURP 2011 177 1.2 (2.5) 182 1.31 (2.3) -0.11 [ -0.61, 0.39 ]
4 after first year
Glazener TURP 2011 175 1.4 (2.3) 179 1.2 (2.2) 0.20 [ -0.27, 0.67 ]
-1 -0.5 0 0.5 1
Favours PFMT Favours control
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Analysis 11.3. Comparison 11 Treatment of UI after TURP: PFMT ± biofeedback versus no treatment,
Outcome 3 Number of men using pads.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 11 Treatment of UI after TURP: PFMT biofeedback versus no treatment
Outcome: 3 Number of men using pads
Study or subgroup
PFMT +/-
biofeed-
back Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 less than 3 months
Glazener TURP 2011 45/153 30/147 1.44 [ 0.96, 2.16 ]
2 within 3-6 months
Glazener TURP 2011 27/150 21/145 1.24 [ 0.74, 2.10 ]
3 within 6-12 months
Glazener TURP 2011 25/135 23/137 1.10 [ 0.66, 1.84 ]
4 after 12 months
Glazener TURP 2011 24/146 24/136 0.93 [ 0.56, 1.56 ]
0.5 0.7 1 1.5 2
Favours experimental Favours control
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Analysis 11.4. Comparison 11 Treatment of UI after TURP: PFMT ± biofeedback versus no treatment,
Outcome 4 Urinary Incontinence Score (ICI-short form).
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 11 Treatment of UI after TURP: PFMT biofeedback versus no treatment
Outcome: 4 Urinary Incontinence Score (ICI-short form)
Study or subgroup
PFMT +
extra
stimulation Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Glazener TURP 2011 201 4.6 (4) 203 4.6 (4.8) 0.0 [ -0.86, 0.86 ]
2 within 3-6 months
Glazener TURP 2011 199 4.1 (3.7) 201 4.1 (4.3) 0.0 [ -0.79, 0.79 ]
3 within 6-12 months
Glazener TURP 2011 193 4.2 (4) 198 4.1 (4.3) 0.10 [ -0.72, 0.92 ]
4 after first year
Glazener TURP 2011 194 3.9 (3.7) 203 4 (4.3) -0.10 [ -0.89, 0.69 ]
-1 -0.5 0 0.5 1
Favours PFMT + Estim Favours no treatment
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Analysis 11.5. Comparison 11 Treatment of UI after TURP: PFMT ± biofeedback versus no treatment,
Outcome 5 Quality of life related to urinary incontinence.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 11 Treatment of UI after TURP: PFMT biofeedback versus no treatment
Outcome: 5 Quality of life related to urinary incontinence
Study or subgroup
PFMT +/-
biofeed-
back Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 less than 3 months
Glazener TURP 2011 201 1.5 (2.1) 203 1.6 (2.5) -0.10 [ -0.55, 0.35 ]
2 within 3-6 months
Glazener TURP 2011 194 1.2 (1.9) 198 1.4 (2.3) -0.20 [ -0.62, 0.22 ]
3 within 6-12 months
Glazener TURP 2011 193 1.3 (2.2) 198 1.4 (2.3) -0.10 [ -0.55, 0.35 ]
4 after first year
Glazener TURP 2011 190 1.2 (1.9) 199 1.3 (2.2) -0.10 [ -0.51, 0.31 ]
-1 -0.5 0 0.5 1
Favours PFMT Favours control
Analysis 11.6. Comparison 11 Treatment of UI after TURP: PFMT ± biofeedback versus no treatment,
Outcome 6 Number of men not carrying out pelvic floor muscle contractions at 12 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 11 Treatment of UI after TURP: PFMT biofeedback versus no treatment
Outcome: 6 Number of men not carrying out pelvic floor muscle contractions at 12 months
Study or subgroup
PFMT +/-
biofeed-
back Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Glazener TURP 2011 66/188 154/193 0.44 [ 0.36, 0.54 ]
0.5 0.7 1 1.5 2
Favours experimental Favours control
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Analysis 16.1. Comparison 16 Prevention of UI after TURP: pre or post-operative PFMT ± biofeedback
versus no treatment, Outcome 1 Number of incontinent men.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 16 Prevention of UI after TURP: pre or post-operative PFMT biofeedback versus no treatment
Outcome: 1 Number of incontinent men
Study or subgroup
PFMT +/-
biofeed-
back
No
treatment
control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 less than 3 months
Porru 2001 1/30 3/28 41.2 % 0.31 [ 0.03, 2.82 ]
Tibaek 2007 4/26 4/21 58.8 % 0.81 [ 0.23, 2.85 ]
Subtotal (95% CI) 56 49 100.0 % 0.60 [ 0.21, 1.77 ]
Total events: 5 (PFMT +/- biofeedback), 7 (No treatment control)
Heterogeneity: Chi2 = 0.55, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.92 (P = 0.36)
2 within 3-6 months
Tibaek 2007 3/26 5/22 100.0 % 0.51 [ 0.14, 1.89 ]
Subtotal (95% CI) 26 22 100.0 % 0.51 [ 0.14, 1.89 ]
Total events: 3 (PFMT +/- biofeedback), 5 (No treatment control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.01 (P = 0.31)
0.01 0.1 1 10 100
Favours PFMT Favours no treatment
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Analysis 16.2. Comparison 16 Prevention of UI after TURP: pre or post-operative PFMT ± biofeedback
versus no treatment, Outcome 2 Health status measure SF-36 within 3-6 months.
Review: Conservative management for postprostatectomy urinary incontinence
Comparison: 16 Prevention of UI after TURP: pre or post-operative PFMT biofeedback versus no treatment
Outcome: 2 Health status measure SF-36 within 3-6 months
Study or subgroup
PFMT +/-
biofeed-
back
No
treatment
control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Physical component
Hou 2013 32 -54.86 (8.62) 29 -49.86 (11.23) -5.00 [ -10.06, 0.06 ]
2 Physical functioning
Hou 2013 32 -89.69 (17.13) 29 -85.82 (21.6) -3.87 [ -13.72, 5.98 ]
3 Body pain
Hou 2013 32 -93.66 (15.16) 29 -89.48 (22.71) -4.18 [ -13.97, 5.61 ]
4 General Health
Hou 2013 32 -82.03 (14.05) 29 -64.93 (27.16) -17.10 [ -28.12, -6.08 ]
5 Physical role limitation
Hou 2013 32 -68.75 (36.48) 29 -51.72 (38.92) -17.03 [ -36.01, 1.95 ]
6 Mental health component
Hou 2013 32 -56.21 (6.2) 29 -48.52 (11.94) -7.69 [ -12.54, -2.84 ]
7 Mental role limitation
Hou 2013 32 -93.75 (21.48) 29 -73.81 (37.8) -19.94 [ -35.58, -4.30 ]
8 Vitality
Hou 2013 32 -80.47 (13.16) 29 -64.14 (24.02) -16.33 [ -26.19, -6.47 ]
9 Mental health
Hou 2013 32 -88 (10.51) 29 -77.38 (18.68) -10.62 [ -18.33, -2.91 ]
10 Social functioning
Hou 2013 32 -90.63 (14.2) 29 -76.29 (29.57) -14.34 [ -26.17, -2.51 ]
-20 -10 0 10 20
Favours PFMT Favours no treatment
Analysis 21.1. Comparison 21 Containment of urinary incontinence from any cause: external penile
compression devices (penile clamps) versus no treatment, Outcome 1 Number of men satisfied with device.
Number of men satisfied with device
Study Control (no device) U-Tex C3 Cunningham
Moore 2004 0/12 0/12 2/12 10/12
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Analysis 21.2. Comparison 21 Containment of urinary incontinence from any cause: external penile
compression devices (penile clamps) versus no treatment, Outcome 2 Mean urine loss (grams of urine on pad
test).
Mean urine loss (grams of urine on pad test)
Study Control (no device) U-Tex C3 Cunningham
Moore 2004 122.8 gm (SD 130.8) 53.3 gm (SD 65.7)
P<0.05 vs Control (no de-
vice)
32.3 gm (SD 24.3)
P<0.05 vs Control (no de-
vice)
17.1 gm (SD 21.3)
P<0.05 vs Control (no de-
vice)
Analysis 21.3. Comparison 21 Containment of urinary incontinence from any cause: external penile
compression devices (penile clamps) versus no treatment, Outcome 3 Penile Doppler blood flow (mean
systolic velocity).
Penile Doppler blood flow (mean systolic velocity)
Study Control (no device) U-Tex C3 Cunningham
Moore 2004 N=12 men
R: 12.4 (SD 2.8)
L: 12.3 (SD 3.0)
N=12 men
R: 11.9 (SD 4.4)
L: 13.8 (SD 7.3)
N=12 men
R: 12.4 (SD 5.5)
L: 11.7 (SD 4.7)
N=12 men
R: 9.5 (SD 2.3)
L: 7.3 (SD 3.0)
P<0.05 vs Control (no de-
vice)
Analysis 21.4. Comparison 21 Containment of urinary incontinence from any cause: external penile
compression devices (penile clamps) versus no treatment, Outcome 4 Penile Doppler blood flow (mean
resistence to flow index).
Penile Doppler blood flow (mean resistence to flow index)
Study Control (no device) U-Tex C3 Cunningham
Moore 2004 N=12 men
R: 0.9 (SD 0.1)
L: 0.87 (SD 0.1)
N=12 men
R: 0.93 (SD 0.08)
L: 0.91 (SD 0.11)
N=12 men
R: 0.92 (SD 0.1)
L: 0.92 (SD 0.11)
N=12 men
R: 0.92 (SD 0.13)
L: 0.86 (SD 0.29)
A D D I T I O N A L T A B L E S
Table 1. Details of interventions
Study ID Intervention Control
Ahmed 2012 A: At catheter removal received standard care of ver-
bal and written instructions, instructed by physio-
therapist to perform 3 sets of 15-20 contractions
daily, for a duration of 3-5 seconds with a 6-10 sec-
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Table 1. Details of interventions (Continued)
ond rest period, encouraged to perform exercises
before functional activities such as sneezing, cough-
ing, or lifting weight, also in the supine position,
sitting, squatting and going up and down stairs
B: ES, treatment started one week after catheter re-
moval, patients received 15minutes of twice weekly
electrical stimulation for 12 weeks
C: PFMT + BFB + ES: Treatment started one
week after catheter removal, patients received twice
weekly treatment with 15 minutes of electrical
stimulation and 15 minutes of biofeedback for 12
weeks, instructed to perform 3 series of 10 rapid
contractions, 3 sustained contractions of 5, 7 or 10
seconds and then 10 contractions during prolonged
expiration in the supine position
All patients were given a logbook to complete daily
regarding self-report of exercises
Bales 2000 PFMT + biofeedback
45 minute session with nurse trained in biofeed-
back. Patients were instructed to perform graded
PFMT. Contractions of 5-10 seconds, 10-15 rep-
etitions were performed with biofeedback (surface
electrodes used to measure muscle strength). Ad-
vised to practice the exercises 4 times per day until
surgery
No biofeedback training
Written and brief verbal instructions from a nurse
onhow toperformPFMT(isolatemuscle that stops
urine flow, practice 4 times per day, 10-15 repeti-
tions)
Burgio 2006 PFMT + biofeedback
Single session of biofeedback (rectal probe to mea-
sure intra-abdominal rectal pressure and external
anal sphincter contraction) assisted behavioural
training. Feedback and verbal instruction used to
teach control of pelvic muscles. Taught to contract
sphincter during 2-10 seconds periods separated by
2-10 seconds of relaxation, dependent on ability
Written instructions for daily at home practice of
45 PFM exercises daily (3 sessions of 15 exercises
each time). Additionally instructed to slow or in-
terrupt voiding once daily. Encouraged to exercise
daily preoperatively, then resume when catheter re-
moved post-operatively
Usual care of brief verbal instructions post opera-
tively to interrupt the voiding stream plus any in-
struction from physician
Centemero 2009 Intervention A: PFMT both pre and post-opera-
tively. A structured PFMT program 30 and 15 days
before surgery, previous physiotherapist evaluation
to provide the patients with feedback about the
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Table 1. Details of interventions (Continued)
quality of pelvic floor muscle function, PC teste
(endurance and contraction quality), breathing co-
ordination, typify muscle contraction as tonic and
modify incorrect physical attitudes. This was also
repeated after the procedure
Intervention B: PFMT post-operatively only
Dijkstra-Eshuis 2013 30 mins of guided PFMT + biofeedback weekly
for 4 weeks before surgery, received written instruc-
tions to: carry out two sets of 30 contractions dur-
ing abdominal breathing, one breath between each
contraction; restart PFMT after catheter removal
(7-10 days after surgery)
All men were seen before surgery by a physiother-
apist, who explained relevant anatomy, anal visual
inspection and digital palpation, biofeedback reg-
istration with rectal probe, All patients received
PFMT + biofeedback or electrical stimulation, or
both, if still incontinent after 6 weeks
Received written instructions on PFMT after
catheter removal (7-10 days after surgery)
Dubbelman 2004 Nine or less sessions of physiotherapy guided pelvic
floor exercises after surgery
Exercise instruction through information folder
Filocamo 2005 Formal instruction (3 treatment sessions plus at
home exercises) in PFMT using verbal explanation,
palpation and visualization of the base of the penis
with a mirror, in different positions and prior to
sneezing, coughing or lifting
No formal instruction
Floratos 2002 Initiated after catheter removal, 15 treatment ses-
sions (3 times per week for 30 minutes) of PFMT
with EMG (surface) biofeedback in clinic
Instruction with verbal feedback and an informa-
tion pamphlet with instructions to perform PFMT
50-100 times daily at home
Fode 2014 Pre-operative session guided PFMT + instruction
on how to use penile vibratory stimulation de-
vice. Instructed to stimulate frenulum once daily,
10 seconds of stimulation then 10 second pause,
repeated 10 times for 1 week pre-operatively, in-
structed to restart stimulation after catheter re-
moval for 6 weeks
All men were offered a PDE5 inhibitor after 1
month post-operatively and also received telephone
contact to ensure compliance with treatment
Preoperative session guided PFMT
Franke 1998 Biofeedback (perineal patch EMG) enhanced
PFMT; exercise treatment sessions at 6, 7, 9, 11,
and 16 weeks post-operatively
No treatment.
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Table 1. Details of interventions (Continued)
Geraerts 2013 Intervention A: PFMT + biofeedback
30 mins of guided PFMT + biofeedback weekly
for 3 weeks before surgery. Patients were instructed
to carry out 60 contractions a day at home; con-
tract their pelvic floor while coughing, and sitting
down or getting up from a chair. Patients were also
instructed to restart PFMT on day 4 after surgery
while catheter was in situ
Intervention B: Instructed to start PFMT on the
day after catheter removal (e.g. 2-3 weeks after
surgery)
All men: Received weekly individual guided exer-
cise programme with digital or EMG biofeedback
after surgery. Advice was given on how to contract
pelvic floor muscles to prevent leakage during func-
tional activities. When patients carried out the in-
structed 60 contractions, they were asked to colour
in three squares in their diary to assess compliance
Ghanem 2013 Pre-operative PFMT for 2 weeks + postoperative
PFMT programme
Postoperative PFMT programme only
Goode 2009 Intervention A: Behavioural therapy with PFMT
for 8 weeks
Intervention B: Behavioural therapy with biofeed-
back and electrical stimulation for 8 weeks
Behavioural therapy consisted of pelvic floor mus-
cle exercises and bladder control strategies in both
groups
No treatment
Hoffman 2005 Intervention A: perineal EStim plus physiotherapy
(PFMT)
Intervention B: anal EStim plus physiotherapy
(PFMT)
PFMT alone
Hou 2013 Guided PFMT + biofeedback after catheter re-
moval (2 days post-operatively), instructed to: con-
tract pelvic muscles for 5 seconds and relax for 10
seconds. After discharge, patients were instructed
to carry out 5 mins of each PFE three times daily.
Patients also receivedmotivational telephone inter-
views once weekly
No description
Joseph 2000 Intervention A: Instruction in PFMT including
biofeedback with visual feedback as well as verbal
to assist in identifying and discriminating muscles
Intervention B: Instruction in PFMT, squeezing of
finger during digital rectal examination
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Table 1. Details of interventions (Continued)
Koo 2009 ExMI, treatment sessionswere for 20minutes twice
weekly for 8 weeks
PFMT alone
Laurienzo 2013 A (15): Standard treatment with verbal instructions
for PFMT
B (17): Pre-operative guided PFMT, with 10 phys-
iotherapy sessions: contractions of the pelvic floor
muscles for 5 seconds in “dorsal decubitus” position
for 10 times, in the same position with the waist
elevated (10 times), lying down with legs adducted
against a plastic ball performed 10 times and stand-
ing and flexing the hips to 60 (10 times)
C (17): Pre-operative PFMT + ES during 10 phys-
iotherapy sessions, ES was with an anal probe last-
ing 15 minutes in total, and men also received
guided PFMT and followed the same training
regime as above
Men did not receive treatment post-operatively
Instructed to start PFMT at home 15 weeks before
surgery.
Liu 2008 Extra-corporeal magnetic innervation (ExMI), the
frequency of the pulse field was 10Hz for 10 min-
utes, followed by a 3minute rest and a second treat-
ment of 50 Hz for 20 minutes. This was done twice
a week
PFMT alone, instructions given to carry out
20mins x 3 a day
Manassero 2007 PFMT re-education program, verbal feedback
The training program involved active PFE. verbal
feedback of the contraction was used to instruct the
patients to correctly and selectively contract their
pelvic muscles while relaxing the abdominal mus-
cles. the strength of the pelvic floor muscles was
measured by digital anal control using a score of
0 to 5 ( 0 = no contraction, 5 = good contraction
against strong resistance)
Initially home practice comprised 45 contractions
(3 sessions of 15) per day at home, progressively
increasing the number until 90 per day. This was
taught by two experienced urologists
No treatment.
Marchiori 2010 Guided PFMT + biofeedback during first session,
second session involved 10 sets of pelvic floor elec-
trical stimulation lasting 15 mins each, instructed
to: carry out three sets of 30 contractions a day at
home for the first month after catheter removal (16
days after surgery)
All men received oral and written information on
pelvic floor anatomy and on PFME, pelvic floor
muscle endurance assessed by digital anal control
Received oral and written information on pelvic
floor anatomy and on PFME, instructed to: per-
form 30 contractions a day at home for the first
month after catheter removal (16days after surgery)
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Table 1. Details of interventions (Continued)
Mariotti 2009 PFMT plus ES and biofeedback twice a week for 6
weeks
ES - a surface electrodes was inserted into the anus
and pulsed, the intensity was adequate to induce
visual lifting of the levator ani and pubococcygeus
muscle, considering the level of comfort to the pa-
tient
Biofeedback - via surface electrodes both perineal
and abdominally
Instructions to conduct PFMT - verbal and written
instructions at catheter removal and follow up visits
Martini 2011 PFMT: 5 sessions of guided PFMT for 2-3 weeks
pre-operatively and continued post-operatively
All men underwent clinical examination of pelvic
muscles function using digital perineal testing ac-
cording to “AIPDA score” and evaluation of void-
ing symptoms
Postoperative standard care, written instructions for
PFMT
Mathewson-Chapman 97 Pre-operatively received further instruction and
practice with PME protocol Home exercises and
biofeedback (anal probe) (Incare 8900); practiced
at home 3 times a week, starting with daily 15
PFMT and increasing by 10 every 4 weeks to a
maximum of 35 PFMT
Post-operatively no further interventions until
week 5 when pelvic muscle strength was assessed
Moore 1999 Intervention A: PFMT alone
Intervention B: PFMT plus rectal ES treated by
one physiotherapist 30 minutes twice a week for 12
weeks
Both included home exercises 3x/day gradually
working up to 30 minutes per session lying, stand-
ing, sitting; strength, endurance, speed and control
with maximum contractions of 5-10 seconds, 10-
20 second relaxation and 12-20 repetitions; sub-
maximum contractions at 65-75% of maximum
strength with hold 20-30 seconds and equal rest
time, 8-10 repetitions; speedwas sets of quick repet-
itive contractions in a 10 second time span; control
involved gradual recruitment tomaximumcontrac-
tion in 3 stages with 5 second hold at each stage
and a slow release with rest 15-30 seconds
oral and written information about PFMT pre and
post- operatively (standard treatment)
Moore 2004 Each participant had 4 periods (each lasted 1 day)
Group A: No device
Group B: C3 device
Group C: U-Tex device
Group D: Cunningham clamp
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Table 1. Details of interventions (Continued)
Moore 2008 Maximum 24 weekly, 30-minute treatment proto-
col (30min biofeedback-assisted PFMT) and home
exercise protocol of 2-3 times a day
Verbal and written information on PFME and
weekly telephone contact by a urology nurse
Morihiro 2011 PFMT + sacral surface therapeutic electrical stimu-
lation (ssTES), ssTES 2x a day for 15 minutes each,
lasting 1 month after catheter removal (day 5)
PFME only, carried out alone
Nowak 2007 Extra-corporeal magnetic innervation (EXMI)
based pelvic floor device
PFMT alone
Opsomer 1994; PFMT plus biofeedback plus electrical stimulation
directed by physiotherapist
PFMT on their own without medical supervision.
Overgard 2008; Instructions on PFMT and physiotherapy, 45 min-
utes weekly
Patients were instructed to perform 3 sets of con-
tractions daily at home, in either a supine, sitting or
standing position. Digital anal palpation to teach
correct contractions, as well as oral and written in-
structions
DVD of instructions given to those living too far
from hospital
Instructions on PFMT alone.
Parekh 2003 Two treatment sessions preoperatively. Session 1
consisted of PFMT in a hook lying position
Session 2 was on an exercise ball. Teaching meth-
ods varied and included verbal cues, visualization
with an anatomical model, palpation or biofeed-
backwith rectal probe. Post-operatively, PFMTwas
reviewed and participants were seen every 3 weeks
for 3 months by a physiotherapist
Home exercise for 6 months or more for those re-
quiring further physical therapy guidance
No formal education on PFMT pre-operatively,
telephone or face to face follow-up at least monthly
Park 2012 Patients performed Kegel exercises together with
other types of exercises which included resistance
training and pelvic flexibility. The intervention
started 3 weeks after surgery and lasted 12 weeks
Details of the combined exercise regime:
Post-operative weeks 1-4
1) Education about postoperative symptoms
2) PerformingKegel exercises, recognizing the para-
pelvic muscles
3) Pelvic floor flexibility fitness: performing pelvic
exercises while sitting on a ball
Post-operative weeks 5-8 (ball exercises)
1) Performing pelvic exercises while sitting on a ball
In the control group, only Kegel exercises were per-
formed
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Table 1. Details of interventions (Continued)
2) Performing lower extremity exercises while plac-
ing a ball on the wall
3) Lifting a heel on the ball while standing face-to-
face with the wall
4) Lifting up and down on the ball while spreading
and bending legs
5) Performing flank exercises while having a ball in
the hand
6) Squeezing the ball with the adductor muscles
while lying on a table
Post-operative weeks 9-12 (elastic band exercises)
1) Lifting the object with an elastic band lateral,
anterior, and posterior to the patient’s arms
2) Lifting the legs and then spreading them while
attaching an elastic band to the foot
Perissinotto 2008 Early pelvic floor rehabilitation program at home
twice dally, Kegel exercises
No formal PFMT
Porru 2001 Initial visit before surgery, digital evaluation of
pelvic muscle contraction strength. Verbal instruc-
tion, feedback and reinforcement on contraction
was given to teach selective contraction of anal
sphincter and relaxation of abdominal muscles.
Verbal and written instruction given for home
PFMT. Weekly digital anal reassessment and grad-
ing of pelvic muscle contraction by the therapist.
Instructed to practice contractions 45 times per day
(3 groups of 15 contractions)
Not specified
Ribeiro 2008 PFMT plus BF weekly for 3 months PFMT oral instructions only
Robinson 2008 Intervention A: Brief verbal instruction in PFMT
before operation and offer of one biofeedback ses-
sion at 2 months after surgery (uptake 33%) plus
PFMT for four weeks with biofeedback
Intervention B: Brief verbal instruction in PFMT
before operation and offer of one biofeedback ses-
sion at 2 months after surgery (uptake 46%)
Robinson 2009 Intervention A: routine brief verbal and written
PFMT plus one PFMT session and 3 weekly nurse
phone calls
Intervention B: routine brief verbal and written
PFMT plus four BF enhanced PFMT sessions and
4 weekly nurse phone calls
Routine brief verbal and written PFMT.
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Table 1. Details of interventions (Continued)
Seleme 2008 Verbal instruction and information on PFMT
plus information on life style changes. Additional
15 physiotherapy sessions consisting of intensive
PFMT with BF and ES
Verbal instruction and information on PFMT plus
information on life style changes
Tibaek 2007 One hour individual session with physiotherapist
to teach correct contraction for PFMT, three 1 hour
group lessons and home training programme
No pre operative physiotherapy. Information about
anatomy and physiology and verbal instructions for
2 to 3 days after TURP in the ward
Tienforti 2012 PFMT + biofeedback
Patients received guided PFMT + biofeedback + in-
formation about the anatomy of pelvic floor mus-
cles the day before surgery and after catheter re-
moval. They were also given oral and written in-
structions on Kegel exercises to be performed at
home which involved three sets of contractions
daily for 10 mins, contracting their pelvic floor
while lying, sitting and standing. The frequency of
contractions was recorded in a training diary and
visits at monthly intervals after catheter removal in-
volved assisted biofeedback and motivation for 20
min
No biofeedback training
Received standard care, oral and written instruc-
tions from urologist on PFMT, Instructed to: start
PFMT after catheter removal (e.g. 2-3 weeks after
surgery)
Tobia 2008 PFMT No PFMT
van Kampen 1998 1 session of PFMT in hospital before discharge and
then saw the physiotherapist for 1-2 weeks for as
long as UI persisted. 90 daily home exercises sit-
ting, standing and lying. 7 men unable to contract
PFM or with weak contraction received electrical
stimulation by anal probe
No formal PFMT instruction but saw the therapist
at 1-2 weeks and received placebo stimulation and
information about aetiology of UI
Wille 2003 Intervention A: PFMT alone
Intervention B: PFMT + ES; PFMT as above plus
instructed by dedicated in ES via surface anal elec-
trode and bio-impulser (biphasic pulse with 1 sec-
ond bursts, 5 second pulse width, 2 second pulse
trains
Intervention C: PFMT + ES + biofeedback. As
above plus biofeedback (anal probe) 15 minutes
twice daily for 3 months
All groups: PFMT by physiotherapist, 20-30
minute sessions for 3 days, instructed to perform
exercises twice daily for 3 months plus 3 week re-
habilitation program after dischargeRegular inter-
action with health professional for 6 weeks after
surgery, encouraged to performed treatment for 3
months post-surgery
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Table 1. Details of interventions (Continued)
Yamanishi 2006 Oral PFMT plus ES for 15 minutes twice daily
Instructed pre-operatively PFMT by nurses and
continued after catheter removal
Oral PFMT plus sham device.
Instructed pre-operatively PFMT by nurses and
continued after catheter removal
Yokoyama 2004 Intervention A: anal electrode for 15 minutes twice
a day for 1 month
Intervention B: extra-corporeal magnetic innerva-
tion, neocontrol system, treatment sessions 20min-
utes, twice a week for 2 weeks
PFMT, digital anal teaching of correct contractions,
then verbal and written instructions for home prac-
tice
Zhang 2007 PFMT plus BF using rectal electrical sensor, initial
45minute sessionwith physical therapist thenwrit-
ten instructions to carry out at home three times a
day for 10 minutes. Plus support group, 6meetings
in 3 months with a health psychologist
PFMT plus BF using rectal electrical sensor, initial
45minute sessionwith physical therapist thenwrit-
ten instructions to carry out at home three times a
day for 10 minutes
A P P E N D I C E S
Appendix 1. Searches performed for the previous versions of this review up to and including Hunter
2007
Details of the searches performed for previous versions of this review, up to and including 2007 (Hunter 2007) are given below.
Systematic searches of electronic bibliographic databases
MEDLINE (January 1966 to January 2006), EMBASE (January 1988 to January 2006), CINAHL (January 1982 to January 2006),
PsycLIT (January 1984 to January 2006), ERIC (January 1984 to January 2006)
The following electronic bibliographic databases were searched (date search was performed: 10 January 2006):
MEDLINE - dates searched: January 1966 to January 2006;
EMBASE - dates searched: January 1988 to January 2006;
PsycLIT - dates searched: January 1984 to January 2006;
CINAHL - dates searched: January 1982 to January 2006;
ERIC - dates searched: January 1984 to January 2006.
The following search terms were used in each database (no limits were applied to the searches):
incontinence, urinary, male, postprostatectomy, stimulation, electrical stimulation, biofeedback, pelvic muscle exercises, Kegel exercises,
behavioural, behaviour, behavior, therapy, behaviour modification, therapy, physiotherapy, lifestyle, weight loss, caffeine, smoking,
extracorporeal magnetic innervation, external penile compression devices, continence, bladder control, quality of life, randomised
(randomized) controlled trial, evaluation, effectiveness, efficacy, outcomes.
Handsearching of conference proceedings
The following conference proceedings were handsearched:
• American Urological Association (years searched: 1989-2005) Supplement to the Journal of Urology, published as a supplement.
• Society of Urologic Nurses and Associates (SUNA) (formerly American Urologic Association Allied) these abstracts are not
published but are available in the SUNA office. Annual meeting (years searched: 1991 to 2003);1991-Las Vegas, NV; 1992-
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Washington, DC; 1993-San Antonio, TX; 1994-San Francisco, CA; 1995-Las Vegas,NV; 1996-Orlando, FL, 1997-New Orleans,
LA. Biannual incontinence meeting: 1992-Tampa, Fla (1st meeting), 1994-Phoenix, 1996-Dallas, 1998-Orlando, 2000-Nashville,
2004-Chicago, 2006-NYC; Understanding urodynamics seminar:1993-Denver, CO; 1994-San Antonio, TX; 1995-Cleveland, OH;
1996-St Louis, MO.
• Wound Ostomy and Continence Nurses (years searched: 1996, 1997,1999 to 2006). Annual meeting: 1996- Seattle, WA; 1997-
Nashville, TN; Incontinence meeting (biannual); 1997-Beverly Hills (1st meeting); 1999-Austin, TX. (No further Incontinence
meetings.)
• International Continence Society (years searched: 1980 to 2006). Published proceedings in Neurourology and Urodynamics.
Appendix 2. Searches performed for the previous version of this review (Campbell 2012)
Extra specific searches (additional to the Specialised Register search) were performed for previous version of the review (Campbell
2012). These are detailed below:
• CINAHL on EBSCO (January 1982 to 20 November 2009) was searched on 7 December 2009;
• EMBASE on Ovid (January 1980 to Week 48 2009) was searched on 3 December 2009.
The search strategies used to search these databases can be found below:
CINAHL on EBSCO (January 1982 to 20 November 2009) was searched on 7 December 2009:
S38 S31 and S35 and S37
S37 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19
or S20 or S21 or S36
S36 TI ( singl* N25 blind* OR singl* N25 mask* OR doubl* N25 blind* or doubl* N25 mask* OR trebl* N25 blind* OR trebl*
N25 mask*OR tripl* N25 blind* OR tripl* N25 mask* ) or AB ( singl* N25 blind* OR singl* N25 mask* OR doubl* N25
blind* or doubl* N25 mask* OR trebl* N25 blind* OR trebl* N25 mask*OR tripl* N25 blind* OR tripl* N25 mask* )
S35 (S32 or S33 or S34)
S34 TI postprostat* OR AB postprostat*
S33 TI post-prostat* OR AB post-prostat*
S32 (MH “Prostatectomy”)
S31 (S22 or S23 or S24 or S25 or S26 or S27 or S28 or S29 or S30)
S30 AB overactive N3 bladder*
S29 TI overactive N3 bladder*
S28 AB urin* N3 leak*
S27 TI urin* N3 leak*
S26 AB incontinen* OR continen*
S25 TI incontinen* OR continen*
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(Continued)
S24 (MH “Incontinence”)
S23 (MH “Overactive Bladder”)
S22 (MH “Urinary Incontinence+”)
S21 (MH “Comparative Studies”)
S20 (MH “Clinical Research+”)
S19 (MH “Static Group Comparison”)
S18 (MH “Quantitative Studies”)
S17 (MH “Crossover Design”) or (MH “Solomon Four-Group Design”)
S16 (MH “Factorial Design”)
S15 (MH “Community Trials”)
S14 (MH “Random Sample”)
S13 TI balance* N2 block* or AB balance* N2 block*
S12 TI “latin square” or AB “latin square”
S11 TI factorial or AB factorial
S10 TI clin* N25 trial* or AB clin* N25 trial*
S9 (MH “Study Design”)
S8 (AB random*) OR (TI random*)
S7 (AB placebo*) OR (TI placebo*)
S6 (MH “Placebos”)
S5 PT Clinical Trial
S4 (MH “Clinical Trials+”)
S3 MH (random assignment) OR (crossover design)
S2 cross-over
S1 crossover
EMBASE on Ovid (January 1980 to Week 48 2009) was searched on 3 December 2009:
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1 Randomized Controlled Trial/
2 controlled study/
3 clinical study/
4 major clinical study/
5 prospective study/
6 meta analysis/
7 exp clinical trial/
8 randomization/
9 crossover procedure/ or double blind procedure/ or parallel design/ or single blind procedure/
10 Placebo/
11 latin square design/
12 exp comparative study/
13 follow up/
14 pilot study/
15 family study/ or feasibility study/ or pilot study/ or study/
16 placebo$.tw.
17 random$.tw.
18 (clin$ adj25 trial$).tw.
19 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).tw
20 factorial.tw.
21 crossover.tw.
22 latin square.tw.
23 (balance$ adj2 block$).tw.
24 factorial design/
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(Continued)
25 parallel design/
26 triple blind procedure/
27 community trial/
28 intervention study/
29 experimental study/
30 prevention study/
31 quasi experimental study/
32 or/1-31
33 (nonhuman not human).sh.
34 32 not 33
35 exp urine incontinence/
36 incontinence/
37 overactive bladder/
38 (incontinen$ or continen$).tw.
39 (urin$ adj2 leak$).tw.
40 (overactive adj2 bladder$).tw.
41 35 or 36 or 37 or 38 or 39 or 40
42 prostatectomy/
43 post-prostat$.tw.
44 postprostat$.tw.
45 42 or 43 or 44
46 electrostimulation/ or electrostimulation therapy/
47 stimulation.mp.
48 (electric$ adj2 stimulat$).tw.
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(Continued)
49 electrostimulat$.tw.
50 magnetotherapy/
51 exmi.tw.
52 (magnet$ adj2 (stimulat$ or innervat$)).tw.
53 feedback system/
54 biofeedback.tw.
55 pelvis floor/ or muscle training/ or pelvic floor muscle training/ or muscle exercise/ or muscle strength/
56 (pelvi$ adj5 (exercis$ or train$)).tw.
57 pfmt.tw.
58 pfe.tw.
59 (kegel adj2 exercis$).tw.
60 behavior therapy/
61 (behavio?r$ adj3 (therap$ or train$ or treat$)).tw.
62 physiotherapy/
63 home physiotherapy/ or physiotherapy practice/
64 physiotherapist/ or physiotherapist assistant/
65 physiotherap$.tw.
66 (physi$ adj3 (therap$ or treat$)).tw.
67 lifestyle/ or lifestyle modification/
68 (lifestyle$ adj3 (chang$ or modif$)).tw.
69 (life adj2 style$ adj3 (chang$ or modif$)).tw.
70 weight reduction/
71 (weight adj3 (los$ or reduc$)).tw.
72 caffeine/
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(Continued)
73 caffeine.tw.
74 smoking cessation/
75 smoking cessation.tw.
76 (peni$ adj3 (device$ or clamp$)).tw.
77 “quality of life”/
78 quality of life.tw.
79 or/46-78
80 34 and 41 and 45 and 79
Appendix 3. Searches performed for the current version of this review
Specific searches were also performed for this update of the review. These are detailed below:
• CENTRAL (on OvidSP) (2014, Issue 1) was searched on 26 February 2014;
• Embase (on OvidSP) (January 1980 to Week 3 2014) was searched on 20 January 2014;
• CINAHL (on EBSCOhost) (January 1982 to 18 January 2014) was searched on 22 January 2014;
• ClinicalTrials.gov (via the Cochrane Register of Studies (CRS) interface) and WHO ICTRP (both searched on 29 January 2014)
The search strategies used to search these databases can be found below:
CENTRAL (on OvidSP) (2014, Issue 1) was searched on 26 February 2014
1. exp urinary incontinence/
2. (incontinen$ or continen$).tw.
3. (urin$ adj2 leak$).tw.
4. or/1-3
5. prostate/
6. prostatectomy/
7. prostatic hyperplasia/
8. prostatic neoplasms/
9. prostatitis/
10. prostatic diseases/
11. prostat$.tw.
12. post-prostat$.tw.
13. postprostat$.tw.
14. or/5-13
15. 4 and 14
16. cochrane incontinence group.gc.
17. 15 not 16
EMBASE (on OvidSP) (January 1947 to Week 3 2014) was searched on 20 January 2014 and limited to entry month January 2010
to Week 3 2014 (using 201$.em.) as the Cochrane Collaboration searches EMBASE centrally and is currently bringing this search up
to date.
237Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
1 Randomized Controlled Trial/
2 controlled study/
3 clinical study/
4 major clinical study/
5 prospective study/
6 meta analysis/
7 exp clinical trial/
8 randomization/
9 crossover procedure/ or double blind procedure/ or parallel design/ or single blind procedure/
10 Placebo/
11 latin square design/
12 exp comparative study/
13 follow up/
14 pilot study/
15 family study/ or feasibility study/ or pilot study/ or study/
16 placebo$.tw.
17 random$.tw.
18 (clin$ adj25 trial$).tw.
19 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).tw
20 factorial.tw.
21 crossover.tw.
22 latin square.tw.
23 (balance$ adj2 block$).tw.
24 factorial design/
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(Continued)
25 parallel design/
26 triple blind procedure/
27 community trial/
28 intervention study/
29 experimental study/
30 prevention study/
31 quasi experimental study/
32 or/1-31
33 (nonhuman not human).sh.
34 32 not 33
35 exp urine incontinence/
36 incontinence/
37 overactive bladder/
38 (incontinen$ or continen$).tw.
39 (urin$ adj2 leak$).tw.
40 (overactive adj2 bladder$).tw.
41 35 or 36 or 37 or 38 or 39 or 40
42 prostatectomy/
43 post-prostat$.tw.
44 postprostat$.tw.
45 42 or 43 or 44
46 electrostimulation/ or electrostimulation therapy/
47 stimulation.mp.
48 (electric$ adj2 stimulat$).tw.
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(Continued)
49 electrostimulat$.tw.
50 magnetotherapy/
51 exmi.tw.
52 (magnet$ adj2 (stimulat$ or innervat$)).tw.
53 feedback system/
54 biofeedback.tw.
55 pelvis floor/ or muscle training/ or pelvic floor muscle training/ or muscle exercise/ or muscle strength/
56 (pelvi$ adj5 (exercis$ or train$)).tw.
57 pfmt.tw.
58 pfe.tw.
59 (kegel adj2 exercis$).tw.
60 behavior therapy/
61 (behavio?r$ adj3 (therap$ or train$ or treat$)).tw.
62 physiotherapy/
63 home physiotherapy/ or physiotherapy practice/
64 physiotherapist/ or physiotherapist assistant/
65 physiotherap$.tw.
66 (physi$ adj3 (therap$ or treat$)).tw.
67 lifestyle/ or lifestyle modification/
68 (lifestyle$ adj3 (chang$ or modif$)).tw.
69 (life adj2 style$ adj3 (chang$ or modif$)).tw.
70 weight reduction/
71 (weight adj3 (los$ or reduc$)).tw.
72 caffeine/
240Conservative management for postprostatectomy urinary incontinence (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
73 caffeine.tw.
74 smoking cessation/
75 smoking cessation.tw.
76 (peni$ adj3 (device$ or clamp$)).tw.
77 “quality of life”/
78 quality of life.tw.
79 or/46-78
80 34 and 41 and 45 and 79
CINAHL (on EBSCOhost) (January 1982 to 18 January 2014) was searched on 22 January 2014
S38 S31 and S35 and S37
S37 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or
S20 or S21 or S36
S36 TI ( singl* N25 blind* OR singl* N25 mask* OR doubl* N25 blind* or doubl* N25 mask* OR trebl* N25 blind* OR trebl*
N25 mask*OR tripl* N25 blind* OR tripl* N25 mask* ) or AB ( singl* N25 blind* OR singl* N25 mask* OR doubl* N25
blind* or doubl* N25 mask* OR trebl* N25 blind* OR trebl* N25 mask*OR tripl* N25 blind* OR tripl* N25 mask* )
S35 (S32 or S33 or S34)
S34 TI postprostat* OR AB postprostat*
S33 TI post-prostat* OR AB post-prostat*
S32 (MH “Prostatectomy”)
S31 (S22 or S23 or S24 or S25 or S26 or S27 or S28 or S29 or S30)
S30 AB overactive N3 bladder*
S29 TI overactive N3 bladder*
S28 AB urin* N3 leak*
S27 TI urin* N3 leak*
S26 AB incontinen* OR continen*
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(Continued)
S25 TI incontinen* OR continen*
S24 (MH “Incontinence”)
S23 (MH “Overactive Bladder”)
S22 (MH “Urinary Incontinence+”)
S21 (MH “Comparative Studies”)
S20 (MH “Clinical Research+”)
S19 (MH “Static Group Comparison”)
S18 (MH “Quantitative Studies”)
S17 (MH “Crossover Design”) or (MH “Solomon Four-Group Design”)
S16 (MH “Factorial Design”)
S15 (MH “Community Trials”)
S14 (MH “Random Sample”)
S13 TI balance* N2 block* or AB balance* N2 block*
S12 TI “latin square” or AB “latin square”
S11 TI factorial or AB factorial
S10 TI clin* N25 trial* or AB clin* N25 trial*
S9 (MH “Study Design”)
S8 (AB random*) OR (TI random*)
S7 (AB placebo*) OR (TI placebo*)
S6 (MH “Placebos”)
S5 (PT Clinical Trial) OR (PT “randomized controlled trial”)
S4 (MH “Clinical Trials+”)
S3 MH (random assignment) OR (crossover design)
S2 cross-over
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(Continued)
S1 crossover
ClinicalTrials.gov (via the Cochrane Register of Studies (CRS) interface) (searched on 29 January 2014)
(Continent OR continence OR incontinent OR incontinence OR overactive OR overactivity) AND (prostate OR prostatectomy OR
postprostatectomy OR prostatic OR prostatectomies OR prostatic OR prostatectomies OR postprostatectomies)
WHO ICTRP (searched on 29 January 2014)
Simple search with each of these lines searched and assessed separately:
Incontinent AND postprostatectomy
Incontinence AND postprostatectomy
Incontinent AND prostatectomy
Incontinence AND prostatectomy
WH A T ’ S N E W
Last assessed as up-to-date: 5 February 2014.
Date Event Description
26 January 2015 Amended Incorporated following sentence in the abstract “It seems unlikely that men benefit from one-to-one
PFMT therapy after TURP.”
H I S T O R Y
Protocol first published: Issue 3, 1998
Review first published: Issue 4, 1999
Date Event Description
19 January 2015 New citation required but conclusions have not
changed
In this update, the review authors have added 13
new trials (Ahmed 2012; Dijkstra-Eshuis 2013; Fader
2013; Fode 2014; Geraerts 2013; Ghanem 2013;
Hou 2013; Laurienzo 2013; Marchiori 2010; Martini
2011; Morihiro 2011; Park 2012; Tienforti 2012).
Risk of bias assessment was performed on all 50 trials
in accordance with the current methodology. Overall,
37/50 trials were also included in the previous update
(Campbell 2012) and 13/50 trials were identified in
this update. Quality of evidence was assessed by adopt-
ing the GRADE approach
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(Continued)
19 January 2015 New search has been performed In this update, the review authors have added 13
new trials (Ahmed 2012; Dijkstra-Eshuis 2013; Fader
2013; Fode 2014; Geraerts 2013; Ghanem 2013;
Hou 2013; Laurienzo 2013; Marchiori 2010; Martini
2011; Morihiro 2011; Park 2012; Tienforti 2012).
Risk of bias assessment was performed on all 50 trials
in accordance with the current methodology. Overall,
37/50 trials were also included in the previous update
(Campbell 2012) and 13/50 trials were identified in
this update. Quality of evidence was assessed by adopt-
ing the GRADE approach
24 August 2011 New search has been performed 18 new trials added
24 August 2011 New citation required and conclusions have changed In this update, 18 new trials have been added (of which
1 was a previously excluded trial). The total number
of trials included is now 37
16 September 2008 Amended Converted to new review format.
21 February 2007 New citation required and conclusions have changed Substantive amendment. In this update (Issue 2 2007)
, 7 trials were added to the review. The total number of
studies included was 17. In this update, comparisons
were separated on the basis of type of surgery and as
well whether the intervention occurred pre- or post-
operatively
25 February 2004 New citation required and conclusions have changed Substantive update Issue 2 2004. In this update, five
trials were added to the review. One trial previously
listed as included was excluded after attempts to con-
tact the author to access data were unsuccessful. The
total number of studies included was 10. 7 extra stud-
ies were excluded
23 January 2001 New citation required and conclusions have changed Substantive update Issue 2 2001
C O N T R I B U T I O N S O F A U T H O R S
For the updates in 2004 and 2006, the original lead review author (KNM) and an additional review author (KFH) independently
undertook the quality assessment, data extraction and collation. KFH took the lead in updating the text and completed the data entry,
which were then checked and commented upon by the other review authors.
For the earlier versions, two of the original review authors undertook the quality assessment of the trials and the data extraction
independently. This information was then collated and checked by the original lead review author (KNM) for agreement and, in the
few instances where this did not occur, consensus was reached after checking with the other review authors. For the 2004 and 2006
updates, KFH updated the text and entered the data. These were checked by the other review authors, whose additional comments
and edits were then incorporated.
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For the update in 2012, CG and SC undertook quality assessment and data abstraction for the 18 new included trials, revised the
previous data as appropriate, analysed the data and wrote the review text assisted by JC. All review authors contributed to writing or
editing the text of the review.
For this update in 2014, CA, MO and CG undertook abstract and full text screening. CA and CG performed data abstraction, cross-
checked by MO. CA, MO and CG performed risk of bias assessment of trials. Quality of evidence was assessed by CA and MO.
Previous data were updated, if necessary, and previously included trials were re-assessed with the additional risk of bias domains. CA
took the lead in drafting the manuscript of the review. All review authors contributed to the analysis of data and made comments and
suggestions on the manuscript, which were incorporated in the review.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Trials were reclassified as ’treatment’ or ’prevention’ trials in a previous version of this review, and hence trials amongst men having
radical prostatectomy or TURP were analysed separately. The trials of containment (penile clamps) were analysed separately from those
of PFMT and its variations.
In the current update, the GRADE method was used to assess quality of evidence.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
Biofeedback, Psychology; Electric Stimulation Therapy [methods]; Erectile Dysfunction [rehabilitation]; Exercise Therapy [methods];
Magnetic Field Therapy [methods]; Pelvic Floor; Prostatectomy [∗adverse effects]; Randomized Controlled Trials as Topic; Urinary
Incontinence [etiology; ∗therapy]
MeSH check words
Humans; Male
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